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Background 
The mere sight and smell of foods can trigger a response of our reward system, both on a 
hormonal and on a neural level (Smeets et al., 2010). Moreover, seeing and smelling a food increases 
desire to eat that specific type of food (Fedoroff et al., 2003; Ramaekers et al., 2016). High-energy, 
palatable foods can trigger food intake even in the absence of energy deficits. This food consumption 
for pleasure, mostly referred to as hedonic eating, can easily cause individuals to overeat and may 
therefore contribute to the development of obesity (Fulton, 2010). Given the rise in obesity rates 
and the health risks associated with being obese, hedonic eating and food reward are receiving 
considerable interest from the scientific community, with different disciplines being involved. 
Hedonic eating and food reward are highly complex biological processes, and many 
questions are still unresolved. Important factors to investigate include food choice behaviour and 
physiological responses to foods in healthy individuals. Furthermore, changes in behavioural and 
(neuro)physiological responses in patients who underwent gastric bypass surgery can provide more 
insight into alterations in food reward. 
The aim of this thesis is to add on to the existing knowledge on food reward. To this end, 
the phenomenon was approached from a behavioural and (neuro)physiological perspective in 
healthy and in gastric bypass populations. This introduction starts with a description of food reward, 
with a focus on three different perspectives: 1) behavioural, 2) physiological, and 3) 
neurophysiological. Focus will then be on changed food reward in obesity and the most effective 
treatment of obesity: gastric bypass surgery. Lastly, the aim and thesis outline are described. 
 
Food reward 
Food reward is elicited by, and fluctuates during the food intake cycle, which is often 
divided into an anticipatory, consummatory, and post-ingestive phase (see Figure 1.1; Kringelbach 
et al., 2012). Food anticipation occurs at regular eating times, that is, right before usual dinner time, 
and in response to the sight and smell of foods. Upon food consumption, the taste and mouth feel of 
a food are sensed. Post-ingestive consequences, related to the energy- and nutrient-content of a 
food, are noticeable after food consumption. Both the taste of a food and the post-ingestive 
consequences facilitate a learning process that steers food preferences and reward elicited by 
anticipation of foods (Kringelbach et al., 2012; Smeets et al., 2010). 
It is important to note that food reward comprises both food ‘wanting’ and food ‘liking’ 
(Berridge, 1996). Food wanting corresponds with desire to eat, or motivation to obtain a food, 
whereas food liking corresponds with a palatability, or pleasantness, response to a food (Berridge, 
1996; Mela, 2006). In animal studies, wanting was found to be predominantly related to dopamine 
activity in the mesocorticolimbic system. Liking is currently more considered to be related to opioid 
activity in limbic brain areas, including the nucleus accumbens shell (Havermans, 2011). 
Importantly, other mediators such as endocannabinoids and gut hormones also influence food 
reward (see e.g. Bewick, 2012; Jager and Witkamp, 2014; Kroemer et al., 2013). 
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Figure 1.1. Schematic overview of the food intake cycle (Based on Blundell et al., 2010; Kringelbach 
et al., 2012). Each stage of food intake, that is anticipation, consumption and post-ingestion, can 
elicit food reward. 
 
Behavioural perspective: food preferences 
An easy method to gain insight into food ‘wanting’ and food ‘liking’ is to use food preference 
questionnaires. Other methods include computerized food preference tasks. 
In food preference questionnaires, participants are asked to rate how much they like or how 
much they desire to eat different foods. The number of foods included in such questionnaires ranges 
from a small selection of specific foods to a wide range of over 300 food products to assess preferences 
for different food groups (Frank and Van der Klaauw, 1994; Geiselman et al., 1998). An example of 
a computerized task is the Leeds Food Preference Questionnaire (LFPQ; Finlayson et al., 2007). In 
the LFPQ, participants are forced to choose their preferred food between two food products from 
different categories, high- or low-fat and sweet or savoury. Other studies adopted different food 
categories, that is, high- or low-protein and sweet or savoury, or high- or low-energy and sweet or 
savoury (Griffioen-Roose et al., 2011; Ijpma et al., 2016; Zoon et al., 2014). At the start of this thesis, 
it was not possible to assess and compare preferences for a full range of macronutrients in one task 
(Ijpma et al., 2016), whereas this was considered essential for our studies. Therefore, in the current 
thesis, a new food preference task that includes multiple food categories and a forced-choice 
procedure was developed. This task was then used to assess food preference under different 
circumstances. 
 
Physiological perspective 
Anticipation of food intake triggers a so-called cephalic phase response (CPR), which serves 
to prepare the body to optimally digest and absorb nutrients (Smeets et al., 2010). Anticipation of 
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food intake can be triggered by the sight or smell of food, but also by learned triggers such as the 
time of day (Mattes, 1997). Several responses to anticipated food intake, such as salivation, gastric 
mobility and insulin release have been described (Mattes, 1997; Power and Schulkin, 2008; Smeets 
et al., 2010). In addition, exposure to the sight of food triggers a rise in ghrelin concentrations 
(Rigamonti et al., 2015; Schussler et al., 2012). Ghrelin is the only known orexigenic hormone, with 
levels rising in anticipation of food intake, and dropping after food intake (Cummings et al., 2001). 
Upon food entering the mouth, salivation increases more (Mattes, 1997) and mastication leads to 
increased concentrations of peptides such as insulin and pancreatic polypeptide (PP; Teff et al., 1991; 
Witteman et al., 1994). 
Often, modified sham-feeding is used as a method to study the CPR. In modified sham-
feeding, a food is chewed on, but instead of being swallowed, it is expectorated (Teff et al., 1991). 
Studies using modified sham-feeding have shown an effect of macronutrient content on release of 
different satiety hormones like PP (Witteman et al., 1994) and ghrelin (Zhu et al., 2014). Moreover, 
palatability has been found to modulate responses of PP and the endocannabinoid 2-
arachidonoylglycerol (2-AG; Mennella et al., 2015). At the start of this thesis, there was one 
published study that investigated the physiological response to actual food consumption of a 
palatable and a non-pleasurable food product. The results suggested a role for ghrelin and 2-AG in 
hedonic eating, or eating for pleasure, in humans (Monteleone et al., 2012). However, the sample 
size in that study was small (n=8) and the results might have been affected by expectations of food 
liking (Monteleone et al., 2012). This thesis extends the knowledge on the role of endocannabinoids, 
ghrelin and PP in food intake, by studying the response to consumption of palatable versus neutral 
foods where palatability was unknown until the first bite. 
 
Endocannabinoid system 
Endocannabinoids are part of the endocannabinoid system (ECS): a neuromodulatory 
system that comprises two cannabinoid receptors, CB1 and CB2, their endogenous ligands, the 
endocannabinoids of which anandamide (AEA) and 2-AG are best known, and the enzymes 
responsible for synthesis and degradation of the endocannabinoids (Howlett, 2002). The ECS plays 
an important role in food reward (Jager and Witkamp, 2014; Piazza et al., 2017). However, most 
studies into the role of the ECS in food reward have been performed in rodents. In animals, 
endocannabinoid stimulation enhances motivation to obtain palatable foods (Droste et al., 2010; 
Higgs et al., 2003) and liking of sweet and fatty foods (De Luca et al., 2012; O'Brien et al., 2013). 
Vice versa, endocannabinoid inhibition reduces liking of palatable foods (Droste et al., 2010; Higgs 
et al., 2003; O'Brien et al., 2013) and decreases total food intake (Chambers et al., 2007; Farrimond 
et al., 2012). Anecdotal evidence suggests that the use of Cannabis preparations increases food 
palatability and intake in humans (Abel, 1975; Foltin et al., 1988; Hart et al., 2002; Smit and Crespo, 
2001; Tart, 1970), a phenomenon colloquially known as ‘the munchies’. Furthermore, the CB1 
inverse agonist rimonabant decreases food intake (Pi-Sunyer et al., 2006; Van Gaal et al., 2005) and 
neural activation in reward-related brain areas in response to palatable food exposure (Horder et al., 
2010). To extend our knowledge on the role of the ECS in food reward in humans, effects of ECS 
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modulation on sweet taste intensity perception and liking, and food preferences are investigated in 
this thesis.  
 
Neurophysiological perspective: brain imaging 
Neurophysiological responses can also provide more insight into underlying mechanisms of 
food reward and therefore brain imaging studies have been performed. Often used paradigms are 
food versus non-food viewing paradigms (see e.g. Killgore et al., 2003; LaBar et al., 2001), which are 
suggested to signal food anticipation (McCrickerd and Forde, 2016). In general, these studies find 
increased activation in reward-related brain areas, including the orbitofrontal cortex, striatum and 
insula, for viewing of foods over non-foods. In addition, looking at pictures of high-energy foods 
elicits more activation than looking at pictures of low-energy foods (van der Laan et al., 2011). 
Other studies used odours to signal food anticipation. In these studies, an olfactometer was 
used to deliver specific odours for short periods of time, that is, seconds. Similar to looking at 
pictures, smelling food odours elicits more reward-related activation than smelling non-food odours 
(Frasnelli et al., 2015; Jiang et al., 2015). 
 
Neurophysiology in obesity 
Brain imaging studies showed increased activation in response to food in reward-related 
brain areas in obese compared to lean individuals (Patriarca et al., 2017), and it has often been 
suggested that obesity is the result of dysfunctional food reward processing (see e.g. Davis et al., 
2004; Nasser, 2001). This seems to be underlined by observations that dopamine signalling is 
impaired in obese individuals (Kroemer and Small, 2016). However, the functional outcomes of this 
impaired dopamine signalling remain debated. 
Some studies suggest that decreased dopamine signalling causes a lower reward response, 
that is, hyposensitivity to reward (Volkow et al., 2008). Obese individuals may increase their food 
intake to compensate for a reward deficit (Kenny, 2011; Stice et al., 2008a). Others suggest that obese 
individuals are hypersensitive to reward. The so-called reinforcement sensitivity model poses that 
obese individuals are more responsive to reward and therefore increase their food intake (Davis et 
al., 2004). Both models, that is, hypo- and hypersensitivity to reward, account for the hypothesis 
that obese individuals have a higher motivation to obtain food rewards (Mela, 2006), either to 
compensate for a reward deficit or as a result of increased reward sensitivity. In support of this 
hypothesis, it has been shown that willingness to work for a high-energy food reward is increased 
in obese compared to lean individuals (Giesen et al., 2010; Saelens and Epstein, 1996). In addition, 
attention for foods is increased in obese compared to lean individuals (Doolan et al., 2014; Hendrikse 
et al., 2015; Nijs et al., 2010). Importantly, obese individuals show a bias towards both high- and 
low-energy foods (Kemps and Tiggemann, 2015). 
 
Learnings from Roux-en-Y gastric bypass surgery  
Several studies suggest that weight loss induces changes in food preferences. In general, 
preference seem to shift away from highly palatable sweet and fatty foods to foods with lower sugar 
and lower fat content (Burgess et al., 2016; Ledikwe et al., 2007; Martin et al., 2011). However, not 
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all studies found a change (see for a review Mathes and Spector, 2012). Importantly, motivation to 
obtain food rewards is not changed after a weight-loss intervention (Cameron et al., 2008), but it is 
decreased after Roux-en-Y gastric bypass (RYGB) surgery (Miras et al., 2012).  
RYGB is currently regarded the most effective treatment to lose weight and to maintain 
weight loss (Buchwald et al., 2004; Gloy et al., 2013; Sjöström, 2013). After RYGB, patients often 
report decreased intake of foods high in carbohydrate and fat (Laurenius et al., 2013). As similar 
food intake behaviour has been found in animal studies (le Roux et al., 2011), this change in eating 
behaviour is likely caused by the effects of RYGB surgery, and not by dietary advice. In RYGB 
surgery, the stomach size is decreased by creating a small gastric pouch, which is then connected to 
the jejunum. After surgery, food bypasses the duodenum and proximal part of the jejunum (Hng 
and Ang, 2012). Both the smaller stomach and the bypass induce weight loss by lowering food intake 
and reducing absorption from the gastrointestinal tract (Ward and Prachand, 2009). Perhaps even 
more important for the effects of RYGB on food intake behaviour are changes in gut hormone 
responses (Pedersen, 2013). This is most likely related to the fact that receptors and feed-back 
mechanisms in the duodenum are no longer triggered by nutrients following food intake. 
Besides the reported changes in food choice, patients also indicate lower preference for 
high-energy foods after RYGB (Behary and Miras, 2015; Pedersen, 2013). When patients who 
underwent surgery are asked to indicate their desire to eat different foods, they indicate that desire 
to eat high-energy foods is decreased compared to the situation before surgery (Hansen et al., 2016; 
Meillon et al., 2013). This is underlined by changes observed in brain reward activation in response 
to food pictures (Ochner et al., 2012b). 
Although several studies assessed food intake, food liking and desire to eat after RYGB 
(Bueter et al., 2011; Cushing et al., 2013; Kruseman et al., 2010; Ochner et al., 2012b), no studies 
have assessed food choice in a forced-choice paradigm. The advantage of a forced-choice procedure 
is that it provides more insight into food preferences. An individual might like two foods equally, 
but show a preference when forced to choose between the two foods. The relative preference for 
one food over another can provide insight into motivation for the chosen food (Finlayson et al., 
2007; Finlayson et al., 2008). In this thesis, a ranking paradigm was used to assess food preferences 
before and after RYGB. Moreover, to gain insight into the mechanisms behind the behavioural 
changes, endocannabinoid and ghrelin plasma concentrations were assessed before and after 
surgery. We also report brain activation in response to viewing and engaging with high- and low-
energy food pictures and odours. 
 
Aims and thesis outline 
To better understand the changes in food preferences and food reward after weight loss and 
RYGB surgery, it is necessary to have in-depth understanding of the behavioural and 
(neuro)physiological mechanisms underlying food reward in healthy weight individuals. Such 
knowledge can guide research into altered food preferences and food reward. Eventually, a better 
understanding of the mechanisms behind changed food preferences might guide novel non-surgical 
interventions that are less invasive while bearing lower risks of complications. 
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Therefore, the overall aim of this thesis is to gain more insight into food reward by 
investigating it from a behavioural and (neuro)physiological perspective in healthy weight and in 
gastric bypass populations. To achieve this, we aim to answer three questions;  
1) Is it possible to develop a method to assess food preferences for four macronutrient and two taste 
categories? 
2) To what extent does modulation of the endocannabinoid system lead to measurable changes in 
food reward and hedonic eating in humans in an experimental setting and, vice versa, is it 
possible to measure peripheral (plasma) responses of the endocannabinoid system to palatable 
food intake from anticipation until two hours after consumption? 
3) What are the effects of Roux-en-Y gastric bypass surgery on food preferences and food reward? 
In chapter 2 a newly developed food preference task, the Macronutrient and Taste 
Preference Ranking Task (MTPRT), is described and the results of a validation study are shown. The 
MTPRT is the first task that employs a ranking procedure with pictures of food products to measure 
food preferences for four macronutrient categories, that is, carbohydrate, fat, protein and low 
energy, and for two tastes, that is, sweet and savoury. The MTPRT was used in chapters 3, 5 and 6 
in this thesis. In the study described in chapter 3, the aim is to determine whether stimulation and 
inhibition of the ECS modulate sweet taste intensity perception and liking. By using the MTPRT, 
effects of the treatments on food preferences were explored. In chapter 4, focus lays on the 
physiological response to consumption of a palatable and a neutral brownie. To this end, a complete 
profile of endocannabinoids, ghrelin and PP responses is measured during anticipatory, 
consummatory and post-ingestive phases up to two hours after ingestion. 
In chapters 5, 6 and 7, focus is on changes in food preferences and food reward after RYGB 
surgery. In chapter 5, the aim is to assess food preferences before, two months after and one year 
after RYGB. To this end, participants complete an online version of the MTPRT at the mentioned 
time points. In chapter 6, the underlying mechanisms of altered food preferences after RYGB are 
studied. Changes in reward-related brain activity in response to food odours and pictures are 
investigated, and a potential role for endocannabinoids and ghrelin in these changes is explored. In 
chapter 7, a food-specific go/no-go task is used to assess changes in neural responsivity during 
response inhibition. 
Lastly, the collective findings of these studies, methodological considerations and 
suggestions for future research are discussed in the general discussion. 
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Abstract 
Food preferences are for a large part determined by the macronutrient content and taste of foods, 
but may change depending on internal and external factors. Here, we discuss a newly developed 
food preference task, the Macronutrient and Taste Preference Ranking Task (MTPRT), in which 
participants rank groups of four food products according to how much they desire to eat the 
products. The MTPRT includes pictures of sweet and savoury food products from four categories: 
high-carbohydrate, high-fat, high-protein and low-energy. A within-subjects study on sensory-
specific satiety was conducted to assess the task’s reliability and validity. Sixty-nine healthy 
participants performed two test sessions that were at least one week apart. Participants ate either a 
sweet or a savoury meal, which were similar in macronutrient content. Before and after eating the 
meal participants rated appetite and completed the MTPRT. In hungry state, preference scores for 
all food categories were significantly correlated between the two test sessions (all r > 0.68, all p < 
0.001). Preference for sweet decreased after the sweet meal and increased after the savoury meal. In 
addition, preference for protein decreased more after consuming the savoury meal than it did after 
consuming the sweet meal. Preference for carbohydrate and fat decreased after meal consumption, 
regardless of taste. Preference for low-energy increased after meal consumption. These results show 
the MTPRT is a reliable and valid task for measuring food preferences. The MTPRT can be used for 
both hypothesis-driven and exploratory studies to examine the influence of different factors on 
changes in food preferences. 
  
17 
 
Introduction 
Sensory properties of foods play an important role in the preferences for and intake of food 
(McCrickerd and Forde, 2016). The basic tastes seem to have specific signalling functions for the 
body, in that sweet taste signals carbohydrates, and salty and savoury taste signals protein and 
electrolytes (Scott, 2008). Indeed, various studies have demonstrated relations between sugar 
content and sweetness, and between protein content and salty and umami taste (Lease et al., 2016; 
Martin et al., 2014; Viskaal Van Dongen et al., 2012). The body uses these signalling cues to maintain 
macronutrient balance. Studies have shown that a protein-depleted state elicits a higher preference 
and reward for and intake of savoury foods in order to restore protein status (Griffioen-Roose et al., 
2012b; Griffioen-Roose et al., 2014). Energy and macronutrient balance may be challenged in 
certain people, which may be related to changed preferences for foods. For instance after gastric 
bypass surgery preference for sweet and high-fat foods decreases (Miras et al., 2012; Pepino et al., 
2014), while other studies report an increased preference for high-protein foods (Ullrich et al., 
2013). In cancer patients undergoing chemotherapy, a reduced taste and smell function is frequently 
reported, which has consequences for food preferences and food intake (Boltong et al., 2014; Boltong 
et al., 2012; de Vries et al., 2016). However, it is important to note that also in the general population 
food preferences are influenced by many factors including the time of the day, the appropriateness 
of foods within a meal context and the meal eaten previously (Birch et al., 1984; De Graaf et al., 
1993; Griffioen-Roose et al., 2010). This multitude of factors that influence food preferences makes 
measuring food preferences a challenge. To better understand how food preferences can shift in 
different situations, it is essential to include macronutrient and taste composition when measuring 
food preferences. However, few methods are available that capture both macronutrient and taste 
composition and that are able to assess shifts in food preferences by these factors. 
A questionnaire that takes both macronutrient and taste composition into account is the 
macronutrient preference checklist (MPC). The MPC is a list of foods divided over four 
macronutrient categories, including both sweet and savoury products. Participants are instructed to 
check off all foods in the MPC that one would like to eat right at that moment (Brisbois-Clarkson 
et al., 2009; Hill 1986; Hill et al., 1987). This method results in frequencies of selected products from 
specific macronutrient or taste categories. Another method that includes different macronutrient 
and taste categories is the Leeds Food Preference Questionnaire (LFPQ; Finlayson et al., 2007). The 
questionnaire uses food pictures rather than words, which is of importance as visual cues are 
important factors in food selection and give input on the edibility, palatability and satiating 
properties of a food (McCrickerd and Forde, 2016). The LFPQ is a computer-based food preference 
task in which participants make forced choices between two food products from four different food 
categories. Thereby, products are not just rated on their own. Instead, products from different 
product categories are directly compared and relative preferences for food categories are measured. 
These relative preferences provide insight in motivation for the chosen food category over the non-
chosen food category (Finlayson et al., 2008). However, the LFPQ includes only two macronutrient-
based categories divided over sweet and savoury taste. In the original LFPQ, Finlayson and 
colleagues used high- and low-fat foods (Finlayson et al., 2007; Finlayson et al., 2008). Later studies 
adapted this to include high- and low-protein (Griffioen-Roose et al., 2011) and to high- and low-
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energy (Zoon et al., 2014). As it is essential to be able to assess preferences for a full range of 
macronutrients, we developed the Macronutrient and Taste Preference Ranking Task (MTPRT), 
which includes both macronutrient and taste categories. The task was developed based on the 
following criteria 1) foods included should be from multiple macronutrient categories and tastes, 2) 
the foods should be presented as pictures rather than words, and 3) should consist of a ranking 
paradigm in order to assess relative food preferences.  
The MTPRT consists of pictures of products from four macronutrient categories, i.e., high-
carbohydrate, high-fat, high-protein and low-energy, including both sweet and savoury products. 
Participants are asked to make rankings of four products based on how much they desire to eat the 
different products at that moment. These rankings are used to assess relative preferences for the four 
macronutrient categories and the two tastes sweet and savoury. In the current study we aim to show 
that the MTPRT is a reliable and valid task to measure food preferences: to demonstrate reliability 
of the task, we assessed test-retest reliability. To demonstrate validity of the task, we assessed the 
discriminative ability of the task by assessing sensory-specific satiety; after eating a food to satiety, 
the pleasantness of sensory properties of that food is decreased more than of foods that have not 
been eaten (Rolls et al., 1981). Based on previous studies we expect preference for sweet products to 
decrease after a sweet test meal and to increase after a savoury test meal. Furthermore we expect 
decreased preferences for high-carbohydrate and high-fat products after eating a meal in general, a 
decreased preference for high-protein products after a savoury test meal and an increased preference 
for low-energy products after eating a meal in general. 
 
Materials and methods 
Products and categories of the MTPRT 
A total of 32 food products from four macronutrient categories, i.e., high-carbohydrate, 
high-fat, high-protein and low-energy was used in the MTPRT. Each category contained eight 
products, of which four products were sweet and four were savoury. The high-protein category 
formed an exception and consisted of eight savoury products, as no products met all requirements 
to be included as high-protein sweet. A product had to meet the following requirements to be 
included in the MTPRT: 
 Commercially available. 
 High-fat, high-protein and high-carbohydrate foods contained at least 50% of total energy from 
their respective macronutrient category classification. 
 Low energy products contained less than 60 kcal/100 gram. 
Hill’s European MPC (Hill 1986; Hill et al., 1987) and Brisbois-Clarkson’s North American 
MPC (Brisbois-Clarkson et al., 2009) were used as starting point to select the food products. Products 
were replaced based on commercial availability in the Netherlands when needed. The Dutch Food 
Composition table was used to ensure appropriate macronutrient composition (RIVM, 2011). The 
final list of products including their respective nutritional values can be found in Supplementary 
Table 2.1.  
For the products that were included in the MTPRT, standardized pictures were provided by 
the Image Sciences Institute, UMC Utrecht, and created as part of the Full4Health project 
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(www.full4health.eu), funded by the European Union Seventh Framework Program (FP7/2007-
2013) under grant agreement nr. 266408, and the I.Family project (http://www.ifamilystudy.eu), 
grant agreement nr. 266044 (Charbonnier et al., 2015b). Pictures of foods were standardized by 
means of the plate on which products are presented, background colour, contrast, camera distance 
and angle (see Fig. 2.1 for examples). 
 
Task procedure 
The MTPRT consisted of three parts: practicing, liking and ranking.  
The practicing part was designed to familiarize participants with the ranking task. 
Participants were presented with four combinations of four pictures and asked to rank these pictures 
according to “what they most desire to eat at this moment”. The pictures used in the practicing part 
were not used in the main task and did not necessarily fit within one of the macronutrient 
categories. 
The liking part was designed to introduce participants to each product by name and picture. 
Liking was assessed by presenting pictures of all 32 products with the question: ‘How much do you 
like [product name]?’ which was rated on a 100 point visual analogue scale (VAS) anchored by ‘do 
not like at all’ and ‘like extremely’.  
The ranking part consisted of two sections, one focused on macronutrients the other on taste, i.e., 
sweet and savoury. In both sections, participants were presented with four different pictures, which 
they had to rank according to “what they most desire to eat at this moment” (Fig. 2.1). Participants 
first clicked on the product they most desired to eat at the moment of completing the task, then 
they clicked on the second most desired product, followed by the third and the product they least 
desired to eat at the moment of completing the task. In the macronutrient section, each of the four 
pictures represented one of the macronutrient categories. In total sixteen combinations of pictures 
were presented, in which each picture was shown twice. In the taste section, the four pictures that 
were presented came from two macronutrient categories. Within each category, one picture 
represented a sweet food item, and the other a savoury one. For example, one sweet product and 
one savoury product were high in carbohydrate and one sweet product and one savoury product 
were high in fat. In the taste section, products from the high-protein category were excluded, as 
this category only contained savoury products. In total twelve rankings were made in the taste 
section. As in the macronutrient section, each picture was shown twice. 
For both sections, the order in which categories were presented on the screen was 
randomized and balanced across trials. For the macronutrient section, this meant that each 
macronutrient appeared four times on each of the four available positions. The same picture never 
appeared on the same position within this section. In the taste section, both tastes appeared six times 
on each of the four available positions. All pictures were presented twice, on two different positions.  
The task took approximately 10 minutes to complete and was executed in E-Prime 2.0 
(Psychology Software Tools, Pittsburgh, PA). The MTPRT can also be executed in EyeQuestion 
software (Logic8 BV), which facilitates participants to complete the task online. 
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Figure 2.1. Lay-out of the macronutrient section (A) and taste section (B) of the MTPRT.  
 
Participants 
Healthy participants aged 18-35 years with a normal weight (BMI 18.5-25 kg/m2) were 
recruited. Exclusion criteria were restraint eating (DEBQ: men: >2.9, women >3.4; Van Strien et al., 
1986), lack of appetite, difficulties swallowing or eating, having taste or smell disorders (self-report), 
energy restricted diet two months prior to the study, weight loss or gain >5 kg during the two 
months prior to the study, being allergic or intolerant for the products under study, smoking, being 
vegetarian or vegan, and for women: being pregnant or lactating. 
Seventy-four participants were included in the study. Five participants were excluded from 
the analyses because they did not comply with study procedures. Analyses were done on data of the 
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remaining 69 participants (16 male/53 female) with an average age of 21.3 years (SD=2.9) and 
average BMI of 21.6 kg/m2 (SD=1.8). All participants received a financial compensation for 
participating. The study was exempt from formal ethical approval by the Medical ethical Committee 
of Wageningen University. All participants signed an informed consent form.  
 
Study design  
We used a randomized crossover design, in which participants were invited to attend two 
test sessions that were at least seven days apart. Participants were told that the purpose of the study 
was to examine the effect of a sweet and savoury lunch on preference for different food products. 
During both test sessions, participants were presented with either a sweet or a savoury test meal, 
the order of which was randomized and balanced across the participants. When participants arrived 
they were instructed to first fill out an appetite questionnaire with 5 questions, i.e., hunger, fullness, 
prospective consumption, appetite for something sweet and appetite for something savoury. 
Questions were rated on a 100 point VAS anchored by ‘not at all’ and ‘extremely’, except for 
prospective consumption which was anchored by ‘nothing at all’ and ‘a very large amount’. Next, 
participants completed the MTPRT, as described under ‘task procedure’. After finishing the MTPRT, 
participants were presented with the test meal and 150 ml water. They were instructed to finish the 
meal and water within 30 minutes. Next, participants rated the test meal for liking on a 100 point 
VAS anchored by ‘not at all’ and ‘extremely’ and completed the appetite ratings and MTPRT again. 
To standardize hunger feelings for all participants in both test sessions, participants were 
instructed to standardize their breakfast and morning physical activity on both test days. They were 
asked to refrain from eating and to drink only water or tea without sugar during the three hours 
prior to the test session. Test sessions started at 11:30, 11:45, 12:00, 13:00, 13:15 and 13:30 and lasted 
approximately one hour. Both test sessions started at the same time for each individual participant. 
 
Test meals 
Participants received a standard amount of each test meal based on their energy 
requirements as calculated by the Schofield formula(Schofield, 1985) with a physical activity level 
of 1.6. The test meal contained 18% of participant’s daily required energy intake, rounded to the 
nearest 50 kcal, which is 81% of the amount of energy provided by an average lunch in the 
Netherlands.(Hulshof et al., 2004) 
Energy and macronutrient composition were similar for both meals and are shown in Table 
2.1. The savoury meal consisted of risotto rice (Lassie, Wormer, The Netherlands) (65%), semi-
skimmed milk (17%), crème fraîche (11%), bouillon (0.3%), garlic powder (0.02%), salt (0.8%) and 
maltodextrin (Fantomalt, Nutricia, The Netherlands) (6%). The sweet meal consisted of risotto rice 
(64%), semi-skimmed milk (21%), water (4%), margarine (4%), cinnamon (0.08%), sucralose 
(0.05%) and maltodextrin (7%). A standard protocol was used to make fresh meals on each test day. 
Meals were kept warm with an average temperature of 81 °C (range 69-89 °C). 
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Table 2.1. Nutritional composition per 100 g of the sweet and savoury meal 
 Sweet meal Savoury meal 
Energy (kcal) 89 91 
Energy (kJ) 375 381 
Protein (g) 1.9 2 
Fat (g) 3.2 3.2 
Carbohydrates (g) 13.1 13.2 
Fibre (g) 0.2 0.2 
 
 
Data analysis 
Each product received a macronutrient preference score based on the place the product was 
ranked. The higher the rank, the higher the score. Scores for all 16 presentations added up to a total 
score that was divided by the 16 times a product from each category was presented. Preference 
scores can range from 1 to 4: 
𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑝𝑝𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟𝑟𝑟𝑟𝑟𝑝𝑝𝑝𝑝𝑟𝑟 𝑠𝑠𝑝𝑝𝑠𝑠𝑟𝑟𝑟𝑟 𝑚𝑚𝑟𝑟𝑝𝑝𝑟𝑟𝑠𝑠𝑝𝑝𝑚𝑚𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟
=
4 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 1) + 3 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 2) + 2 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 3) + 1 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 4)
16
 
Similarly a preference score was calculated based on taste rankings. As both sweet and 
savoury products were presented twice in all 12 rankings the ranks-based score is divided by 24 and 
this preference score can range from 1.5 to 3.5: 
 
𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑝𝑝𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟𝑟𝑟𝑟𝑟𝑝𝑝𝑝𝑝𝑟𝑟 𝑠𝑠𝑝𝑝𝑠𝑠𝑟𝑟𝑟𝑟 𝑠𝑠𝑠𝑠𝑟𝑟𝑟𝑟𝑟𝑟
=
4 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 1) + 3 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 2) + 2 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 3) + 1 ∗ (# 𝑟𝑟𝑟𝑟𝑝𝑝𝑟𝑟 4)
24
 
In case of no apparent preference for a specific category, all macronutrients would be ranked 
on each position twice and preference scores are 2.5.  
As the preference scores for sweet and savoury are each other’s opposites, i.e., savoury score 
= 5 - sweet score, we report only sweet preference scores in this article. 
Data are presented as means with standard deviation (SD) unless otherwise specified. Data 
was analysed using IBM SPSS 21 (IBM Corporation, Armonk, New York, USA). Results were 
considered statistically significant at p<0.05. 
To compare liking of both test meals a paired-samples T-test was conducted. Repeated 
measures ANOVA was used to analyse appetite ratings and the preference scores with hunger state 
(before and after a meal) and taste of the test meal (sweet and savoury) as factors. 
Non-parametric tests were used to determine relative preference for the different 
macronutrient and taste categories. To compare preference scores for macronutrient categories 
within conditions, e.g., before the sweet meal, Friedman ANOVA was used. Post-hoc analyses were 
done using Wilcoxon signed rank tests with Bonferroni correction. To determine relative preference 
for taste, sweet and savoury preference scores were compared using Wilcoxon signed rank tests. 
Pearson’s correlations were determined to assess reproducibility of food preferences measured with 
the MTPRT. 
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Liking scores were calculated by using the average liking rating within a category. These 
were analysed with repeated measures ANOVA to compare liking scores before and after the two 
different test meals. Post-hoc analyses were done using Bonferroni correction. 
 
Results 
Liking of test meals 
Average liking of the sweet test meal was 40.7 (SD=27.7), compared to 45.3 (SD=23.2) for 
the savoury meal. Liking of both meals did not differ significantly, T(1,68)=1.12, p=0.27. 
 
Appetite ratings 
Regardless of taste, eating a test meal decreased hunger, prospective consumption, appetite 
for something sweet and appetite for something savoury, but increased fullness (all p<0.001, Table 
2.2). The interaction between hunger state and taste of the test meal showed that appetite for 
something sweet decreased more after eating the sweet test meal than after eating the savoury test 
meal, F(1,68)=27.92, p<0.001. Similarly, appetite for something savoury decreased more after eating 
the savoury test meal than after eating the sweet test meal, F(1,68)=34.31, p<0.001. 
 
Table 2.2. Pre and post meal appetite ratings per type of meal 
 Sweet meal Savoury meal 
 Pre Post* Pre Post* 
Hunger 71±16 19±19 67±15 20±18 
Fullness 22±13 72±20 28±17 76±18 
Prospective consumption 66±14 27±20 64±15 25±19 
Appetite for sweet1 58±23 21±26 55±23 44±28 
Appetite for savoury1 73±15 48±24 68±18 23±22 
Ratings performed on a 100 point VAS. Values are means±SD. *Post meal ratings are significantly different 
from pre meal ratings. 1Significant difference between post meal ratings between sweet and savoury meal. 
 
Test-retest reliability of preference scores 
The preference scores in hungry state on the two test days did not significantly differ from 
each other (all p>0.05). In addition, these preference scores significantly correlated with each other 
within all macronutrient categories and the sweet category, r = 0.77, 0.68, 0.78, 0.69, 0.74 for high-
carbohydrate, high-fat, high-protein, low-energy, and sweet respectively, all p<0.001 (Fig. 2.2). 
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Figure 2.2. Correlation preference scores for sweet (A), high-carbohydrate (B), high-fat (C), high-
protein (D) and low-energy (E) products in hungry condition between test day 1 and test day 2.  
 
Food preferences 
Before consumption, preference scores for all categories did not differ between the sweet 
and savoury test meal conditions (all p>0.05). In both conditions, participants showed a relative 
preference for sweet over savoury (both p<0.001), but no relative preference for one of the 
macronutrient categories (Fig. 2.3). 
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Figure 2.3. Preferences for high-carbohydrate (A), high-fat (B), high-protein (C) and low-energy 
(D) products (mean±SD). Dotted line represents chance level. * indicates significant change 
compared to pre meal at p<0.05 level, ** indicates significant difference at p<0.05 level. 
 
After consumption of the test meal, sweet preference shifted dependent on taste of the meal 
as shown by the interaction between hunger state and taste of the test meal: F(1,68)=53.26, p<0.001, 
partial η2=0.44. Sweet preference decreased after the sweet meal and increased after the savoury 
meal (Fig. 2.4). After consumption of the sweet test meal, participants lost their relative preference 
for sweet products over savoury products, Z=-1.53, p=0.127. 
Fig. 2.3 shows the preferences for the four macronutrient categories. Preference for high-
carbohydrate and for high-fat products decreased after meal consumption, regardless of taste, main 
effect carbohydrate: F(1,68)=18.87, p<0.001, partial η2=0.22; fat: F(1,68)=38.92, p<0.001, partial 
η2=0.36. Hunger state interacted with taste of the test meal for high protein foods, F(1,68)=22.13, 
p<0.001, partial η2=0.25. This was explained by a decrease for high protein products after the savoury 
meal, but no change in preference for high protein products after the sweet meal. Preference for 
low-energy products increased after eating a meal, main effect: F(1,68)=85,30, p<0.001, partial 
η2=0.56. Hunger state interacted with taste of the test meal; low-energy preference increased more 
after the savoury meal than after the sweet meal F(1,68)=22.13, p<0.001, partial η2=0.11.  
After both meals, participants showed a relative preference for low-energy products 
compared to the other macronutrient categories (all p<0.01). After the savoury meal, high-fat 
products were preferred over high-protein products (p<0.05). 
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Figure 2.4. Preferences for sweet products before and after the sweet and savoury meal (mean ± SD). 
Dotted line represents chance level. * indicates significant change compared to pre meal at p<0.05 
level, ** indicates significant difference at p<0.05 level. 
 
 
Liking of food categories 
Fig. 2.5 shows the liking ratings for the different food categories. After eating both test 
meals, liking of the sweet, savoury, high-carbohydrate, high-fat and high-protein products 
decreased (all p<0.05), but liking of the low-energy products did not change (p=0.832). For savoury, 
F(1,68)=10.96, p=0.001, and for high-protein, F(1.68)=8.49, p=0.005, hunger state interacted with 
taste of meal. For both categories, liking decreased more after the savoury meal than after the sweet 
meal. 
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Figure 2.5. Liking ratings (0-100 VAS) for sweet (A), savoury (B), high-carbohydrate (C), high-fat 
(D), high-protein (E) and low-energy (F) products (mean±SD). * indicates significant change 
compared to before meal at p<0.05 level. ** indicates significant difference at p<0.05 level. 
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Discussion 
The current study demonstrates the reliability and validity of the Macronutrient and Taste 
Preference Ranking Task, the first food preference ranking task that includes both taste and four 
macronutrient dimensions. First, we showed that food preference scores for all categories in a 
hungry condition were highly correlated over two test sessions indicating test-retest reliability. 
Second, we showed a decreased preference for sweet products after eating a sweet meal and an 
increased preference for sweet products after eating a savoury meal. Preference for high-protein 
products decreased more after eating a savoury meal than it did after eating a sweet meal. 
Preferences for high-carbohydrate and high-fat products decreased after eating a meal, regardless 
of the taste of the meal. Preferences for low energy products increased after eating a meal, and this 
increase was most pronounced after the savoury meal. These results indicate that the MTPRT is a 
valid task to detect changes in food preferences. 
Food preferences as measured with the MTPRT were shown to be reproducible. 
Correlations of preference scores for the different food categories as measured under similar 
circumstances were comparable to those found in previous studies that assessed test-retest reliability 
of methods to measure food preferences (Asao et al., 2012; Brisbois-Clarkson et al., 2009; Ledikwe 
et al., 2007). Given the reproducibility and the high variation in individual food preference scores 
between participants, the MTPRT may be able to identify individuals with specific preferences. 
Further studies are needed to assess whether there are specific individual characteristics that 
determine these individual food preferences.  
In addition, the discriminative ability of the MTPRT was successfully demonstrated by 
assessing the effect of sensory-specific satiety. Similar to other methods used in previous studies, 
preferences for sweet decreased after the sweet meal and increased after the savoury meal 
(Griffioen-Roose et al., 2010; Guinard and Brun, 1998). Moreover, we were able to discriminate 
preferences between four different macronutrient categories, i.e., high-carbohydrate, high-fat, 
high-protein and low-energy. Preferences for high-carbohydrate and high-fat products decreased 
after eating a meal, regardless of the taste of the meal. Conversely, preference for low-energy 
products increased after meal consumption. This increased preference for low-energy products can 
be explained by the fact that participants were feeling full after the meal. This induced a shift from 
energy-dense to low-energy products and is consistent with other studies (Charbonnier et al., 2015a; 
Zoon et al., 2014). Preferences for high-protein products decreased after consumption of the savoury 
meal, but not after consumption of the sweet meal. This finding can be explained by the fact that 
savoury products are generally associated with high protein content (Lease et al., 2016; Viskaal Van 
Dongen et al., 2012). Contrarily, a previous study into the effects of taste of a 24-hour diet on food 
preferences did not find a difference in preference for protein (Griffioen-Roose et al., 2012a). 
However in that study, protein content of high-protein products was at most 26 energy percent and 
included both sweet and savoury products. This difference between high-protein products could 
explain these different findings. Another possible explanation could be that the preference for 
protein was confounded by preference for savoury. In that case, we would have expected an 
increased preference for protein after the sweet meal, similar to the increased preference for 
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savoury. However, preference for protein did not change after the sweet meal. We therefore 
consider this explanation unlikely. 
The meals in our study were carefully composed to be similar with regard to nutritional 
content, and only differed in the taste, sweet and savoury. Therefore we mainly observe effects 
which can be explained by the taste and detect less differentiation on the macronutrients. Most 
likely, when varying meals in macronutrient content pronounced changes in macronutrient 
preferences would become apparent (Barkeling et al., 1990; Hopkins et al., 2016; Ledikwe et al., 
2007). Compared to the LFPQ, the MTPRT has more macronutrient categories and can therefore be 
used in a wide range of studies that assess the influence of different factors on changes in preferences 
for different macronutrients and tastes in a variety of populations.  
By using a ranking procedure, we can assess food preferences for categories of foods relative 
to other categories. In our study, we detected changes in preference for all food categories included 
in the MTPRT, while we did not detect these for all categories in the liking part. One important 
difference is that liking of sweet products decreased in a similar fashion after both the sweet and 
the savoury meal, whereas the preference score for sweet increased after the savoury meal. 
Furthermore, the ranking showed an increased preference for low-energy products after eating the 
meals, while liking of low-energy products did not change. Therefore, the ranking procedure is 
more sensitive compared to the liking procedure, and is thus able to detect more subtle shifts in food 
preferences.  
The ranking method makes the MTPRT an easy and quick tool for evaluating food 
preferences over a wide range of food categories, i.e., high-carbohydrate, high-fat, high-protein and 
low-energy, both sweet and savoury. Because of this range, the food preference task can be used in 
a variety of studies without changing food categories based on the research question. In the current 
study the experiment was focused on assessing sensory-specific satiety in a controlled setting and 
within subjects. However food preferences are influenced by many factors and further research is 
needed to assess the use of the task in a less controlled, more natural setting, and to assess the effect 
of time of day, meal context and person characteristics like gender, age and eating type.  
The current study did not measure actual food intake and thus cannot compare preference 
scores with actual intake. No conclusions can be drawn, therefore, on how food preferences as 
assessed with the MTPRT translate into actual behaviour. Based on previous comparisons of a 
forced-choice procedure with actual food intake (Griffioen-Roose et al., 2010; Griffioen-Roose et 
al., 2011), where strong correlations were found between relative food preference and food intake, 
we would hypothesize that the preference scores as measured with the MTPRT correlate with actual 
food choice behaviour. 
It is important to note that the MTPRT does not include sweet high-protein products. 
Within the range of products that contain at least 50 energy percent of protein, there are no sweet 
products. The same applies to other food preference measures (Barkeling et al., 1990; Brisbois-
Clarkson et al., 2009) and therefore we do believe that the products in the high-protein category are 
a good representation of this macronutrient. In addition, the food products currently included in 
the task are chosen based on their commercial availability in the Netherlands. As Dutch 
consumption patterns may differ from consumption patterns in other countries, it might be 
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necessary to exchange a few individual food products in the MTPRT when using the task in other 
countries. 
The MTPRT is the first food preference task that uses a ranking procedure and can detect 
shifts in preferences for both taste and macronutrients. The MTPRT was shown to be a reliable and 
valid method to measure food preferences, as results were reproducible under similar conditions, 
and differentiated food preferences based on macronutrients and taste in an experimental setting. 
The task can be used to examine the effect of internal and external factors that influence food 
preferences. 
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Supplementary table 2.1. Nutritional values for the selected 32 products 
  Energy (kJ/100 
grams) 
Energy 
(kcal/100 
grams) 
Protein 
(en%) 
CHO 
(en%) 
Fat (en%) 
High carbohydrate 
Sweet 
 Ginger bread 1346 318 3,4 88,9 5,9 
 
Syrup waffles  
(Dutch: Stroopwafels) 
1985 473 3,1 59,4 36,7 
 Pancakes 826 196 16,9 59,6 22,5 
 Winegums 1481 349 6,3 92,8 0,8 
Savoury 
 Tortilla chips 2039 487 5,7 51,3 41,2 
 French fries 1282 306 5,9 50,1 42,1 
 Nibbits 1989 475 3,4 53,9 41,7 
 Salty sticks 1654 395 9,4 81,0 8,2 
High fat 
Sweet 
 
Chocolate bar  
(milk chocolate) 
2278 546 5,1 40,2 53,6 
 Cream pie 1465 350 4,0 33,1 64,3 
 
Apple turnover  
(Dutch: Appelflap) 
1506 361 3,9 39,3 55,8 
 
Large chocolate eclair (Dutch: 
Bossche bol) 
1275 307 5,9 23,6 70,1 
Savoury 
 Salted peanuts 2390 577 16,6 7,6 73,3 
 Sausage roll 1596 382 12,4 35,8 51,4 
 Chips (salted) 2254 541 4,7 37,9 55,7 
 Cheese cubes 1508 363 25,0 0,0 73,4 
High protein 
 Chicken satay 667 158 78,2 0,0 21,6 
 Cod fillet 498 118 72,9 2,0 25,2 
 Pork chop 743 177 64,0 0,0 35,6 
 Turkey fillet (cold cut) 479 113 69,7 11,0 19,1 
 Roast beef 656 156 69,7 0,5 29,4 
 Gammon (cold cut) 569 136 53,5 7,1 38,4 
 Shrimps 397 94 84,3 0,4 15,3 
 Steak 616 146 80,3 0,0 19,7 
Low energy 
Sweet 
 Peach 172 41 9,8 77,1 0,0 
 Strawberries 123 29 9,7 70,3 0,0 
 Apple 254 60 1,3 86,7 3,0 
 Melon galia 107 25 0,0 96,0 0,0 
Savoury 
 Tomato 96 23 12,2 53,9 19,6 
 Cucumber 55 13 18,5 58,5 13,8 
 Pickles 44 11 36,4 36,4 0,0 
 Celery sticks 60 14 28,6 57,1 0,0 
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Abstract 
INTRODUCTION: The endocannabinoid system (ECS) plays an important role in food reward. For 
example, in humans liking of palatable foods is assumed to be modulated by endocannabinoid 
activity. Studies in rodents suggest that the ECS also plays a role in sweet taste intensity perception, 
but it is unknown to what extent this can be extrapolated to humans. Therefore, this study aimed 
at elucidating whether Δ9-tetrahydrocannabinol (THC) or cannabidiol (CBD) affect sweet taste 
intensity perception and liking in humans, potentially resulting in alterations in food preferences. 
MATERIALS AND METHODS: In a randomized placebo-controlled, double-blind, crossover study, 
ten healthy males participated in three test sessions that were two weeks apart. During the test 
sessions, participants received THC-rich, CBD-rich or placebo cannabis by inhalation divided over 
two doses (4 + 1 mg THC; 25 + 10 mg CBD). Participants tasted seven chocolate milk-like drinks 
that differed in sugar concentration and they rated sweet taste intensity and liking of the drinks. 
They were then asked to rank the seven drinks according to how much they liked the drinks and 
were offered ad libitum access to their favourite drink. In addition, they completed a computerized 
food preference task and completed an appetite questionnaire at the start, midway and at the end of 
the test sessions. 
RESULTS: Inhalation of the cannabis preparations did not affect sweet taste intensity perception 
and liking, ranking order, or ad libitum consumption of the favourite drink. In addition, food 
preferences were not influenced by the interventions. Reported fullness was lower, whereas desire 
to eat was higher throughout the THC compared to the CBD condition. 
CONCLUSIONS: These results suggest that administration of cannabis preparations at the low doses 
tested does not affect sweet taste intensity perception and liking, nor does it influence food 
preferences in humans.  
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Introduction 
There is growing evidence that the endocannabinoid system (ECS) plays an important role 
in the regulation of hedonic hunger, i.e., consuming foods for the experience of reward and not for 
the compensation of any energy deficit (Lowe and Butryn, 2007). More specifically, the ECS seems 
to modulate palatability-dependent appetite (Argueta and DiPatrizio, 2017; DiPatrizio et al., 2011; 
DiPatrizio and Simansky, 2008; Droste et al., 2010), though the underlying mechanisms are far from 
clear. 
It is important to note that palatability, or pleasantness, is not a fixed function of the sensory 
properties (e.g. taste, smell, texture) of a food, but also depends on the hedonic evaluation of more 
qualitative (liking) and contextual (eating occasion) characteristics (Cooper, 2004; Rogers, 1990). 
Considering taste, there seem to be two ways in which taste intensity perception and liking 
can be modulated. One is via alterations in quantitative taste intensity perception, reflected by a 
shift in the psychophysical (concentration-intensity) function. In case of, for example, sweet taste, 
the same sugar concentration is perceived as more or less intensely sweet. The other way is related 
to changes in hedonic evaluation, reflected by a shift in the psychohedonic (intensity-pleasantness) 
function, where for example, the perceived sweetness intensity of a sugar concentration is 
unchanged, but the perceived sweetness is liked more or less (de Graaf et al., 1996). 
In rodents, endocannabinoid activity modulates sweet taste palatability. Endocannabinoid 
stimulation enhances liking of sweet taste (De Luca et al., 2012; O'Brien et al., 2013) and 
motivational behaviour aimed at obtaining a sucrose solution (Higgs et al., 2003), whereas 
endocannabinoid inhibition reduces liking and motivational behaviour (Higgs et al., 2003; O'Brien 
et al., 2013). Some studies suggest that administration of CBD decreases food intake (Farrimond et 
al., 2012; Wierucka-Rybak et al., 2014), possibly via indirect antagonism of the ECS (McPartland et 
al., 2015; Pertwee, 2008), whereas other studies do not find an effect of CBD on food intake (Riedel 
et al., 2009; Wiley et al., 2005). Taken together, it is clear that CBD is far from being a classical 
ligand for the CB1 or CB2 receptor. The molecule displays a wide spectrum of activities on various 
molecular targets and produces multiple pharmacological effects (Ligresti et al., 2016; McPartland 
et al., 2015). 
Administration of endocannabinoids was found to specifically increase responses to sweet 
taste in the Chorda tympani, the nerve that innervates the tongue, in wild-type mice, but not in CB1 
knock-out mice (Yoshida et al., 2010). Administration of a CB1 antagonist decreased responses to 
sweet taste in the Chorda tympani (Niki et al., 2015). Together, these results suggest that modulating 
the ECS selectively changes the psychophysical function for sweet taste in mice. 
In humans, anecdotal evidence suggests that the use of Cannabis preparations increases food 
palatability and intake (Abel, 1975; Foltin et al., 1988; Hart et al., 2002; Smit and Crespo, 2001; Tart, 
1970), a phenomenon colloquially known as ‘the munchies’. Furthermore, the CB1 inverse agonist 
rimonabant decreases food intake (Pi-Sunyer et al., 2006; Van Gaal et al., 2005). Thus far, only one 
study examined the effects of oral administration of delta-9-tetrahydrocannabinol (THC) on taste 
intensity and liking in humans. In a double-blind, placebo-controlled study, acute Cannabis 
administration was found not to affect taste intensity perception and liking for sweet, sour, salty 
and bitter food stimuli at baseline, and 2, 4 and 6 hours post-dosing. However, THC bioavailability 
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varied widely and THC could not be detected in plasma of all participants (Mattes et al., 1994b), 
Based on the limited number of studies performed in humans, the aim of the current study was to 
further investigate whether modulating the ECS by administering phytocannabinoid preparations 
affects sweet taste intensity perception and liking in humans, and whether this results in altered 
food preferences. 
 
Methods 
Participants 
Ten healthy, normal weight (BMI=21.7±1.2 kg/m2) males aged 23.4±1 years participated in 
the current study. Participants were incidental cannabis-users to ensure familiarity with the 
psychotropic effects of cannabis use. Frequency of use ranged from four times a year to once a week. 
To limit the risk of adverse events, males were excluded from participation when they had ever 
experienced negative effects from using cannabis (e.g. bad trip, cannabis-induced psychosis). Other 
exclusion criteria were restraint eating (DEBQ: score >2.9; Van Strien et al., 1986), lack of appetite, 
difficulties swallowing or eating, having taste or smell disorders (self-report), following an energy 
restricted diet two months prior to the study, weight change >5kg during the two months prior to 
the study, being allergic or intolerant for the products under study. Participants were instructed to 
abstain from cannabis from two weeks before the first test session until study completion. 
Compliance was tested by means of a urine sample (SureScreen Diagnostics Ltd.) at the beginning 
of each test session. Participants were also asked not to use alcohol in the two days before a test 
session, and not to eat or drink anything except water or weak tea during the two hours before a 
test session. Participants gave written informed consent before the start of the study and they 
received financial compensation at the end of the study. The study was approved by the Medical 
Ethical Committee of Wageningen University and was conducted in accordance with the Helsinki 
declaration of 1975, as revised in 2008. The study was registered on clinicaltrials.gov as 
NCT02112292. 
 
Design and procedures 
The study had a randomized, placebo-controlled, double-blind, crossover design. All 
participants completed one practice session (familiarization with the test procedures) and three test 
sessions after administration of cannabis either rich in THC, CBD or placebo (for details see “Study 
drugs and administration”). Test sessions were two weeks apart to allow for complete clearance of 
drugs. 
Each test session consisted of repeated measurements of appetite and subjective effects using visual 
analogue scales (VAS), venous blood sampling to determine plasma concentrations of THC and CBD, 
a taste test with chocolate milk-like drinks that differed in sugar concentration (for details see 
“Sweet taste intensity perception and liking”), a control task, a ranking test with the drinks, ad 
libitum intake of the preferred chocolate milk-like drink, and the Macronutrient and Taste 
Preference Ranking Task (MTPRT; (de Bruijn et al., 2017). See Figure 3.1 for a schematic overview 
of the test procedure. 
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Figure 3.1. Schematic overview of a test session. A = appetite questionnaire, H = feeling high (VAS), 
B = blood sample, MTPRT = Macronutrient and Taste Preference Ranking Task, T = time 
 
Study drugs and administration 
The active preparations consisted of the dried, milled and homogenized flowers of two 
varieties of the plant C. sativa and were obtained from the Office for Medicinal Cannabis (OMC; 
The Netherlands); variety Bedrocan® (19% THC, <1% CBD), and variety Bedrolite® (<1% THC, 
9% CBD). The placebo (variety “Bedrocan”®; <0.5% THC) had a moisture content and terpenoid 
profile (providing the typical smell and taste of cannabis) identical to the active drug, and was 
obtained from Bedrocan BV (official supplier to the OMC; Kowal et al., 2015). From here onwards 
we will refer to the three treatments as the THC (Bedrocan®), CBD (Bedrolite®) and placebo 
condition. In the THC condition, participants received an initial dose of four mg of THC, followed 
by one mg of THC as a top-up dose after 35 minutes to maintain stable levels of central nervous 
system effects (Kleinloog et al., 2014). In the CBD condition, the initial and top-up dose of CBD 
were 25 and 10 mg, respectively. 
For each individual dose, exact amounts of Bedrocan® or Bedrolite® and placebo were 
mixed so that each dose was equal to 250 mg of plant preparation total weight. According to GMP 
guidelines and to ensure double-blindness, study medication was prepared, packed and coded by 
ACE Pharmaceuticals BV (Zeewolde, The Netherlands), a company licenced to prepare trial 
medication. Study medication was stored at a temperature of -18°C and taken out of the freezer 
thirty minutes before the start of a test session. Administration was performed with a MINIVAP 
vaporizer (HERMES MEDICAL ENGINEERING, S.L) that was set at a temperature of 230°C. For 
each administration, participants were instructed to inhale 12 times with a duration of five seconds 
per inhalation and a pause of 25 seconds between adjacent inhalations. 
 
Plasma levels and subjective effects 
Venous blood samples were collected in NaF/KOx (anticoagulant) tubes at baseline (T=0), 
T=30 and T=75 minutes, and stored at 4°C until the end of the test session. Then, tubes were 
centrifuged at 1300g for 10 minutes at 4°C and plasma samples were collected and stored at -80°C 
until analyses. Plasma was analysed for THC and CBD concentrations (ng/ml) using LC-MS/MS by 
Analytical Biochemical Laboratory BV (Assen, The Netherlands). Due to budget restraints, the 
samples of the placebo condition were only analysed for half of the sample (n=5). 
Subjective effects of the treatments were assessed with a VAS on which participants rated 
‘feeling high’ throughout the test sessions. 
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Sweet taste intensity perception and liking 
A series of chocolate milk-like drinks that differed in sugar concentration was used to assess 
sweet taste intensity perception and liking. Samples were prepared freshly on the morning of each 
test session. First, a basic drink was prepared, containing vanilla sugar (Ruf; 2%), Nutilis powder 
(Nutricia; 3%), cream (De Zaanse Hoeve; 18%), skimmed milk (De Zaanse Hoeve; 74.5%), and cocoa 
powder (Blooker; 2.5%). Then, different amounts of basic chocolate milk-like drink and sucrose 
(Van Gilse) were mixed to get seven drinks with 2, 4.4, 6.7, 10, 15, 22.5, 33.8 grams of added sugar 
per 100 ml, respectively (Table 3.1). These sugar concentrations were chosen to cover a full 
psychophysical sweetness intensity curve, ranging from not that sweet to very sweet.  
The drinks were coded with random three-digit numbers and presented to the participants 
in 20 mL samples, in a random order that differed between participants, but was kept constant per 
participant across test sessions. Participants were instructed to take a sip and then first rate sweet 
taste liking, followed by sweet taste intensity on a 200 point labelled affective magnitude scale 
(Schutz and Cardello, 2001) and a 100 point labelled magnitude scale (Green et al., 1993) 
respectively. In between samples, participants were instructed to rinse their mouth with water and 
wait 30 seconds before tasting the next sample. 
 
Table 3.1. Composition of the different chocolate milk-like drinks per 100 ml.  
Added sugar 
(g/100ml) Total weight (g) Basic (g) Sugar (g) 
2 85 85 0 
4.4 86 83.6 2.4 
6.7 87 82.3 4.7 
10 88.6 80.6 8 
15 91.5 78.5 13 
22.5 95.7 75.2 20.5 
33.8 102.2 70.4 31.8 
The basic drink contained 2 g/100ml added vanilla sugar. 
 
The drinks were coded with random three-digit numbers and presented to the participants 
in 20 mL samples, in a random order that differed between participants, but was kept constant per 
participant across test sessions. Participants were instructed to take a sip and then first rate sweet 
taste liking, followed by sweet taste intensity on a 200 point labelled affective magnitude scale 
(Schutz and Cardello, 2001) and a 100 point labelled magnitude scale (Green et al., 1993) 
respectively. In between samples, participants were instructed to rinse their mouth with water and 
wait 30 seconds before tasting the next sample. 
 
Control task 
To check whether the cannabis treatments did not affect task performance or perception in 
general, a control task was added to the procedures. Participants were asked to rate the greyness of 
seven shades of grey on a 100 point VAS that was anchored by ‘white’ and ‘black’ (de Graaf et al., 
1996). Reflection percentages of the different shades were 96, 84, 64, 44, 20, 8 and 4% respectively, 
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with shades ranging from almost white to almost black. Analyses showed that ratings did not differ 
between conditions and that participants were able to differentiate between the different shades of 
grey (results not reported).  
 
Appetite, ranking task and ad libitum intake 
Throughout the test sessions participants three times (see Fig 3.1) rated levels of hunger, 
fullness, desire to eat and prospective consumption on a 100 point VAS anchored by ‘not at all’ and 
‘extremely’, except for prospective consumption which was anchored by ‘nothing at all’ and ‘a very 
large amount’ (Blundell et al., 2010). 
After the control task, participants were presented with 80 mL of the seven chocolate milk-
like drinks and were asked to rank them according to how much they liked the drinks. During the 
ad libitum intake test, participants were presented with one litre of their favourite drink, which 
they could consume ad libitum for 10 minutes. 
 
Food preferences 
Food preferences were assessed using the MTPRT. In this task, participants were presented 
with four pictures of different food products at a time and asked to rank the products according to 
what they most desire to eat at that moment. Food products included in this task were either high 
in carbohydrate, high in fat, high in protein or low in energy, and had a sweet or savoury taste. 
Examples of foods included in the food preference test are pancakes (high-carbohydrate sweet), salty 
sticks (high-carbohydrate savoury), chocolate bar (high-fat sweet), cheese cubes (high-fat savoury), 
shrimps (high-protein), strawberries (low-energy sweet) and cucumber (low-energy savoury). In 
short, the task consists of a macronutrient section, in which participants are presented with one 
product from each of the four macronutrient categories, and a taste section, in which participants 
are presented with two sweet and two savoury products. Based on the rankings, preference scores 
for different macronutrient and taste categories, i.e. high-carbohydrate, high-fat, high-protein and 
low-energy, and sweet and savoury are calculated as described elsewhere (de Bruijn et al., 2017). 
Preference scores for the macronutrient categories can range from 1 to 4, with a higher score 
indicating a higher preference for a category. A score of 1 indicates all products from that category 
were ranked last, a score of 4 indicates all products from that category were ranked first. As each 
ranking in the taste section comprises two sweet and two savoury products, preference scores for 
sweet and savoury can range from 1.5 to 3.5. Because preference scores for sweet and savoury are 
each other’s opposite, we only report preference scores for sweet in this article. 
 
Data analyses 
Data are presented as means with standard error of the mean (SEM). Data was analysed using 
IBM SPSS 22 (IBM Corporation, Armonk, New York, USA). Results were considered statistically 
significant at p<0.05. When statistically significant main effects were found, post-hoc tests were 
performed using Bonferroni correction. 
Liking ratings of the chocolate milk-like drinks were transferred to 100 points by dividing 
the scores by two. Using repeated measures ANOVA, rated sweetness intensity and liking of the 
drinks were compared, with condition (THC, CBD and placebo) and sugar concentration as factors. 
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For the ranking task, the mean rank was calculated for each chocolate milk-like drink in each 
condition. Friedman ANOVA was used to compare mean ranks between conditions for each drink 
separately and to compare ranks of the drinks within conditions. For the ad libitum task, the 
consumed amount and energy content of the consumed drink were used to calculate the consumed 
energy. Repeated measures ANOVA was used to test if the consumed energy differed between 
conditions.  
Preference scores from the MTPRT were compared between conditions using repeated 
measures ANOVA. To compare preference scores within each condition, Friedman ANOVA was 
used for the macronutrient categories and Wilcoxon signed rank tests were used to compare the 
sweet and savoury preference scores.  
Appetite ratings were compared using repeated measures ANOVA with condition (THC, 
CBD, placebo) and time as factors. Because of one missing data point for one participant, mixed 
models ANOVA was used to analyse ‘feeling high’ with condition, time and condition*time as fixed 
factors and subject as a random factor. 
 
Results 
Plasma levels and subjective effects 
Table 3.2 shows the mean TCH and CBD plasma levels for all three conditions. In some 
participants, low levels of CBD were detected in the THC condition and vice versa. Low levels of 
THC were detected in plasma samples after administration of placebo, but these were 8- vs. 6.5-fold 
lower as compared to T=30 and T=75 min in the THC condition. 
 
Table 3.2. THC and CBD plasma levels for all three conditions.  
Condition Compound T=30 T=75 
THC THC 1.6±0.5 1.3±0.4 
 CBD 0.34±0.1  0.26±0.1  
CBD THC 0.16  0.21±0.03  
 CBD 2.8±0.8 3.0±0.7 
Placebo THC 0.22±0.05  0.21±0.04  
 CBD ND ND 
Plasma levels in ng/ml. Values are means±SEM. ND=not detected. n=10 for THC in THC condition and CBD 
in CBD condition. CBD was detected in 4 participants (T=30 and T=75) in the THC condition, THC was 
detected in 1 (T=30) and in 3 (T=75) participants in the CBD condition. Placebo condition was tested for 5 
participants. THC was detected in 4 (T=30) and in 5 (T=75) participants. 
 
As shown in Figure 3.2, reported levels of ‘feeling high’ differed between conditions, 
F(2,13)=4.60, p<0.05, and over time, F(4,22)=7.35, p<0.05. Post-hoc analyses showed that 
participants felt significantly more ‘high’ in the THC compared to the placebo condition. 
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Figure 3.2. Reported ‘feeling high’ (means±SEM). Arrows indicate treatment administration. For the 
first arrow: 4 mg THC, 25 mg CBD or placebo. For the second arrow: 1 mg THC, 10 mg CBD or 
placebo. * indicates significant difference from T=0 (p<0.05). ** indicates difference between THC 
and placebo conditions (p<0.05). PLA=placebo. 
 
Sweet taste intensity perception and liking 
Drinks that contained more sugar were perceived as more sweet, F(6,54)=57.87, p<0.05, but 
perceived sweet taste intensity of the seven chocolate milk-like drinks did not differ between the 
three conditions, F(2,18)=0.66, p=0.53 (Fig 3.3A). Liking of the different drinks differed with sugar 
concentration, F(6,54)=2.47, p<0.05, where the drinks that contained the least and the most sugar 
were liked least. Similar to the intensity findings, the liking of the seven drinks did not differ 
between conditions, F(2,18)=0.94, p=0.41 (Fig 3.3B). 
 
Ranking task 
Ranks of the different drinks did not differ between conditions, all p>0.05. In addition, the ranking 
task did not show differences between the drinks, Χ2(6)=11.10, p=0.085, Χ2(6)=12.73, p=0.048, and 
Χ2(6)=12.51, p=0.051 for THC, CBD and placebo respectively. 
 
Appetite and ad libitum intake 
Results from the appetite questionnaire can be found in Figure 3.4. Reported hunger did not differ 
between conditions, F(2,18)=2.62, p=0.10, and did not change over time, F(2,18)=2.47, p=0.11. 
However, reported fullness differed between conditions, F(2,18)=3.74, p<0.05, and changed over 
time, F(2,18)=4.38, p<0.05. Throughout the whole test session, fullness ratings were higher in the 
CBD condition than in the THC condition. Desire to eat differed between conditions, F(2,18)=6.50, 
p<0.05, and was higher in the THC condition than in the CBD condition throughout the whole test 
session, but did not change over time, F(2,18)=2.43, p=0.12. Prospective consumption differed 
between conditions, F(2,18)=4.83, p<0.05, but did not change over time, F(2,18)=3.34, p=0.06. 
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Condition Compound T=30 T=75 
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 CBD ND ND 
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in CBD condition. CBD was detected in 4 participants (T=30 and T=75) in the THC condition, THC was 
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As shown in Figure 3.2, reported levels of ‘feeling high’ differed between conditions, 
F(2,13)=4.60, p<0.05, and over time, F(4,22)=7.35, p<0.05. Post-hoc analyses showed that 
participants felt significantly more ‘high’ in the THC compared to the placebo condition. 
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Figure 3.2. Reported ‘feeling high’ (means±SEM). Arrows indicate treatment administration. For the 
first arrow: 4 mg THC, 25 mg CBD or placebo. For the second arrow: 1 mg THC, 10 mg CBD or 
placebo. * indicates significant difference from T=0 (p<0.05). ** indicates difference between THC 
and placebo conditions (p<0.05). PLA=placebo. 
 
Sweet taste intensity perception and liking 
Drinks that contained more sugar were perceived as more sweet, F(6,54)=57.87, p<0.05, but 
perceived sweet taste intensity of the seven chocolate milk-like drinks did not differ between the 
three conditions, F(2,18)=0.66, p=0.53 (Fig 3.3A). Liking of the different drinks differed with sugar 
concentration, F(6,54)=2.47, p<0.05, where the drinks that contained the least and the most sugar 
were liked least. Similar to the intensity findings, the liking of the seven drinks did not differ 
between conditions, F(2,18)=0.94, p=0.41 (Fig 3.3B). 
 
Ranking task 
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Χ2(6)=12.51, p=0.051 for THC, CBD and placebo respectively. 
 
Appetite and ad libitum intake 
Results from the appetite questionnaire can be found in Figure 3.4. Reported hunger did not differ 
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42 
 
 
Figure 3.3. Ratings (means±SEM) for A) Sweet taste intensity, and B) Sweet taste liking. PLA = 
placebo. Drinks were rated as more intensely sweet with increasing sugar concentration. The drinks 
with the least and the most amount of added sugar were liked less (p <0.05). 
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Figure 3.4. Rated scores (means±SEM) for A) hunger, B) fullness, C) desire to eat and D) prospective 
consumption. * indicates difference throughout THC and CBD condition (p<0.05). PLA = placebo. 
 
Ad libitum intake of the most liked chocolate milk-like drink did not differ between 
conditions, F(2,18)=0.50, p=0.62. Participants consumed on average 537±67 kcal in the THC 
condition, 581±66 kcal in the CBD condition and 595±65 kcal in the placebo condition. 
 
Food preferences 
The preference scores can be found in Table 3.3. Treatments did not affect preference for 
sweet or for any of the macronutrients, all p>0.05. In all three conditions, participants had a 
preference for savoury over sweet, all p<0.05, but not for one of the macronutrients over the others, 
all p>0.05. 
 
Table 3.3. Food preference scores in all three conditions. 
 THC CBD Placebo 
High-carbohydrate 2.39±0.07 2.30±0.13 2.43±0.14 
High-fat 2.61±0.15 2.42±0.12 2.42±0.11 
High-protein 2.74±0.26 2.74±0.20 2.84±0.19 
Low-energy 2.26±0.25 2.54±0.26 2.31±0.24 
Sweet 2.20±0.09 2.22±0.08 2.20±0.10 
Values are means±SEM. Preference scores for macronutrient categories can range between 1 and 4, 
preference score for sweet can range between 1.5 and 3.5. 
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Discussion 
To the best of our knowledge, the current study is the first randomized, placebo-controlled, 
double-blind study investigating sweet taste intensity perception, sweet taste liking and possible 
consequent changes in food preference following inhalation of THC and CBD. The results indicate 
no changes in sweet taste intensity perception and liking, nor in food preferences, as related to taste 
(sweet versus savoury) and macronutrient composition (carbohydrate, protein, fat, low-energy). 
The lack of effects on sweet taste intensity and liking after activating or inhibiting the ECS 
is contradictory to our expectations based on previous studies that showed endocannabinoid 
modulation of sweet taste intensity perception in mice (Niki et al., 2015; Yoshida et al., 2010). 
However, the current findings are in line with a study in humans that assessed taste intensity 
perception after oral THC administration. In that study, THC did not affect intensity and liking of 
sweetness, saltiness, sourness and bitterness (Mattes et al., 1994b). 
In line with the results from the taste test, preference for sweet taste in the MTPRT did not 
differ between the THC, CBD and placebo conditions. In addition, preference for macronutrients 
was not affected by administration of THC or CBD. Earlier studies in humans showed that cannabis 
increases intake of snack foods, with a specific increased intake of sweet snacks (Abel, 1975; Foltin 
et al., 1988). 
In the current study, participants had a preference for savoury over sweet. Just before 
completing the MTPRT, participants had consumed a large amount of a sweet drink to satiety. This 
might have caused sensory-specific satiety, i.e. decreased pleasantness of sensory properties of the 
food that has just been consumed to satiety (Rolls et al., 1981). The effect of sensory-specific satiety 
might have overruled a potential effect of endocannabinoid modulation on preference for sweet 
taste. However, given that THC and CBD administration did not influence sweet taste intensity 
perception and liking of the chocolate milk-like drinks, we think it is more likely that there is no 
effect of endocannabinoid modulation on sweet taste preference. 
Desire to eat was higher and fullness was lower in the THC condition compared to the CBD 
condition, possibly related to baseline differences. However, despite these differences, ad libitum 
intake of the most preferred chocolate milk-like drink did not differ between conditions. In a 
previous study in cancer patients, THC treatment increased appetite, but did not affect total energy 
intake (Brisbois et al., 2011). Also in a healthy population, THC did not affect total energy intake 
(Mattes et al., 1994a). However, other studies in humans showed that THC increases food intake 
(Abel, 1975; Foltin et al., 1988). CBD has previously been shown not to affect appetite in patients 
that suffer from type 2 diabetes (Jadoon et al., 2016). In rats, however, CBD has been shown to 
decrease food intake (Farrimond et al., 2012; Wierucka-Rybak et al., 2014), which may be caused 
by higher fullness. These contradicting findings warrant further investigation. 
The plasma levels of THC and CBD showed that the administration of pharmacological doses 
by inhalation was successful in our study. The placebo cannabis contained traces of THC, which led 
to detectable but very low THC plasma levels in the placebo condition. As THC plasma levels in the 
placebo condition were eight times lower than in the THC condition, the functional consequences 
on outcome measures are likely minimal.  
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The relatively small sample size could be regarded as a limitation of our exploratory study. 
However, we would expect to find similar results in a larger sample. With ten participants, we see 
a great overlap of the mean sweet taste intensity and liking of the different drinks, which suggests 
that we will also not see any differences with more participants included in the study. Especially for 
the sweet taste liking, there is a large variation between participants. For the food preference task, 
one may expect to find differences in preference for low-energy products with a larger sample size. 
As CBD increases fullness and decreases desire to eat, we would expect that it also increases 
preference for low-energy products based on previous experience with the MTPRT (de Bruijn et al., 
2017). 
The current study included only male participants. As endocannabinoid pharmacology 
differs between males and females (Craft et al., 2013; Diaz et al., 2009), females might respond 
differently to inhaled THC and CBD. Future studies should take this into account and consider to 
include both males and females. 
Another plausible explanation for our negative results might be that we used a relatively 
low dose of THC compared to other studies (Kleinloog et al., 2014; Kowal et al., 2015). We chose 
this dose as we did not want obvious intoxication to influence the results. However, it is possible 
that the dose is too low to evoke an effect and that we would have seen an effect of THC on sweet 
taste intensity perception and liking if we would have used a higher dose. Importantly, the effects 
of THC and other CB1 agonists usually follow an inverted u-shape, i.e., there is an optimal dose at 
which the largest effect occurs and for higher doses, the effect wears off (Bellocchio et al., 2010; 
DiPatrizio and Simansky, 2008; Wiley et al., 2005). Dosing too high could therefore also lead to no 
effect. Future studies should take this in consideration.  
Based on the results from the current study, we conclude that challenging the ECS with low 
doses of THC or CBD does not influence sweet taste intensity perception and liking in humans. In 
addition, low doses of THC and CBD do not affect food preferences. 
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Abstract 
BACKGROUND: Previous studies suggest that food palatability modulates endocannabinoid, 
ghrelin and pancreatic polypeptide (PP) responses across anticipatory, consummatory and post-
ingestive phases. However, in some of these studies, participants knew in advance whether they 
were offered a palatable or a neutral food. Expected palatability, based on sensory cues such as sight 
and smell, likely affects anticipatory hormone responses and may also affect subsequent post-
ingestive responses. In addition, post-ingestive endocannabinoid responses have only been 
measured at a limited number of time points and/or for a limited time period after tasting or 
ingesting a food, and insight into the full (pre-)prandial and post-prandial endocannabinoid 
response appears to be lacking. 
AIM: To assess a complete profile of seven endocannabinoids and structural congeners, ghrelin and 
PP responses during anticipatory, consummatory and post-ingestive phases up to two hours after 
ingestion of a palatable versus a neutral food where palatability of the food was unknown until the 
first bite was taken. 
MATERIALS AND METHODS: Twenty-five healthy males completed two test sessions that were 
two weeks apart during which they consumed either a palatable brownie or a neutral brownie in 
randomized order. The two brownies were selected based on pre-study individual liking scores. 
During the test sessions, participants did not know palatability of the brownie until their first bite. 
Before, during and up to two hours after brownie consumption, blood samples were drawn. 
RESULTS: Endocannabinoid, ghrelin and PP profiles did not differ between the palatable and 
neutral brownie. Concentrations did not change during anticipation or consumption, but they did 
go down for most of the measured endocannabinoids and ghrelin after food intake. In addition, PP 
concentrations increased shortly after food intake. 
CONCLUSIONS: These results suggest that actual palatability of a food does not affect 
endocannabinoid, ghrelin and PP responses to its intake.  
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Introduction 
The rewarding gustatory properties of a food can tempt us into eating even when we feel 
satiated. This so-called hedonic eating may contribute to overeating (Lowe and Butryn, 2007) and 
consequently to weight gain and obesity. Several studies point out a role for the endocannabinoid 
system (ECS) in the physiological mechanisms that underlie hedonic eating (for a review see Jager 
and Witkamp, 2014). The ECS comprises two cannabinoid receptors, CB1 and CB2, their endogenous 
ligands, so-called endocannabinoids of which anandamide (AEA) and 2-arachidonoylglycerol (2-
AG) are best known, and the enzymes responsible for synthesis and degradation of the 
endocannabinoids (Howlett, 2002). 
Another important mediator of hedonic eating is ghrelin (Buss et al., 2014; Monteleone et 
al., 2013). Ghrelin is the only known orexigenic peptide, with plasma concentrations rising in 
anticipation of food intake and dropping after food intake (Cummings et al., 2001; Tschöp et al., 
2001). Previous studies suggested that plasma concentrations of AEA follow a similar pattern (Gatta-
Cherifi et al., 2012). Similarly, plasma concentrations of the endocannabinoid congeners 
palmitoylethanolamide (PEA) and oleoylethanolamide (OEA) were shown to decrease after food 
intake (Monteleone et al., 2012; Rigamonti et al., 2015). 
The rise and drop of ghrelin and endocannabinoid plasma concentrations seem to be 
modulated by both the expected and actual (experienced) palatability of a food. Anticipation of 
palatable food intake increased concentrations of ghrelin and the endocannabinoid 2-AG whereas 
anticipation of a neutral food did not (Monteleone et al., 2012; Rigamonti et al., 2015). Ghrelin and 
endocannabinoids also respond to tasting a food, so even before ingesting it. This has been studied 
in a modified sham-feeding experiment, in which food was tasted and chewed on, but was 
expectorated instead of swallowed. Ghrelin plasma concentrations were found to be higher after 
modified sham-feeding of a neutral pudding compared to a palatable, sweet tasting, and an aversive, 
bitter tasting, pudding (Mennella et al., 2015). In addition, 2-AG concentrations were higher in the 
palatable and neutral condition compared to the aversive condition (Mennella et al., 2015). In the 
same study, pancreatic polypeptide (PP) plasma concentrations were found to be increased after 
modified sham-feeding of the palatable pudding compared to the neutral and the aversive pudding. 
PP is released during mastication and after food ingestion, and has been suggested to decrease food 
intake (Khandekar et al., 2015). 
Taken together, previous studies indicate that food palatability modulates endocannabinoid, 
ghrelin and PP plasma responses across anticipatory, ingestive and subsequent digestive and 
absorptive phases of food intake (see Figure 4.1 for a schematic overview). However, in previous 
studies, participants knew in advance whether they were offered a palatable or a neutral food. 
Expected palatability, based on sensory cues as sight and smell, likely affects the anticipatory pre-
ingestive response and may subsequently affect the post-ingestive response. In addition, post-
ingestive endocannabinoid responses have only been measured at a limited number time points 
and/or for a limited time period after tasting or ingesting a food. Thus, we still lack a full 
endocannabinoid curve across food intake and post-ingestive phases (digestion and absorption). 
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Figure 4.1. Schematic model of food intake behaviour as applicable in the current study. Before food 
consumption, the sight and smell of a food trigger anticipation, which is influenced by expectations. 
These expectations influence ingestive and post-ingestive responses. In addition, the taste of a food 
also influences post-ingestive responses. For hunger: the darker the colour, the higher feeling of 
hunger. Adapted with permission from Smeets et al., 2010. 
 
Therefore, the aim of the current study was to assess a complete profile of seven 
endocannabinoids and related compounds, ghrelin and PP responses during anticipatory, 
consummatory and post-ingestive phases up to two hours after ingestion of a palatable versus a 
neutral food where palatability of the food was unknown until the first bite was taken.  
To this end, we used chocolate brownies that only differed in salt content, and thus 
palatability, whereas they looked and smelled the same. Starting from the design by Monteleone 
and colleagues (2012), participants were first asked to look at and smell the brownie, before they 
could consume it. Participants were kept naïve about the study aim and did not know the 
palatability of the brownie until they took the first bite. In addition to endocannabinoids, ghrelin 
and PP, glucose concentrations and appetite ratings were assessed at different time points during 
the test session as control measures. These markers should respond to nutrient and caloric intake, 
but not to the palatability of the food. To further elucidate the post-ingestive endocannabinoid 
response, we not only measured AEA, 2-AG, OEA and PEA, but included three more 
endocannabinoid-related compounds that have been suggested to be relevant for food intake or 
induce cannabinomimetic behavioural effects, namely stearoylethanolamide (SEA; Terrazzino et al., 
2004), dihomo-γ-linolenoylethanolamide (DLE; Barg et al., 1995), and 
docosahexaenoylethanolamide (DHEA; Barg et al., 1995; Friedman et al., 2016). 
We hypothesised that exposure (viewing and smelling) to the palatable and the neutral 
brownie would not induce differences in any of the endocannabinoids, ghrelin or PP. After brownie 
intake, concentrations of 2-AG, ghrelin and PP were expected to be increased for the palatable 
compared to the neutral brownie. Brownie intake, independent of palatability, would lead to 
decreased concentrations of AEA, OEA and PEA after ingestion. 
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Methods 
Participants 
Twenty-five males aged 21.8 (SD=3.1) years, with a mean BMI of 22.4 (SD=1.7) kg/m2 
participated in the study. All participants were healthy (self-reported). To ensure participants were 
not anaemic and could safely undergo repeated blood sampling, their blood haemoglobin (Hb) 
concentration was determined with a Hb analyser (HemoCue 201) at screening and had to be 
between 8.1 and 11.0 mmol/L. As regular cannabis use influences the endocannabinoid system (Sim-
Selley et al., 2006; Walter et al., 2013), participants were not allowed to use cannabis more than 12 
times a year. Other exclusion criteria were restrained eating (Dutch Eating Behaviour Questionnaire 
(DEBQ; Van Strien et al., 1986), score>2.90), lack of appetite, an energy restricted diet during the 
last two months, more than five kilograms body weight change during the last two months, 
smoking, drinking more than fourteen units of alcohol per week and not willing to consume or 
being allergic to products used in the study. Individuals who expressed interest in participating in 
the study where invited for an information and screening meeting at Wageningen University, 
during which they rated liking of six different brownies (see section 2.2) in random order on a 100-
point visual analogue scale (VAS). Only participants who rated one of the brownies as neutral, i.e., 
VAS-score between 40 and 60, and another brownie as palatable, i.e., VAS-score > 70, were included 
in the study. Which two brownies were rated as neutral and palatable, and thus later presented in 
the test sessions could differ between participants. All participants provided written informed 
consent at the start of the information and screening meeting, and were debriefed at the end of the 
study. The study was approved by the Medical Ethical Committee of Wageningen University and 
was registered on clinicaltrials.gov as NCT03113474. 
 
Products 
Brownies were chosen as food product, as they are generally well liked. Palatability of the 
brownies was manipulated by adding 0–12.5 grams of salt to one kilogram of brownie dough, 
creating six different brownies that only differed in salt content. The salt affected palatability of the 
brownies, whereas the brownies looked and smelled the same. The brownies contained 62 g 
carbohydrates, 13 g fat, 5 g protein and 20 g water per 100 g and had an energy density of around 
390 kcal/100 g. A local bakery obtained brownie mix from Dawn Foods and prepared the brownies. 
After baking and cooling down, the brownies were stored in 100 gram serving portions in a freezer 
at -18 °C. On each study day, the needed brownies were defrosted at room temperature for at least 
two and a half hours, before being presented to the participants on paper plates.  
 
Procedures 
Before participants were included in the study, they attended an information and screening 
meeting. During this meeting, participants received a small piece (~25 g) of each brownie and tasted 
the different brownies in random order. Participants were instructed to taste one piece, to rate liking 
on a 100 point VAS and then rinse their mouth with water. There was a waiting time of at least one 
minute between tasting two pieces of brownies. To keep participants naïve to the real aim of the 
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study, they were informed that they were participating in a study investigating the effects of eating 
on satiety hormones and that during the test sessions they would either receive two different 
brownies or the same brownie twice. Participants were also told they could receive either one of 
the six brownies, palatability was not mentioned in this explanation. 
The study consisted of two test sessions that were two weeks apart. To limit the influence 
of recent food intake on outcome measures, participants were instructed to consume a standardized 
evening meal at home the evening before each test session and a standardized breakfast at the test 
location. The standardized evening meal was provided to the participants and consisted of a ready-
meal with chicken and soy sauce (2115 kJ / 495 kcal), a salad with eggs, potato and vegetables (931 
kJ / 224 kcal) and a fruit salad (598 kJ / 140 kcal). The total meal contained 859 kcal. Participants 
were instructed to consume the meal at their usual dinner time. They were instructed to eat the 
whole meal and to not consume any food or drinks afterwards, but to only drink water, tea or coffee. 
On the morning of each test session, participants came to the university where they received a 
standardized breakfast, consisting of two bread rolls (960 kJ / 225 kcal), butter (140 kJ / 34 kcal), one 
slice of ham (59 kJ / 14 kcal), jelly (166 kJ / 41 kcal) and a cup of tea. The total breakfast contained 
314 kcal. Within 90 minutes after breakfast, an indwelling cannula was placed in the cephalic vein 
for blood sampling. Two hours after breakfast, a baseline blood sample was collected (T=-5). 
Participants were then presented with 100 g of either the palatable or the neutral brownie in a 
counter-balanced order; 13 participants received the palatable brownie at the first test session and 
the neutral brownie at the second test session, whereas the other 12 participants received the 
brownies in the reversed order. Importantly, to minimize expectations, participants were told that 
they would receive one of the six brownies that they had tasted during the screening session and 
that they would receive either two different brownies or the same brownie twice in both test 
sessions. After brownie presentation, participants were instructed to look at and smell the brownie 
for five minutes, but to not eat it (anticipation phase). Three and five minutes later blood was 
collected (T=-2, T=0). Subsequently participants were instructed to eat the brownie within five 
minutes and additional blood samples were collected one, three and five minutes (T=1, T=3, T=5) 
after participants started eating (consumption phase). Two participants did not consume the whole 
neutral brownie within five minutes, they ate 60 and 86 grams respectively. Data for both 
participants was included in analyses. Additional blood samples were collected at T=10, 15, 30, 45, 
60, 90, and 120 minutes after participants started eating (post-ingestive phase). An appetite 
questionnaire was used to assess hunger, appetite for something sweet, and appetite for something 
savoury on a 100 point VAS. This questionnaire was completed at T=-5, T=0, T=5 and T=7, 10, 15, 
30, 45, 60, 90, and 120 minutes after participants started eating. At T=5, immediately after eating 
the brownie, participants also rated liking of the brownie. At time points where the appetite 
questionnaire and blood drawing coincided, the questionnaire was directly followed by the blood 
sampling. See Figure 4.2 for a schematic overview of the procedures starting at the first appetite 
questionnaire and blood sampling. Not all parameters were measured at all time points. Relevant 
time points were selected based on literature (Mennella et al., 2015; Monteleone et al., 2013; 
Witteman et al., 1994). See Table 4.1 for an overview. 
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Table 4.1. Overview of parameters included in the different time points. 
 
 
Figure 4.2. Schematic overview of a test session from the first blood sampling. Time (T) in minutes. 
The triangles indicate blood sampling, the arrows indicate appetite questionnaire. At time points 
the appetite questionnaire and blood drawing coincided, the questionnaire was directly followed by 
the blood sampling. 
 
Blood sampling and biochemical analyses 
For glucose measures, a syringe was used to collect a blood drop from the cannula. With the 
HemoCue 201 glucose concentrations in whole blood were determined. For ghrelin, 
endocannabinoids and PP measures, blood was collected in tubes with EDTA as anticoagulant. For 
ghrelin, at all times except T=3 and T=15, one tube with EDTA and added AEBSF (Millipore) was 
collected. After centrifuging, HCl was added to a final concentration of 0.05 N. Immediately after 
collection, tubes were put on ice until being centrifuged at 1190 x g for 10 minutes at 4 °C. Plasma 
samples were portioned into aliquots and stored at -80 °C. To one aliquot, phenylmethylsulfonyl 
fluoride (Sigma-Aldrich) and URB602 (Sigma-Aldrich) were added to a final concentration of 100 
µM for both. This was done to inhibit breakdown of endocannabinoids. 
Plasma concentrations of the endocannabinoids AEA and 2-AG, and the related N-
acylethanolamines OEA, PEA, SEA, DHEA and DLE were measured using an LC-MS/MS technique 
as described elsewhere (Balvers et al., 2009). ELISAs were used to measure total ghrelin and PP 
concentrations (Millipore). 
 
Statistical analyses 
Results are expressed as means+SD unless otherwise specified. Paired-samples T-tests were 
used to compare liking scores of the palatable brownie to the neutral brownie at screening and 
Time: -5 -2 0 1 3 5 10 15 30 45 60 90 120 
eCB X X X X X X X X X X X X X 
PP X  X   X X X X X   X 
Ghrelin X X X X  X X  X X X X X 
Glucose X  X X X X X   X   X 
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during the test sessions. Mixed model ANOVAs were used to analyse the appetite ratings and 
biochemical parameters. Condition, i.e., palatable versus neutral brownie, time and condition*time 
were included as fixed factors, and subject was included as a random factor. When relevant, post-
hoc analyses were performed using Bonferroni correction. Results were considered statistically 
different at p<0.05. Statistical analyses were performed using SPSS version 22.0 (IBM Corporation, 
Armonk, New York, USA). 
 
Results 
Liking of brownies 
The palatable brownies were liked more than the neutral brownies in the screening session 
T(1,24)=16.38, p<0.05 (mean liking palatable brownie: 82±8, neutral brownie: 51±5). During the test 
sessions, liking of the palatable and neutral brownies was still significantly different, T(1,24)=2.37, 
p<0.05 (mean liking palatable brownie: 69±15, neutral brownie: 60±22), though the difference was 
smaller than expected based on the ratings during screening. 
 
Appetite ratings 
Hunger ratings did not differ between the two conditions, i.e., consuming a palatable or a 
neutral brownie, but did change over time (Figure 4.3). At T=-5, mean hunger ratings were 54±16 
and 57±15 for the palatable and the neutral condition, respectively. Reported hunger increased after 
exposure (viewing and smelling) to a brownie (mean hunger palatable brownie: 61±19, neutral 
brownie: 66±15), and decreased after consuming a brownie to a minimum at T=15 (palatable 
brownie: 38±18, neutral brownie: 45±22), all p<0.05. At T=120, reported hunger was comparable to 
before brownie exposure (palatable brownie: 59±22, neutral brownie: 60±20). 
Similar to the reported hunger ratings, reported appetite for sweet increased after viewing 
and smelling a brownie (mean score at T=-5 and T=0, respectively palatable brownie: 54±20 and 
65±19, neutral brownie: 53±19 and 65±18) and decreased after consuming a brownie, p<0.05 (mean 
score at T=5 palatable brownie: 47±22, neutral brownie: 45±25), but appetite for sweet did not differ 
between conditions, p>0.05. Appetite for savoury did not increase after viewing the brownie, p>0.05 
(mean score at T=-5 and T=0, respectively palatable brownie: 55±19 and 53±18, neutral brownie: 
57±20 and 59±22), but it did decrease after brownie consumption, p<0.05 (mean score at T=5 
palatable brownie: 39±21, neutral brownie: 51±25. 
 
Glucose 
Before brownie consumption, which was two hours after breakfast, mean glucose 
concentrations were 4.3±0.7 mmol/L for the palatable brownie and 4.1±1.0 mmol/L for the neutral 
brownie. These values are comparable to the study by Monteleone, et al (2012). Glucose 
concentrations increased after consuming either brownie to a maximum at T=45, p<0.05 (palatable 
brownie: 5.7±1.1 mmol/L, neutral brownie: 5.6±0.8 mmol/L) and did not differ between the 
palatable and the neutral brownie (Figure 4.3). 
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Figure 4.3. Hunger ratings (top panel) and glucose concentrations (bottom panel) during the test 
session (means±SD). Anticipation increases feelings of hunger (p<0.05), whereas food intake 
decreases feelings of hunger (p<0.05). * indicates significant difference from T=-5. 
 
 
Endocannabinoids 
AEA concentrations were not modulated by palatability, p>0.05, and they did not change 
after exposure (viewing and smelling) to a brownie, p>0.05. However, they did decrease after intake 
of either brownie to a minimum at T=90, p<0.05 (mean plasma concentrations at T=-5, T=0 and 
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Figure 4.3. Hunger ratings (top panel) and glucose concentrations (bottom panel) during the test 
session (means±SD). Anticipation increases feelings of hunger (p<0.05), whereas food intake 
decreases feelings of hunger (p<0.05). * indicates significant difference from T=-5. 
 
 
Endocannabinoids 
AEA concentrations were not modulated by palatability, p>0.05, and they did not change 
after exposure (viewing and smelling) to a brownie, p>0.05. However, they did decrease after intake 
of either brownie to a minimum at T=90, p<0.05 (mean plasma concentrations at T=-5, T=0 and 
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T=90 palatable brownie: 0.22±0.05, 0.22±0.05 ng/mL and 0.13±0.05 ng/mL; neutral brownie: 
0.22±0.05, 0.21±0.06 ng/mL and 0.13±0.05 ng/mL) (Figure 4.4). 
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Figure 4.4. AEA plasma concentrations during the test session (means±SD). * indicates significant 
difference from T=-5. 
 
Similar results were obtained for DLE, OEA, PEA and SEA, i.e., no differences were found 
between the palatable and the neutral brownie, all p>0.05, and concentrations did not change during 
anticipation or consumption, all p>0.05. However, concentrations were decreased near the end of 
the test sessions, all p<0.05 (Supplementary Figure 4.1).  
For DHEA and 2-AG, no differences were found between the palatable and the neutral 
brownie, both p>0.05, and contrary to the other endocannabinoids, concentrations did not change 
over time, both p>0.05 (Supplementary Figure 4.1). 
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Ghrelin concentrations did not differ between conditions, p>0.05, but did decrease over 
time leading to significantly decreased concentrations towards the end of the test session, p<0.05 for 
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PP 
Consuming a brownie lead to an immediate increase in PP concentrations p<0.05 (mean 
concentrations palatable brownie: 248±180 pg/mL and 376±218 pg/mL, neutral brownie: 200±203 
pg/mL and 352±237 pg/mL for T=0 and T=5 respectively), but this did not differ between the 
palatable and the neutral brownie, p>0.05 (Figure 4.5; see Supplementary Figure 4.2 for changes 
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Figure 4.5. Plasma ghrelin (top panel) and PP (bottom panel) concentrations during the test sessions 
(means±SD). * indicates significant difference from T=-5. 
 
 
Discussion 
To the best of our knowledge, the current study is the first to cover an elaborate profile of 
endocannabinoids, ghrelin and PP responses during anticipatory, consummatory and post-ingestive 
phases up to two hours after ingestion for a palatable versus a neutral food where palatability of the 
food was unknown until the first bite was taken. As expected, anticipation (viewing and smelling) 
of either brownie did not induce differences in endocannabinoid, ghrelin or PP plasma 
concentrations. Contrary to our hypotheses, results indicate no differences in endocannabinoid, 
ghrelin or PP responses between the palatable and the neutral brownie after brownie intake. We 
did find a decrease in plasma concentrations of most N-acylethanolamides after food intake, 
independent of palatability. 
In the current study, anticipation (viewing and smelling) did not affect endocannabinoid, 
ghrelin and PP concentrations. Anticipation of the palatable and the neutral brownie significantly 
increased feelings of hunger and appetite for sweet. Appetite for savoury did not change during 
anticipation. This is line with previous studies in which participants reported increased appetite for 
the food they were exposed to (see e.g. Fedoroff et al., 2003; Ramaekers et al., 2016). After brownie 
consumption, hunger concentrations, appetite for sweet and appetite for savoury decreased. Toward 
4 
 
56 
 
T=90 palatable brownie: 0.22±0.05, 0.22±0.05 ng/mL and 0.13±0.05 ng/mL; neutral brownie: 
0.22±0.05, 0.21±0.06 ng/mL and 0.13±0.05 ng/mL) (Figure 4.4). 
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Figure 4.4. AEA plasma concentrations during the test session (means±SD). * indicates significant 
difference from T=-5. 
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the end of the test session, which was close to normal lunch time in The Netherlands, participants 
started to feel more hungry again. 
Importantly, participants were told that they would receive either one of the six brownies 
they tasted during the screening session and that they would receive either two different brownies 
or the same brownie twice in both test sessions. This led to insecurity about brownie palatability 
until taking the first bite. As we did not find differences between the palatable and the neutral 
condition for any of the plasma parameters and appetite-related questions during anticipation, we 
conclude that we were successful in keeping participants insecure about brownie palatability. 
Ghrelin and 2-AG did not differentially respond to consumption of the palatable versus the 
neutral brownie. This finding is contrary to previous studies which suggested that anticipation of 
and consuming a palatable versus a neutral food increases 2-AG and ghrelin plasma concentrations 
(Monteleone et al., 2016; Monteleone et al., 2012; Rigamonti et al., 2015). These discrepancies might 
be caused by differences in expected palatability. In the current study, participants did not know 
the palatability of the brownie that they were about to consume until they took the first bite, 
whereas in previous studies palatability was known beforehand. Indeed, anticipation of palatable 
food has previously been shown to affect 2-AG and ghrelin concentrations (Monteleone et al., 2012; 
Rigamonti et al., 2015), and may have affected post-ingestive concentrations as well. Together, these 
findings suggest that expected, but not actual palatability affects 2-AG and ghrelin concentrations. 
This points to a role for 2-AG and ghrelin in motivation to eat and not in liking of a food during 
consumption. Indeed, ghrelin concentrations rise before meal initiation and correlate with self-
reported feelings of hunger (Cummings et al., 2004; Cummings et al., 2001). Exposure to palatable 
foods triggers a rise in ghrelin concentrations (Rigamonti et al., 2015; Schussler et al., 2012) and in 
this way may stimulate food intake. 
The role for ghrelin and the ECS in anticipation of food intake is substantiated by results 
from brain imaging studies. Ghrelin concentrations are related with brain activation in reward-
related areas in response to pictures of food, which cue food anticipation (Kroemer et al., 2013). 
Modulating ECS activity alters reward-related activation in response to the sight of chocolate 
(Horder et al., 2010; Tudge et al., 2015). Moreover, in animals it was found that ECS activation leads 
to increased motivation to obtain a palatable sucrose solution (Higgs et al., 2003), whereas ECS 
inhibition specifically decreases reward value of palatable foods (Higgs et al., 2003; Rasmussen et 
al., 2012). Future studies could investigate whether the ECS also modulates motivation to obtain 
food in humans. 
Ghrelin and the endocannabinoids AEA, OEA, PEA, SEA and DLE were decreased after 
food intake, whereas DHEA and 2-AG did not respond to food intake. For ghrelin, AEA, OEA and 
PEA, this is in line with previous studies (Cummings et al., 2001; Gatta-Cherifi et al., 2012; 
Monteleone et al., 2012; Rigamonti et al., 2015; Tschöp et al., 2001). Our finding that 2-AG is not 
affected by food intake is in line with a previous study (Gatta-Cherifi et al., 2012). For SEA, DLE 
and DHEA, the current study is the first to report pre- and post-ingestive profiles. SEA and DLE 
followed similar patterns as AEA, OEA and PEA, and might therefore play a role in food 
consumption in humans. More studies that measure these N-acylethanolamides after food intake 
are necessary to confirm the current results. 
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As expected, PP concentrations rose in response to food intake. However, there were no 
differences between palatable and neutral food intake. A previous study showed that PP 
concentrations were higher after tasting, but not swallowing, a palatable versus a neutral food 
(Mennella, et al., 2015). In the current study, participants swallowed the food, which caused a post-
ingestive response that may have overruled the effects of taste. PP does not play a role in anticipation 
of food intake, but the role of PP is more related to tasting a food and food ingestion. Previous studies 
showed that PP differentially responds to macronutrient content of foods (Crystal and Teff, 2006; 
Witteman et al., 1994), which might be more important than palatability. 
In the current study, we measured plasma concentrations of endocannabinoids. The exact 
function of plasma endocannabinoids remains to be elucidated. It has been suggested that plasma 
endocannabinoids are a result of spill-over from tissues like the brain and gut (Hill et al., 2008; 
Matias et al., 2012), however, it is unknown to what extent plasma concentrations reflect 
endocannabinoid concentrations in these other tissues. A previous study suggested a link between 
plasma endocannabinoid concentration and feelings of appetite (Friedman et al., 2016). 
An important strength of the current study is that we used one food product, i.e., brownie, 
which we modulated to only change liking (taste). Because we used one food product, 
macronutrient content and energy density were similar for both the palatable and the neutral food. 
Participants tasted and rated liking for six different brownies and for each participant the palatable 
and neutral brownie were selected based on individual liking. Even though brownies were selected 
to be experienced as palatable and neutral, the difference in liking ratings between the palatable 
and the neutral brownie during the test sessions was smaller, though still significant, than in the 
screening session. A possible explanation for this is that participants rated liking of one bite during 
the screening session and of 100 grams during the test session. In future studies it is recommended 
to also ask liking after one bite during the test session. 
In addition, to gain more insight into the respective roles of expected and actual palatability 
on the endocannabinoid, ghrelin and PP response to food intake, a future study could match and 
mismatch expected and actual palatability. Expected palatability has previously been shown to 
induce differences in 2-AG and ghrelin (Monteleone et al., 2012). If actual palatability does not 
affect these responses, then matched or mismatched foods should not induce different responses. 
Future studies that assess post-ingestive endocannabinoid concentrations should adhere to a similar 
sampling schedule to confirm the current results. In addition, it could be of interest to assess 
different types of foods, i.e. more snack-like versus complete meals, to investigate whether there are 
differences in endocannabinoid responses to different food types. 
In conclusion, food intake decreases concentrations of ghrelin, AEA, OEA, PEA, SEA, and 
DLE, but does not affect 2-AG or DHEA. In addition, it increases concentrations of PP. However, 
creating insecurity about the palatability of a food before the first bite is taken, blocks differences 
in endocannabinoid, ghrelin and PP responses during anticipatory, consummatory and post-
ingestive phases of consuming a palatable versus a neutral brownie. 
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Supplementary Figure 4.1: Plasma concentrations of the endocannabinoids 2-AG (top left panel), 
DHEA (top right panel), DLE (middle left panel), OEA (middle right panel), PEA (bottom left panel) 
and SEA (bottom right panel) during the test sessions (means±SD). * indicates significant difference 
from T=-5. 
Time (min)
Pl
as
m
a 
2-
AG
 (n
g/
m
l)
-5 0 5 10 15
0
2
4
6
8
10
30 60 90 120
Palatable
Neutral
Time (min)
Pl
as
m
a 
D
H
EA
 (n
g/
m
l)
-5 0 5 10 15
0.0
0.1
0.2
0.3
0.4
0.5
30 60 90 120
Palatable
Neutral
Time (min)
Pl
as
m
a 
D
LE
 (n
g/
m
l)
-5 0 5 10 15
0.00
0.02
0.04
0.06
0.08
30 60 90 120
Palatable
Neutral
* *
Time (min)
Pl
as
m
a 
O
EA
 (n
g/
m
l)
-5 0 5 10 15
0.0
0.5
1.0
1.5
2.0
2.5
30 60 90 120
Palatable
Neutral
*
*
Time (min)
Pl
as
m
a 
PE
A 
(n
g/
m
l)
-5 0 5 10 15
0.0
0.5
1.0
1.5
2.0
30 60 90 120
Palatable
Neutral
*
Time (min)
Pl
as
m
a 
SE
A 
(n
g/
m
l)
-5 0 5 10 15
0.0
0.5
1.0
1.5
2.0
30 60 90 120
Palatable
Neutral
*
*
 
  
4 
 
60 
 
Acknowledgements 
We would like to thank Anouk Andeweg, Henriëtte Fick-Brinkhof, Diana Emmen-Benink, Els 
Siebelink and Jantien Takens for their help in carrying out the study, and Richard Bas, Maarten 
Hekman, Frederique van Holthoon and Nhien Ly for their assistance with plasma analyses. 
Research presented in this publication was financially supported by the Graduate School VLAG. 
  
61 
 
Supplementary Figure 4.1: Plasma concentrations of the endocannabinoids 2-AG (top left panel), 
DHEA (top right panel), DLE (middle left panel), OEA (middle right panel), PEA (bottom left panel) 
and SEA (bottom right panel) during the test sessions (means±SD). * indicates significant difference 
from T=-5. 
Time (min)
Pl
as
m
a 
2-
AG
 (n
g/
m
l)
-5 0 5 10 15
0
2
4
6
8
10
30 60 90 120
Palatable
Neutral
Time (min)
Pl
as
m
a 
D
H
EA
 (n
g/
m
l)
-5 0 5 10 15
0.0
0.1
0.2
0.3
0.4
0.5
30 60 90 120
Palatable
Neutral
Time (min)
Pl
as
m
a 
D
LE
 (n
g/
m
l)
-5 0 5 10 15
0.00
0.02
0.04
0.06
0.08
30 60 90 120
Palatable
Neutral
* *
Time (min)
Pl
as
m
a 
O
EA
 (n
g/
m
l)
-5 0 5 10 15
0.0
0.5
1.0
1.5
2.0
2.5
30 60 90 120
Palatable
Neutral
*
*
Time (min)
Pl
as
m
a 
PE
A 
(n
g/
m
l)
-5 0 5 10 15
0.0
0.5
1.0
1.5
2.0
30 60 90 120
Palatable
Neutral
*
Time (min)
Pl
as
m
a 
SE
A 
(n
g/
m
l)
-5 0 5 10 15
0.0
0.5
1.0
1.5
2.0
30 60 90 120
Palatable
Neutral
*
*
 
  
 
 
62 
 
Supplementary Figure 4.2. Differences from baseline for plasma ghrelin (top panel) and PP (bottom 
panel) during the test sessions (means±SD). * indicates significant difference from T=-5. 
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Supplementary Figure 4.2. Differences from baseline for plasma ghrelin (top panel) and PP (bottom 
panel) during the test sessions (means±SD). * indicates significant difference from T=-5. 
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Abstract 
BACKGROUND: After Roux-en-Y gastric bypass (RYGB) surgery, patients report a shift in food 
intake from high-energy to low-energy foods, which corresponds with reported decreased desire to 
eat high-energy foods. However, follow-up over time has been limited and food preferences have 
not been measured in a forced-choice paradigm. An important advantage of forced-choice 
paradigms over liking questionnaires is that products from different food categories are directly 
compared, and this provides more insight into food choices. 
AIM: To assess the effect of RYGB on food preferences for four macronutrient and two taste 
categories from pre-surgery to two months and one year after surgery.  
METHODS: Seventy-nine RYGB patients completed an online food preference task, the 
Macronutrient and Taste Preference Ranking Task, two weeks before surgery, and two months and 
one year after surgery. 
RESULTS: Preference for high-carbohydrate and high-fat foods decreased, whereas preference for 
low-energy foods increased after surgery. Preference for sweet was decreased at two months, but 
not at one year after surgery. Compared with pre-surgery, liking of the high-carbohydrate and high-
fat foods decreased at two months and one year after surgery, whereas liking of low-energy foods 
was increased at one year after surgery only. Loss in BMI at one year after RYGB surgery was 
positively correlated with changes in preference for high-carbohydrate foods at one year after RYGB 
surgery. 
CONCLUSION: RYGB induces decreased preference for high-carbohydrate and high-fat foods, and 
increased preference for low-energy foods at two months and one year after surgery. These changes 
seem to be related to changes in liking of high-carbohydrate and high-fat foods. The change in 
preference for high-carbohydrate foods is significantly correlated with loss of BMI. 
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Introduction 
Currently, the most effective long-term treatment for obesity is bariatric surgery, with 
Roux-en-Y gastric bypass (RYGB) surgery regarded as the golden standard (Buchwald et al., 2004; 
Gloy et al., 2013). In RYGB, a small stomach pouch is created, and then attached to the jejunum. 
After surgery, food bypasses the distal stomach, duodenum and proximal part of the jejunum. 
Importantly, other surgical techniques, like vertical-banded gastroplasty and sleeve gastrectomy, 
only create a smaller stomach, but do not bypass the upper part of the intestine (Hng and Ang, 2012). 
After RYGB, patients not only lose weight, but they also change their dietary patterns. 
Patients have proportionally lower intake of fatty foods (Mathes and Spector, 2012; Meillon et al., 
2013) and some studies suggest increased consumption of fruit and vegetables (Laurenius et al., 2013; 
Ullrich et al., 2013). These changes in food choice and dietary patterns correspond with changes in 
measures of food reward (le Roux et al., 2011). Desire to eat high-energy foods was found to be 
decreased one month after surgery, whereas desire to eat low-energy foods did not change (Ochner 
et al., 2012b). In a progressive-ratio paradigm, patients were less willing to work for a chocolate 
reward eight weeks after compared to two weeks before RYGB. Effort for a vegetable reward did 
not change after surgery (Miras et al., 2012). After a longer period of time, median eight months 
after surgery, RYGB patients rated high-calorie foods as less appealing compared to BMI-matched 
participants (Scholtz et al., 2014). More than one year after surgery, RYGB patients reported a 
decreased urge for obtaining palatable foods (Schultes et al., 2010; Ullrich et al., 2013). Importantly, 
not all patients report decreased enjoyment of highly palatable foods and similarly, only part of the 
patients reports increased enjoyment of healthy foods. This higher enjoyment of healthy dietary 
behaviour is associated with successful weight loss after two years (Vuorinen et al., 2016). 
Thus far, most studies assessed food preferences at a single time-point and only a few studies 
have performed follow-up of changes in food reward or food intake over time. These studies suggest 
changes immediately after RYGB that last for twelve to eighteen months, but after two years, eating 
habits start to return to pre-surgery habits (Cushing et al., 2013; Laurenius et al., 2013). This return 
to pre-surgery habits might be related to weight regain that starts to occur after approximately two 
years in a subset of patients (Courcoulas et al., 2013; Magro et al., 2008). 
Although several studies assessed the changes in food reward after RYGB (Cushing et al., 
2013; le Roux et al., 2011; Ochner et al., 2012b), food preferences have not been measured in a 
forced-choice or ranking paradigm. An important advantage of forced-choice paradigms over liking 
questionnaires is that products from different food categories are directly compared. Two foods 
might be liked equally, but in a forced-choice procedure, preference for one food over the other 
may become apparent. The relative preference for one food over another can provide insight into 
motivation for the chosen food over the non-chosen food (Finlayson et al., 2008). 
Therefore, the aim of current study is to assess the effect of RYGB on relative food 
preferences for four macronutrient and two taste categories from pre-surgery to two months and 
one year after surgery. To reach this aim, food preferences were measured using the Macronutrient 
and Taste Preference Ranking Task (MTPRT; de Bruijn et al., 2017). In this task, participants are 
asked to rank four food products from different macronutrient and taste categories on how much 
they desire to eat those products at that moment. We hypothesised that at both time points after 
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Abstract 
BACKGROUND: After Roux-en-Y gastric bypass (RYGB) surgery, patients report a shift in food 
intake from high-energy to low-energy foods, which corresponds with reported decreased desire to 
eat high-energy foods. However, follow-up over time has been limited and food preferences have 
not been measured in a forced-choice paradigm. An important advantage of forced-choice 
paradigms over liking questionnaires is that products from different food categories are directly 
compared, and this provides more insight into food choices. 
AIM: To assess the effect of RYGB on food preferences for four macronutrient and two taste 
categories from pre-surgery to two months and one year after surgery.  
METHODS: Seventy-nine RYGB patients completed an online food preference task, the 
Macronutrient and Taste Preference Ranking Task, two weeks before surgery, and two months and 
one year after surgery. 
RESULTS: Preference for high-carbohydrate and high-fat foods decreased, whereas preference for 
low-energy foods increased after surgery. Preference for sweet was decreased at two months, but 
not at one year after surgery. Compared with pre-surgery, liking of the high-carbohydrate and high-
fat foods decreased at two months and one year after surgery, whereas liking of low-energy foods 
was increased at one year after surgery only. Loss in BMI at one year after RYGB surgery was 
positively correlated with changes in preference for high-carbohydrate foods at one year after RYGB 
surgery. 
CONCLUSION: RYGB induces decreased preference for high-carbohydrate and high-fat foods, and 
increased preference for low-energy foods at two months and one year after surgery. These changes 
seem to be related to changes in liking of high-carbohydrate and high-fat foods. The change in 
preference for high-carbohydrate foods is significantly correlated with loss of BMI. 
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Introduction 
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they desire to eat those products at that moment. We hypothesised that at both time points after 
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RYGB, preference for foods high in carbohydrate and fat would be decreased, and preference for 
low-energy foods would be increased. 
 
Methods 
Participants 
Seventy-nine participants (12 males) participated in the current study. Mean age at surgery 
was 42.3 years (SD=8.9) and mean BMI before surgery was 43.6 kg/m2 (SD=5.2). All participants 
were enlisted to undergo RYGB surgery at Rijnstate hospital, Arnhem, the Netherlands. 
Requirements for the surgery were a Body Mass Index (BMI) of >40 kg/m2 or >35 kg/m2 with co-
morbidity that was expected to improve after surgically-induced weight loss, long-lasting obesity 
(>5 years), proven failed attempts to lose weight in a conventional way, and intention to adhere to 
a postoperative follow-up program. Inclusion and screening of participants took place at Rijnstate 
hospital, on the same day as the standard intake for the surgery. Patients were individually informed 
about the study and asked to participate. When patients expressed interest to participate, they signed 
informed consent and completed a short questionnaire to check inclusion and exclusion criteria. 
Participants had to be between 18 and 65 years of age, and were excluded when they were allergic 
to products used in the MTPRT, reported a lack of appetite, or reported difficulties swallowing or 
eating. Participants received a gift card for their contribution. The protocol was approved by the 
Medical Ethical Committee of Wageningen University and was registered on clinicaltrials.gov as 
NCT02068001. 
 
Macronutrient and Taste Preference Task 
The MTPRT (de Bruijn et al., 2017) is a computerized task to assess liking of and food 
preferences for four macronutrient categories, i.e., high-carbohydrate, high-fat, high-protein and 
low-energy, and two taste categories, i.e., sweet and savoury. The MTPRT includes pictures of 32 
food products, equally divided over the macronutrient categories. Four out of the eight products per 
macronutrient category are sweet and the other four products are savoury, with the exception of 
the high-protein category that consists of eight savoury products. Participants first rate liking of all 
32 food products on a 100 point visual analogue scale (VAS) and are then presented with 28 arrays 
of four products. They are asked to rank the four products according to how much they desire to eat 
those products at that moment. The first sixteen rankings are focused on macronutrients and the 
four pictures represent products from all four macronutrient categories. The last twelve rankings 
are focused on taste and include two sweet and two savoury pictures, which come from two 
macronutrient categories. High-protein products are not used in this part of the task. Based on the 
rankings, relative preference scores for products from different macronutrient and taste categories, 
i.e. high-carbohydrate, high-fat, high-protein and low-energy, and sweet and savoury are calculated 
as described elsewhere (de Bruijn et al., 2017). Preference scores for the macronutrient categories 
can range from 1 to 4, with a higher score indicating a higher preference for a category. A score of 
1 indicates that all products from that category were ranked last; a score of 4 indicates all products 
from that category were ranked first. As each ranking in the taste section comprises two sweet and 
two savoury products, preference scores for sweet and savoury can range from 1.5 to 3.5. For both 
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macronutrient and taste categories, a score of 2.5 indicates no relative preference. Because 
preference scores for sweet and savoury are each other’s opposite, we only report preference scores 
for sweet in this article (de Bruijn et al., 2017). 
 
Procedure 
The online version of the MTPRT was presented in EyeQuestion software (Logic8 BV). 
Participants received an e-mail with a link to the MTPRT two weeks before, two months after and 
one year after surgery. They were asked to complete the task in one go, which took about fifteen 
minutes. In addition, participants were weighed before, and at four weeks and one year after surgery 
as part of standard care. 
Of the 79 participants who completed the online MTPRT before surgery, 66 participants 
completed the online MTPRT two months after surgery and 46 participants completed the online 
MTPRT one year after surgery. 
Of the 79 participants who completed the online MTPRT before surgery, weight was 
available of 78 participants before surgery, 74 participants at four weeks after surgery and of 43 
participants at one year after surgery. 
 
Data analysis 
Data are presented as means ± standard deviation (SD) unless otherwise specified. The 
rankings were used to calculate relative preference scores for the different macronutrient and taste 
categories as explained elsewhere (de Bruijn et al., 2017). Liking scores per category were calculated 
by taking the average liking of all products within a specific category. For example, liking ratings of 
all high-carbohydrate products were added up and divided by eight to calculate average liking of 
high-carbohydrate. 
Data was analysed using IBM SPSS 22 (IBM Corporation, Armonk, New York, USA). Results 
were considered statistically significant at p<0.05. 
Mixed models analysis was used to assess weight loss and differences in preference scores 
between time points. Time was added as fixed effect. Compound symmetry was chosen as covariance 
structure. When a statistically significant main effect was found, post-hoc analyses were performed 
using Bonferroni correction. 
To assess specific preferences within time points, Friedman ANOVA was used to compare 
preference scores for the macronutrients. When significant effects were found, Wilcoxon signed 
rank tests were used as post-hoc with Bonferroni correction. A Wilcoxon signed rank test was also 
used to assess relative preference for sweet or savoury taste. 
To gain more insight into the meaning of the relative preference scores, liking scores were 
compared using mixed models analyses with time as fixed effect and participant ID as random factor. 
When a statistically significant main effect was found, post-hoc analyses were performed using 
Bonferroni correction. To assess differences in liking within time points, one-way ANOVA was used 
to compare liking of the macronutrients. When significant effects were found, post-hoc analyses 
were performed using Bonferroni correction. A paired-samples T-test was used to asses differences 
in liking for sweet or savoury taste within time points. 
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To assess correlations between BMI loss and changes in food preferences, Spearman’s rank 
correlation coefficient was used. For this, change in BMI and change in preference scores from 
before surgery to two months and to one year after RYGB surgery were used. 
 
Results 
Weight loss 
Before surgery, participants had a mean weight of 126±18 kg and a mean BMI of 43.6±5.2 
kg/m2. After surgery, participants lost weight to a mean weight of 116±18 kg at four weeks and 
82±15 kg at one year after RYGB surgery. BMI decreased to 40.1±5.4 kg/m2 at four weeks and 
28.7±4.8 kg/m2 at one year after RYGB surgery, p<0.05. 
 
Ranking 
Food preference scores for the four macronutrient categories are shown in Figure 5.1. 
Preference for high-carbohydrate and high-fat foods were decreased two months and one year after 
surgery compared to before, all p<0.05. Preference for low-energy foods was increased two months 
and one year after surgery, p<0.05. Preference for high-protein foods did not change over time, 
p>0.05. 
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Figure 5.1. Preference scores for high-carbohydrate (A), high-fat (B), high-protein (C) and low-
energy (D) before, two months after and one year after RYGB surgery. Means±SD. * indicates 
significant change compared to before surgery at p<0.05 level. The dotted line represents chance 
level. 
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Preference for sweet
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Figure 5.2. Preference for sweet before, two months after and one year after RYGB surgery. 
Means±SD. * indicates significant change compared to before surgery at p<0.05 level. Dotted line 
represents chance level. 
 
Before surgery, participants had a lower preference for high-carbohydrate foods compared 
to the other macronutrients, all p<0.05. Two months after surgery, participants had a preference for 
low-energy foods over the other macronutrient categories, all p<0.05. In addition, preference for 
high-protein foods was higher than preference for high-carbohydrate and high-fat foods, both 
p<0.05. Preference for high-carbohydrate and high-fat foods did not differ, p>0.05. At one year after 
surgery, participants showed a preference for low-energy and high-protein foods over high-
carbohydrate and high-fat foods, all p<0.05. 
Preference for sweet is shown in Figure 5.2. Preference for sweet foods changed over time, 
p<0.05. Post-hoc analyses showed that preference for sweet foods was decreased at two months after 
surgery compared to before, but not at one year. Before surgery, participants had a preference for 
sweet over savoury taste, Z=-4.51, p<0.001. After surgery, participants did not have a preference for 
either taste; Z=-1.68, p=0.09 and Z=-1.71, p=0.09 at two months and one year after surgery 
respectively. 
 
Liking 
Mean liking scores for the macronutrient categories are shown in Figure 5.3. Liking of high-
carbohydrate, high-fat and low-energy foods changed over time, all p<0.05. Bonferroni-corrected 
post-hoc analyses showed that the high-carbohydrate and high-fat foods were liked less at two 
months and one year after surgery, all p<0.05. In addition, they indicated increased liking of the 
low-energy foods one year after surgery, p=0.05. Similar to the rankings, liking of high-protein foods 
did not change over time, p>0.05. 
Before surgery, liking of high-carbohydrate and high-fat foods was lower than liking of low-
energy foods. High-protein foods were liked more than high-carbohydrate foods, all p<0.05. Two 
months and one year after surgery, low-energy foods were liked more than all other foods. High-
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protein foods were liked more than high-carbohydrate and high-fat foods. Liking for the latter two 
did not differ. 
Mean liking scores for the taste categories are shown in Figure 5.3. Similar to the preference 
scores, liking of sweet foods differed over time, p<0.05. At two months and one year after surgery, 
participants indicated that they liked the sweet foods less than before surgery, p<0.05. Liking of 
savoury foods did not change over time, p>0.05. Before, two months after and one year after RYGB 
surgery, sweet foods were liked more than savoury foods, all p>0.05. 
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Figure 5.3. Average liking of high-carbohydrate (A), high-fat (B), high-protein (C), low-energy (D), 
sweet (E) and savoury (F) foods before, two months after and one year after RYGB surgery. 
Means±SD * indicates significant change compared to before surgery at p<0.05 level. 
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Correlations 
Loss in BMI over one year was positively correlated with a decrease in preference for high-
carbohydrate foods over one year, r=0.605, p<0.05, see Figure 5.4. Loss in BMI did not correlate with 
changes in preference for foods from other macronutrient or taste categories. 
 
Figure 5.4. Correlation between change in BMI and change in preference for high-carbohydrate 
foods over one year after RYGB surgery. R=0.605, p<0.05. 
 
Discussion 
The current study assessed changes in food preferences two months and one year after 
compared with before RYGB surgery. Preference for high-carbohydrate and high-fat foods 
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Figure 5.3. Average liking of high-carbohydrate (A), high-fat (B), high-protein (C), low-energy (D), 
sweet (E) and savoury (F) foods before, two months after and one year after RYGB surgery. 
Means±SD * indicates significant change compared to before surgery at p<0.05 level. 
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Correlations 
Loss in BMI over one year was positively correlated with a decrease in preference for high-
carbohydrate foods over one year, r=0.605, p<0.05, see Figure 5.4. Loss in BMI did not correlate with 
changes in preference for foods from other macronutrient or taste categories. 
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that is, decreased liking of high-energy foods and unchanged liking of low-energy foods after RYGB 
surgery (Faulconbridge et al., 2016; Ochner et al., 2012b). In line with this, a previous study showed 
decreased reward value of a high-energy food and unchanged reward value of a low-energy food 
after RYGB surgery (Miras et al., 2012). 
The mechanisms behind the changes in food preferences remain to be determined. Previous 
studies showed lower neural responsivity to high-energy foods after compared with before RYGB 
surgery (Hansen et al., 2016). The neural changes correlate with changes in desire to eat high-energy 
foods (Ochner et al., 2012b). Another important change that has been suggested to occur after RYGB 
is changes in appetite-related gut hormones. A rise in gut hormone concentrations after RYGB 
surgery might contribute to an increased sensation of satiety (Borg et al., 2006; Meek et al., 2016; 
Pedersen, 2013). Furthermore, changes in fasting ghrelin concentrations were found to be related 
to changes in neural responsivity to high-energy foods (Faulconbridge et al., 2016). However, more 
studies in larger populations are necessary to be able to draw more definitive conclusions. 
Another reason for changed food preferences is negative consequences of intake of high-
energy foods after RYG surgery. It is estimated that 75% of patients experiences dumping syndrome 
to some extent after RYGB surgery, characterized by sweating, palpitation, dizziness and nausea in 
response to foods high in sugar or fat (Hammer, 2012; Li-Ling and Irving, 2001). Some studie suggest 
that dumping syndrome decreases preferences for high-energy foods (Schultes et al., 2010; 
Sugerman et al., 1987). It would be interesting for future studies to investigate the effects of dumping 
on changes in food preference and liking. 
Prior to surgery, high-carbohydrate foods were preferred less relative to foods from the 
other macronutrient categories. As for liking, high-carbohydrate foods were liked less than high-
protein and low-energy foods. This difference in liking might have caused the dispreference for 
high-carbohydrate foods, although high-fat foods were also liked less than the high-protein and 
low-energy foods but were not ranked lower. In a previous study that used the MTPRT, high-
carbohydrate foods were also liked and preferred less than the other macronutrient categories in a 
healthy population (de Vries et al., 2017). Further studies are needed to gain insight into the reasons 
for lower preference for and liking of the high-carbohydrate foods. 
The current study was performed on-line. This way patients could easily participate from 
home at the time of their convenience, instead of having to travel to a test location or inviting 
researchers to their house for a fifteen-minute test session. However, this gain of convenience led 
to loss of control over the circumstances under which participants completed the MTPRT. Future 
on-line studies could take this into account by including a few questions about time since last meal 
and details on the location and social context. 
It is important to note that the rankings in the current study are subject to positive bias, as 
participants might have had a tendency to give socially desirable answers. These participants are 
encouraged to lose weight prior to surgery, which makes the low-energy foods the “better” foods. 
In addition, these patients commonly have a long history of non-surgical weight loss attempts. We 
would therefore expect that socially desirable answers in the sense that low-energy foods are “liked” 
and “preferred” are given to the same extent before as after surgery. 
The ranking procedure employed in the current study provides more insight into food 
preferences, as it captures motivation to eat the higher ranked foods over the others. Food choice is 
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more than just a comparison of what product is liked more, and liking only predicts food choice to 
a certain extent. However, it remains to be determined to what extent food choice in the MTPRT 
predicts actual food choice. Thus far, one study employed an ad libitum buffet meal test in a gastric 
bypass population. They showed no differences in food choice in the buffet, but an increased 
preference for low-fat savoury foods in a picture display test (Nielsen et al., 2017). As results of the 
picture display task were not reported for the separate categories, it is unknown whether this effect 
is driven by higher preference for low-fat or for savoury foods. The food products in the buffet and 
in the picture display test were divided over high- and low-fat and sweet and savoury, but the study 
does not provide insight into energy density (Nielsen et al., 2017), which could explain why no 
differences in food choice in the buffet task were found. 
Even though the current study is one of the few studies to assess (changes in) food 
preferences over a longer period of time, an increased follow-up time would be interesting. Given 
that weight regain starts at eighteen to twenty-four months (Courcoulas et al., 2013; Magro et al., 
2008), future studies should include follow-up at two years after surgery, to assess whether food 
preferences remain constant after surgery or return to pre-surgery status. 
To conclude, RYGB induces decreased preference for high-carbohydrate and high-fat foods, 
and increased preference for low-energy foods at two months and one year after surgery. These 
changes seem to be related to decreased liking of high-carbohydrate and high-fat foods. The change 
in preference for foods high in carbohydrates is significantly correlated with loss of BMI. 
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Abstract 
BACKGROUND: After Roux-en-Y gastric bypass (RYGB) surgery, patients report a shift in food 
preferences away from high-energy foods.  
OBJECTIVE: We aimed to elucidate the potential mechanisms underlying this shift in food 
preferences by assessing changes in neural responses to food pictures and odours before and after 
RYGB. Additionally, we investigated whether altered neural responsivity was associated with 
changes in plasma endocannabinoid and ghrelin concentrations. 
DESIGN: 19 RYGB patients (4 men; age 41±10 years; BMI 41±1 kg/m2 before; BMI 36±1 kg/m2 after) 
participated in this study. Before and two months after RYGB surgery, they rated their food 
preferences using the Macronutrient and Taste Preference Ranking Task and BOLD fMRI responses 
towards pictures and odours of high-, and low-energy foods and non-food items were measured. 
Blood samples were taken to determine plasma endocannabinoid and ghrelin concentrations pre- 
and post-surgery. 
RESULTS: Patients demonstrated a shift in food preferences away from high-fat/sweet and towards 
low-energy/savoury food products, which correlated with decreased superior parietal lobule 
responsivity to high-energy food odour and a reduced difference in precuneus responsivity to high-
energy versus low-energy food pictures. In the anteroventral prefrontal cortex (superior frontal 
gyrus) the difference in deactivation towards high-energy versus non-food odours reduced. The 
precuneus was less deactivated in response to all cues. Plasma concentrations of anandamide were 
higher after surgery, while plasma concentrations of other endocannabinoids and ghrelin did not 
change. Alterations in appetite-related hormone concentrations did not correlate with changes in 
neural responsivity.  
CONCLUSIONS: RYGB leads to changed responsivity of the frontoparietal control network that 
orchestrates top-down control to high-energy food compared to low-energy food and non-food 
cues, rather than in reward related brain regions, in a satiated state. Together with correlations with 
the shift in food preference from high- to low-energy foods this indicates a possible role in new food 
preference formation.  
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Introduction 
Roux-en-Y gastric bypass (RYGB) surgery is currently the most effective long-term 
treatment for morbid obesity (Sjöström, 2013). After RYGB, patients report decreased hunger and 
lower caloric intake. In addition, a shift in food preferences from high- to low-energy foods is 
typically observed (Hansen et al., 2016). This change in food preferences has been related to 
alterations in taste perception and food reward, with fMRI studies showing decreased activation in 
the mesocorticolimbic reward network in response to high-energy compared to low-energy food 
cues (Behary and Miras, 2015). However, the exact mechanism behind this shift in food preferences 
and related neural responses is not completely understood. Potential mediators include changes in 
subjective hedonic evaluation of food (cues), changes in gut hormones signalling hunger and satiety, 
post-ingestive side effects of surgery, and changes in nutrient sensing in the gut (Meillon et al., 
2013). A better understanding of the mechanisms behind changed food preferences may help to 
identify factors responsible for the success of this weight-loss intervention, and might guide novel 
non-surgical strategies that have less risk of complications. 
As previously shown, the decreased desire to eat high-energy foods correlates with 
decreased activation in reward-related brain areas to pictures of high-energy compared to low-
energy foods (Behary and Miras, 2015; Hansen et al., 2016; Ochner et al., 2012b). In a scanner setting 
it is difficult to realistically mimic an eating environment and thus far, neuroimaging studies used 
pictures as food cue. However, other sensory modalities might be equally or more important for 
food choice and the anticipation of food intake. Specifically, food odours play a crucial role in 
initiating food intake (Bragulat et al., 2010; McCrickerd and Forde, 2016; Yeomans, 2006) by 
steering appetite (Zoon et al., 2016) and cravings for specific foods (Fedoroff et al., 2003; Larsen et 
al., 2012). Given their largely unconscious role in priming eating decisions, it is of interest to 
investigate (alterations in) neural reward responses to palatable food odours as well, in relation to 
changes in food preferences after RYGB.  
There is mounting evidence that gut hormones play a role in altered food preferences after 
RYGB (Pedersen, 2013). In general, gut hormones play an important role in food choice and food 
intake, by signalling nutritional status and food reward value to the brain (Bewick, 2012). Most gut 
hormones are anorexigenic, with higher circulating plasma concentrations resulting in a suppression 
of food intake. Ghrelin, however, is an orexigenic gut hormone that can stimulate food intake (Wren 
et al., 2000). Moreover, ghrelin is not only involved in regulating homeostatic eating; eating to fill 
a need for energy or nutrients, but also in hedonic eating; eating for pleasure (Buss et al., 2014; 
Monteleone et al., 2012). The orexigenic effect of ghrelin appears to be mediated through the 
endocannabinoid (eCB) system (Kola et al., 2008). The eCB system is a neuromodulatory system that 
consists of endogenous ligands, so called endocannabinoids, their receptors and enzymes involved 
in their synthesis and breakdown. Ghrelin and eCB plasma concentrations increase in anticipation 
of hedonic eating (Monteleone et al., 2012; Rigamonti et al., 2015), and neuroimaging studies suggest 
a role for ghrelin and the eCB system in reward processing (Horder et al., 2010; Kroemer et al., 2013; 
Tudge et al., 2015). Thus far, only a few studies examined the role of ghrelin, and none have explored 
the eCB system, in relation to altered brain reward activation after RYGB and food preferences 
(Faulconbridge et al., 2016; Scholtz et al., 2014). 
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To improve our understanding of the changes in food preferences typically seen after RYGB, 
we assessed neural changes in response to high- and low-energy appetizing food cues in two 
different sensory modalities: odours and pictures. Additionally, to better explain these neural 
mechanisms, plasma eCB and ghrelin concentrations, as well as food preferences were measured 
and correlated to changes in brain activation pre- to post-surgery. 
 
Participants and Methods 
Participants 
Twenty-one morbidly obese individuals participated in this study. All participants were 
enlisted to undergo RYGB surgery at Rijnstate hospital, Arnhem, the Netherlands. Requirements 
for the surgery were: Body Mass Index (BMI) of >40 kg/m2 or >35 kg/m2 with co-morbidity that 
was expected to improve after surgically-induced weight loss, long-lasting obesity (>5 years), proven 
failed attempts to lose weight in a conventional way, intention to adhere to a postoperative follow-
up program. Reasons not to consider individuals for surgery were being pregnant or lactating, 
psychiatric disorders, alcohol or drug dependency, life threatening conditions or being dependent 
on the care of others. Individuals were screened for participation in the study at Rijnstate hospital. 
All participants were right-handed, non-smoking, did not have conditions that interfered with the 
MRI measurements (e.g. claustrophobic, metal implants, pacemaker, neurological disorders), had a 
normal sense of smell (scoring ≥10 on the identification part of the Sniffin' Sticks; Hummel et al., 
2007), were not vegetarian and did not have allergies or intolerances to the foods used and cued 
(visual/olfactory stimuli) in the study. Participants received a monetary reward for their 
contribution. All participants provided written informed consent before entering the study. The 
protocol was approved by the Medical Ethical Committee of Wageningen University 
(NL45837.081.13) and was executed in accordance with the ethical principles of the Declaration of 
Helsinki of 1975, as revised in 2013.  
 
Overall design and experimental procedure 
This study had a 2x2x3 within-subject design, including the factors time (pre- and post-
gastric bypass surgery), stimulus modality (visual/olfactory) and stimulus category (high-fat/high-
sugar (HFHS) food, low-fat/low-sugar (LFLS) food, Non-Food (NF)).  
Participants visited the test facilities at three occasions. First, they were familiarized with the MRI 
test environment and the experimental task and stimuli used, in a dummy MRI scanner at 
Wageningen University (training session). Following the training session, there were two identical 
test sessions during which the actual measurements were taken. The first test session took place 3.4 
(SD=1.8) weeks before and the second test session took place 9.2 (SD=1.3) weeks after RYGB. Each 
participant was scanned at approximately the same time of day for both sessions, between 14:00-
17:00 at hospital Gelderse Vallei (Ede, The Netherlands). Participants were instructed to refrain 
from eating and drinking anything but water and weak tea in the three hours before a test session. 
Upon arrival at the hospital, blood samples were taken for analysis of plasma endocannabinoid and 
ghrelin concentrations. In order to measure responses underlying hedonic eating (eating for 
pleasure, in the absence of hunger), participants were offered orange juice, and after a short break 
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they consumed a standardized meal consisting of bread roll(s), cheese, ham and butter (see 
Supplementary Table 6.1 for more detailed information), to evoke a state of satiety (Table 6.1). 
Following this, they waited for 15 minutes to allow digestion. Before entering the MRI room, 
participants were presented with the odours and pictures used in the reward task to familiarize with 
the stimuli and reinforce the appropriate association with the stimuli. They also rated their hunger, 
fullness, prospective consumption, desire to eat, and thirst on 100 point visual analogue scales (VAS). 
During the scan session, first, a reward task was performed while functional MR images were 
acquired. Second, structural MR images were collected. Thereafter, participants took part in two 
additional functional runs in which a food-related go/no-go task was performed (data reported 
elsewhere). At the end of the test session, olfactory performance was assessed using the Sniffin’ 
Sticks (threshold, discrimination, identification; Hummel et al., 2007). The regular Identification 16 
was used during screening, thus to prevent a potential learning effect, we used the Identification 
16+ for the second test session (Sorokowska et al., 2015). Paired sample T-tests revealed that the 
overall olfactory performance (TDI score) was not different between test sessions (before: 33.7±4.7; 
after: 35.0±4.2; p=0.328). 
 
Table 6.1. Weight and hunger ratings pre- and post-surgery. 
  Pre-surgery Post-surgery Significance 
Weight (kg)  120±14 104±15 p<0.001 
BMI (kg/m2)  41±3 36±4 p<0.001 
Hunger 13±21 11±24 p=0.738 
Fullness 70±25 68±34 p=0.867 
Prospective consumption 27±25 8±18 p=0.020 
Desire to eat 22±20 12±23 p=0.197 
Thirst 66±26 51±30 p=0.022 
Hunger ratings performed on a 100 point VAS. Values are means±SD. BMI = Body mass index. 
 
Food preferences  
Food preferences were assessed two weeks before and two months after RYGB using the 
online version of the macronutrient and taste preference ranking task (MTPRT; de Bruijn et al., 
2017). In this task, participants were presented with four pictures of different food products at a 
time and asked to rank the products according to what they most desire to eat at that moment. Food 
products included in this task were either high in carbohydrate, high in fat, high in protein or low 
in energy, and had a sweet or savoury taste. The MTPRT was presented in EyeQuestion software 
(Logic8 BV). 
 
Food stimuli (odours and pictures) 
Odours and pictures were selected to signal either high-fat, high-sugar food (HFHS), low-
fat, low-sugar food (LFLS) or non-food (NF) items (as control) by means of pilot studies in separate 
samples of participants. Odours were selected to be similar in perceived intensity and liking, 
different in the associated energy-density, and correctly associated to the corresponding food 
product/object. The selected odours were Chocolate (HFHS; International Flavors and Fragrances 
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To improve our understanding of the changes in food preferences typically seen after RYGB, 
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(IFF) 10810180; 8.5% in Propylene Glycol (PG)), Caramel (HFHS; IFF 10895342; 20% in PG), 
Tomato (LFLS; IFF 15039016; 24% in PG), Cucumber (LFLS; IFF 73519595; 34% in PG), Fresh Green 
(NF; AllSens–Voit Aroma Factory No. 819; 2.2% in PG), Wood (NF; AllSens–Voit Aroma Factory 
No. 821; 2.2% in PG). Pictures were selected to be similar in liking, and consistently matched to a 
food product/object and to one of the selected odours. For each odour we selected three different 
pictures to reduce effects of boredom. We selected Chocolate muffin, Brownie, and Chocolate 
bonbons for Chocolate odour; Caramel ice-cream, Stroopwafel (Dutch caramel syrup waffle), and 
Boterkoek (Shortbread) for Caramel odour; Tomato slices with pepper, Tomato slices, and Tomato 
slices with basil for Tomato odour; Cucumber slices with peel, Cucumber salad, and Cucumber 
chunks for Cucumber odour; Green soap, Tulips, and White flowers for Fresh Green odour; and 
Chunk of wood, Pine branches, and Purple soap for Wood odour. Standardized food images used in 
the fMRI task were provided by the Image Sciences Institute, UMC Utrecht, and created as part of 
the Full4Health project (www.full4health.eu), funded by the European Union Seventh Framework 
Program (FP7/2007-2013) under grant agreement nr. 266408, and the I.Family project 
(http://www.ifamilystudy.eu), grant agreement nr. 266044 (Charbonnier et al., 2015b). 
 
(f)MRI paradigm and measurements 
The reward task lasted ~40 min and consisted of olfactory and visual cues of HFHS food, 
LFLS food and NF were presented one by one, in pseudo random order (see Figure 6.1). Six olfactory 
stimuli and 18 visual stimuli (3 related to each odour) were presented. Each odour was presented 15 
times and each picture was presented 5 times, resulting in a total of 90 odour and 90 visual 
presentations. Trials started with the presentation of a red fixation cross (1s) during which 
participants were instructed to slowly inhale via the nose. Following this, either an odour or a 
picture (2s) was presented. During presentation of an odour the red fixation cross remained on the 
screen. Over the entire run participants were asked to provide liking and wanting ratings twice for 
each stimulus, and intensity ratings for the odours (7s). Between trials a rest period (3-11s) was 
included, during which a white fixation cross was visible. The inter-stimulus interval between 
odour presentations was kept between 17-24 s to prevent adaptation and was jittered to prevent 
habituation. Olfactory stimuli were presented using an fMRI-compatible computer-controlled 8-
channel olfactometer (Burghart, Wedel, Germany) that delivered the odours via a small nasal 
cannula in a constant air flow (8 L/min) that was heated to 37 °C and humidified to 80% relative 
humidity to prevent irritation of the nasal mucosa. Visual stimuli were projected using a back-
projection screen, which could be viewed by the participants via a mirror positioned on the head 
coil. The reward task ran in E-Prime 2.0 Professional (Psychology Software Tools Inc.). An MR 
compatible button box was used to answer questions in the task. Head movements were restricted 
by placing foam cushions next to the participants’ head. In addition, surgical tape was placed across 
the forehead to provide feedback on head movements. Earplugs were provided for noise reduction.  
A 3-Tesla Siemens Magnetom Verio MRI scanner in combination with a 32-channel head 
coil was used, to acquire 993 T2*-weighted gradient echo images with BOLD contrast (repetition 
time = 2240 ms, echo time = 25 ms, flip angle = 90°, field of view = 192 x 192 mm, 45 axial slices, 
ascending order, voxel size 3 x 3 x 3 mm) in one functional run. The imaging volume was tilted at 
an oblique angle of 30° to the anterior-posterior commissure line to reduce signal dropout in the 
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orbitofrontal and ventral temporal lobes (Deichmann et al., 2003). A high-resolution T1-weighted 
anatomical MRI scan was acquired (MPRAGE: repetition time = 1900 ms, echo time = 2.26 ms, flip 
angle = 9°, field of view = 256 x 256 mm, 192 sagittal slices, voxel size = 0.5 x 0.5 x 1 mm).  
 
Figure 6.1. Design of the fMRI reward paradigm. Trial presentation started with a red fixation cross 
for 1s during which participants were instructed to slowly inhale via the nose (‘slowly sniff’), an 
odour or picture was then presented for 2s. Occasionally participants provided liking, wanting or 
intensity ratings on a 100 point VAS within 7s. Between trials a rest period (3-11s) was included, 
during which a white fixation cross was visible. 
 
Data analyses 
Results are expressed as means ± SD unless otherwise specified. Behavioural data were 
analysed in SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA). Results were 
considered statistically significant at p<0.05. Paired-samples T-tests were used to test differences in 
weight, BMI and hunger ratings pre- and post-surgery. Mixed-models were used to analyse the 
differences in liking, wanting and intensity ratings that were provided in the test sessions before 
surgery and after surgery (see Supplementary Table 6.2). 
Food preferences. Sixteen participants completed the online MTPRT pre- and post-surgery. 
Preference scores for high-fat sweet and low-energy savoury products were calculated based on 
rankings in the MTPRT using the formula below. The higher the rank, the higher the score. The 
preference scores can range from 1 to 4 (de Bruijn et al., 2017). 
𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝 𝑠𝑠𝑝𝑝𝑠𝑠𝑝𝑝𝑝𝑝 =
4 ∗ (# 𝑝𝑝𝑟𝑟𝑝𝑝𝑟𝑟 1) + 3 ∗ (# 𝑝𝑝𝑟𝑟𝑝𝑝𝑟𝑟 2) + 2 ∗ (# 𝑝𝑝𝑟𝑟𝑝𝑝𝑟𝑟 3) + 1 ∗ (# 𝑝𝑝𝑟𝑟𝑝𝑝𝑟𝑟 4)
8
 
Paired samples T-test were used to compare preference scores for high-fat sweet and low-
energy savoury pre- and post-surgery. 
Ghrelin and endocannabinoids. Blood was collected in tubes with EDTA as anticoagulant. 
To one tube, 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (Sigma-Aldrich) was added 
to reach a concentration of 1 mg/ml in the collected blood. The tubes were centrifuged at 1300 x g 
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for 10 minutes at 4 °C. Plasma was then portioned into aliquots and stored at -80 °C. Prior to storage, 
hydrochloric acid was added to a final concentration of 0.05 N to the plasma that contained 4-(2-
aminoethyl)benzenesulfonyl fluoride hydrochloride. This plasma was later used for ghrelin 
analyses. To another aliquot, phenylmethylsulfonyl fluoride (Sigma-Aldrich) and URB602 (Sigma-
Aldrich) were added to a final concentration of 100 µM for both. This was used to measure plasma 
concentrations of the eCBs anandamide and 2-arachidonoylglycerol (2-AG), and the related N-
acylethanolamines docosahexaenoyl ethanolamide (DHEA), dihomo-γ-linoleonylethanolamide 
(DLE), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), stearoylethanolamide (SEA), 
using an LC-MS/MS technique described elsewhere (Balvers et al., 2009). ELISA was used to 
measure total ghrelin concentrations in plasma (Millipore). 
For each biochemical parameter, normality was checked. Only DHEA was normally 
distributed and a paired-samples T-test was used to compare plasma concentrations before and two 
months after surgery. For all other parameters Related-Samples Wilcoxon Signed Rank Tests were 
used. Correlations between pre- to post- surgery changes in gut hormones (eCBs, ghrelin) and 
changes in BMI, changes in body weight, and changes in liking and wanting of the stimuli were 
tested in SPSS using Spearman’s rho correlation coefficient. 
fMRI. Two out of 21 datasets were excluded from further analyses, because realignment 
parameters indicated substantial movement artefacts (>5 mm). Whole brain functional images of 19 
individuals (4 men and 15 women; age 41±10 years) were preprocessed and analysed using the 
SPM12 software package (Wellcome Trust Centre for Neuroimaging, London, UK) run with 
MATLAB 7.12.0 (R2011a, The Mathworks Inc.). Functional images were slice timed, realigned and 
coregistered. A DARTEL framework was used to create a study-specific template and participant-
specific deformation fields (Ashburner, 2007). The images were then spatially normalized to the 
MNI standard brain using the study-specific DARTEL template and the participant-specific 
deformation fields. Smoothing was applied to the normalized images using an isotropic Gaussian 
kernel with a 6-mm full width at half maximum.  
Subject level analyses: Each test session (pre-/post-surgery) was modelled separately. Motion 
related variance was corrected for by including motion-correction parameters in the model. Subject 
level analyses included calculation of six contrast images for odour, and six contrast images for 
picture presentations (HFHS vs rest; LFLS vs rest; NF vs rest; HFHS vs LFLS; HFHS vs NF; LFLS vs 
NF). Image calculation was used to subtract the contrast images post-surgery from the contrast 
images pre-surgery, creating a contrast image in which the within-subject changes from pre- to 
post-RYGB were captured.  
Group level analyses: For our main contrast of interest, pre- to post-surgery changes in the 
difference between BOLD responses to HFHS and LFLS cues (HFHS>LFLSpre-HFHS>LFLSpost) 
were analysed for odours and pictures in two separate T-tests. Six T-tests were performed to analyse 
pre- to post-surgery differences in BOLD responses to the different stimulus categories (HFHSpre-
HFHSpost; LFLSpre-LFLSpost; NFpre-NFpost;), for visual and olfactory cues separately. Also, we 
performed four T-tests to analyse differences in BOLD responses between HFHS and NF stimuli and 
between LFLS and NF stimuli (HFHS>NFpre-HFHS>NFpost; LFLS>NFpre-LFLS>NFpost), separate 
for odours and pictures. We used a whole brain approach, with a significance level of p=.001 (unc.) 
and a cluster extent threshold of k=8 contiguous voxels. For all contrasts, the mean beta values of 
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significant clusters were extracted with use of the MarsBar toolbox 
(http://marsbar.sourceforge.net/). Mean beta values of each significant cluster were subsequently 
correlated with pre- to post- surgery changes in endocannabinoid and ghrelin concentrations, 
changes in BMI, changes in body weight, changes in liking and wanting of the stimuli, and changes 
in preference for high-fat sweet and low-energy savoury products. Correlation analyses were 
performed in SPSS using Spearman’s rho correlation coefficient.  
 
Results 
After RYGB surgery, the mean body weight of our study population decreased from 120±3 
to 104±3 kg, a mean weight loss of 16±4 kg. This weight change led to a decrease in BMI from 41±1 
to 36±1 kg/m2 (see Table 6.1).  
 
Hunger, liking and wanting ratings 
Our standardized meal was successful in achieving a state of satiety, as observed from the 
hunger, fullness and desire to eat ratings, which were similar before and after RYGB surgery. Ratings 
for prospective consumption and thirst were significantly higher pre- compared to post-surgery (see 
Table 6.1).  
HFHS pictures were significantly less liked (pre: 47±6, post: 29±5) and wanted (pre: 42±6, 
post: 26±5) after surgery (both p<0.001). Similarly, HFHS odours were less liked (pre: 50±8, post: 
30±7; p<0.001) and less wanted (pre: 40±7, post: 24±6; p=0.018) after surgery. Liking and wanting 
ratings remained the same in both test sessions for LFLS pictures and odours, and for NF pictures. 
NF odours were significantly less liked (pre: 35±7; post: 23±7; p=0.008) and wanting ratings were 
similar pre- and post-surgery. Intensity ratings for HFHS, LFLS and NF odours were similar between 
the two test sessions (for all, see Supplementary Table 6.2).  
 
Food preferences 
Preference for high-fat/sweet products decreased after surgery (pre: 2.6±0.72, post: 2.0±0.8; 
T(1,15)=3.39, p<0.05). Preference for low-energy/savoury products increased after surgery (pre: 
2.3±0.6, post: 2.7±0.6; T(1,15)=-3.50, p<0.05).  
 
Functional imaging data 
Pictures: Pre- to post-surgery differences. In the left precuneus, the difference in brain 
responses to HFHS and LFLS pictures was significantly smaller after compared to before surgery (see 
Table 6.2 and Figure 6.2). Before surgery, viewing LFLS cues led to greater deactivation of the left 
precuneus than viewing HFHS cues. After RYGB, deactivation in response to food pictures was 
minimal in this region and did not differ between HFHS and LFLS. Participants showed significantly 
smaller responses to LFLS pictures in the left superior frontal gyrus (anteroventral PFC) after surgery 
(see Table 6.2). The pre-surgical deactivation of this region to LFLS pictures, was no longer present 
in the post-surgery session. Right superior parietal lobule responses to NF pictures were significantly 
different pre- and post-RYGB, showing deactivation pre- and activation post-surgery (see Table 6.2). 
Further, the difference in right precuneus response to HFHS compared to NF pictures was reversed 
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for odours and pictures. We used a whole brain approach, with a significance level of p=.001 (unc.) 
and a cluster extent threshold of k=8 contiguous voxels. For all contrasts, the mean beta values of 
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significant clusters were extracted with use of the MarsBar toolbox 
(http://marsbar.sourceforge.net/). Mean beta values of each significant cluster were subsequently 
correlated with pre- to post- surgery changes in endocannabinoid and ghrelin concentrations, 
changes in BMI, changes in body weight, changes in liking and wanting of the stimuli, and changes 
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Results 
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post: 26±5) after surgery (both p<0.001). Similarly, HFHS odours were less liked (pre: 50±8, post: 
30±7; p<0.001) and less wanted (pre: 40±7, post: 24±6; p=0.018) after surgery. Liking and wanting 
ratings remained the same in both test sessions for LFLS pictures and odours, and for NF pictures. 
NF odours were significantly less liked (pre: 35±7; post: 23±7; p=0.008) and wanting ratings were 
similar pre- and post-surgery. Intensity ratings for HFHS, LFLS and NF odours were similar between 
the two test sessions (for all, see Supplementary Table 6.2).  
 
Food preferences 
Preference for high-fat/sweet products decreased after surgery (pre: 2.6±0.72, post: 2.0±0.8; 
T(1,15)=3.39, p<0.05). Preference for low-energy/savoury products increased after surgery (pre: 
2.3±0.6, post: 2.7±0.6; T(1,15)=-3.50, p<0.05).  
 
Functional imaging data 
Pictures: Pre- to post-surgery differences. In the left precuneus, the difference in brain 
responses to HFHS and LFLS pictures was significantly smaller after compared to before surgery (see 
Table 6.2 and Figure 6.2). Before surgery, viewing LFLS cues led to greater deactivation of the left 
precuneus than viewing HFHS cues. After RYGB, deactivation in response to food pictures was 
minimal in this region and did not differ between HFHS and LFLS. Participants showed significantly 
smaller responses to LFLS pictures in the left superior frontal gyrus (anteroventral PFC) after surgery 
(see Table 6.2). The pre-surgical deactivation of this region to LFLS pictures, was no longer present 
in the post-surgery session. Right superior parietal lobule responses to NF pictures were significantly 
different pre- and post-RYGB, showing deactivation pre- and activation post-surgery (see Table 6.2). 
Further, the difference in right precuneus response to HFHS compared to NF pictures was reversed 
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from pre- to post-surgery (see Table 6.2 and Figure 6.2). Deactivation in response to HFHS pictures 
was greater than deactivation to NF pictures before surgery, and smaller than deactivation to NF 
pictures after surgery. 
 
Table 6.2. Significant differences in neural activation by food and non-food cue exposure (picture 
or odour), pre- to post-RYGB 
     cluster size Z-score 
Peak 
coordinates 
       x y z 
PICTURE         
HFHS-LFLSpre > 
HFHS-LFLSpost 
L Precuneus 9 3.43 -3 -54 69 
LFLSpre < LFLSpost L 
Superior Frontal 
gyrus/anteroventral PFC 
13 3.73 -21 51 9 
NFpre < NFpost R Superior Parietal lobule 11 3.45 24 -66 63 
HFHS-NFpre < HFHS-
NFpost 
R Precuneus 8 3.49 15 -54 21 
ODOUR         
HFHSpre < HFHSpost R Precuneus 9 3.92 15 -42 51 
 L Superior Parietal lobule 8 3.66 -21 -54 51 
LFLSpre < LFLSpost R Precuneus 11 3.57 9 -48 72 
 R Superior Parietal lobule  3.52 15 -54 72 
 L Precuneus 10 3.51 -3 -66 45 
NFpre < NFpost L Superior Parietal lobule 20 3.89 -21 -54 69 
 L Precuneus 12 3.69 -12 -69 63 
HFHS-NFpre > HFHS-
NFpost 
L 
Superior Frontal gyrus / 
anteroventral PFC 
8 3.92 -21 63 3 
Whole brain results; p<.001(unc.). HFHS = high-fat/high-sugar; LFLS = low-fat/low-sugar; L = left; NF = non-food; 
R = right; RYGB = Roux-en-Y gastric bypass;  
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Figure 6.2. Significant differences in neural activation by food and non-food cue exposure (picture 
or odour), pre- to post-RYGB. Results for the brain images were thresholded at p=.005 for 
visualization. Upper: Post-surgery, the left precuneus (L.PCUN, MNI: -3 -54 69) showed 
significantly less difference between activation to low-fat/low-sugar (LFLS) and high-fat/high-sugar 
(HFHS) food pictures (k=9, z=3.43). Pre-surgery, more deactivation was observed in response to 
LFLS compared to high-fat/high-sugar (HFHS) pictures while post-surgical responses to these two 
stimuli appeared similar. Middle: Post-surgery, the right precuneus (R.PCUN, MNI: 15 -54 21) 
showed significantly more difference between activation to high-fat/high-sugar (HFHS) food and 
non-food (NF) pictures (k=8, z=3.49). Pre-surgical deactivation in response to HFHS food pictures 
was higher, while post-surgical deactivation to HFHS food pictures was lower compared to non-
food pictures. Lower: Post-surgery, the left superior frontal gyrus (L.SFG, MNI: -21 63 3) showed 
significantly less difference between activation to high-fat/high-sugar (HFHS) food and non-food 
(NF) odours (k=8, z=3.92). Post- compared to pre-surgery, activation to HFHS odour appeared 
similar, while increased activation was observed in response to NF odour.  
6 
 
86 
 
from pre- to post-surgery (see Table 6.2 and Figure 6.2). Deactivation in response to HFHS pictures 
was greater than deactivation to NF pictures before surgery, and smaller than deactivation to NF 
pictures after surgery. 
 
Table 6.2. Significant differences in neural activation by food and non-food cue exposure (picture 
or odour), pre- to post-RYGB 
     cluster size Z-score 
Peak 
coordinates 
       x y z 
PICTURE         
HFHS-LFLSpre > 
HFHS-LFLSpost 
L Precuneus 9 3.43 -3 -54 69 
LFLSpre < LFLSpost L 
Superior Frontal 
gyrus/anteroventral PFC 
13 3.73 -21 51 9 
NFpre < NFpost R Superior Parietal lobule 11 3.45 24 -66 63 
HFHS-NFpre < HFHS-
NFpost 
R Precuneus 8 3.49 15 -54 21 
ODOUR         
HFHSpre < HFHSpost R Precuneus 9 3.92 15 -42 51 
 L Superior Parietal lobule 8 3.66 -21 -54 51 
LFLSpre < LFLSpost R Precuneus 11 3.57 9 -48 72 
 R Superior Parietal lobule  3.52 15 -54 72 
 L Precuneus 10 3.51 -3 -66 45 
NFpre < NFpost L Superior Parietal lobule 20 3.89 -21 -54 69 
 L Precuneus 12 3.69 -12 -69 63 
HFHS-NFpre > HFHS-
NFpost 
L 
Superior Frontal gyrus / 
anteroventral PFC 
8 3.92 -21 63 3 
Whole brain results; p<.001(unc.). HFHS = high-fat/high-sugar; LFLS = low-fat/low-sugar; L = left; NF = non-food; 
R = right; RYGB = Roux-en-Y gastric bypass;  
 
 
87 
 
 
Figure 6.2. Significant differences in neural activation by food and non-food cue exposure (picture 
or odour), pre- to post-RYGB. Results for the brain images were thresholded at p=.005 for 
visualization. Upper: Post-surgery, the left precuneus (L.PCUN, MNI: -3 -54 69) showed 
significantly less difference between activation to low-fat/low-sugar (LFLS) and high-fat/high-sugar 
(HFHS) food pictures (k=9, z=3.43). Pre-surgery, more deactivation was observed in response to 
LFLS compared to high-fat/high-sugar (HFHS) pictures while post-surgical responses to these two 
stimuli appeared similar. Middle: Post-surgery, the right precuneus (R.PCUN, MNI: 15 -54 21) 
showed significantly more difference between activation to high-fat/high-sugar (HFHS) food and 
non-food (NF) pictures (k=8, z=3.49). Pre-surgical deactivation in response to HFHS food pictures 
was higher, while post-surgical deactivation to HFHS food pictures was lower compared to non-
food pictures. Lower: Post-surgery, the left superior frontal gyrus (L.SFG, MNI: -21 63 3) showed 
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similar, while increased activation was observed in response to NF odour.  
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Odours: Pre- to post-surgery differences During HFHS odour exposure significantly greater 
deactivation was found in the right precuneus and left superior parietal lobule pre- compared to 
post-surgery (see Table 6.2). We also observed significantly different precuneus responses to LFLS 
odours pre- versus post-surgery (see Table 6.2). The right precuneus was deactivated pre- and 
activated post-surgery. Before surgery there was an absence of response in the left precuneus, but 
after surgery this region was activated in response to LFLS odours. In response to NF odours 
deactivation of the left precuneus and left superior parietal lobule was observed pre- surgery, this 
was significantly different after surgery, when activation was seen in these regions (see Table 6.2). 
The difference in response of the left superior frontal gyrus (anteroventral PFC) to HFHS odours vs 
NF odours was significantly different pre- and post-surgery (see Table 6.2 and Figure 6.2). This effect 
appears to be mainly driven by increased activation in response to NF odours after surgery.  
 
Correlations between neural changes and behavioural measures 
No significant correlations were found between changes in neural responses to odours or 
pictures, changes in BMI or body weight, and changes in liking, wanting and intensity ratings for 
odours (all p>0.05). An increased reduction of deactivation of the left superior parietal lobule to 
HFHS odour after RYGB was correlated with a greater increase in preference for low-fat/savoury 
food (r=-0.550, p=0.027), and albeit not significant, associated with a greater decrease in preference 
for high-fat/sweet food (r=0.417, p=0.108). An increased reduction in activation of the left precuneus 
to HFHS pictures relative to LFLS pictures was correlated with a greater decrease in preference for 
high-energy/sweet relative to low-energy/savoury food (r=-0.530, p=0.035). 
 
Endocannabinoids and ghrelin  
Plasma concentrations of anandamide were significantly greater post- than pre-surgery 
(before: 0.38±0.17 ng/ml, after: 0.48±0.15 ng/ml. Z=-2.77, p=0.006. For the other eCBs, 2-AG, DHEA, 
DLE, OEA, PEA, SEA, and ghrelin, concentrations did not change significantly (see Table 6.3 for 
values).  
Changes in eCB and ghrelin concentrations did not correlate with changes in neural activation, nor 
with changes in liking and wanting of pictures and odours, nor with BMI or body weight changes 
(all p>0.05). 
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Table 6.3. Plasma concentrations of endocannabinoids and ghrelin pre- and post-RYGB surgery 
Compound Pre-surgery Post-surgery Difference 
Anandamide* 0.4±0.2 0.5±0.2 0.1±0.2 
2-arachidonoylglycerol 8±3 14±17 6±17 
Docosahexaenoylethanolamide 0.5±0.1 0.4±0.1 -0.1±0.2 
Dihomo-γ-linoleonylethanolamide 0.1±0.05 0.09±0.04 -0.01±0.05 
Oleoylethanolamide 2.6±1 2.6±1 0.0±1 
Palmitoylethanolamide 1.7±0.7 1.6±0.4 -0.17±0.8 
Stearoylethanolamide 2.5±1 2.2±1 -0.3±1 
Ghrelin 459±190 442±171 -17±159 
Concentrations in ng/mL. Values are means±SD. n=18, for endocannabinoids, n=17 for ghrelin. *Significant 
difference (p=0.006) pre- and post-Roux-en-Y gastric bypass (RYGB). 
 
Discussion 
The aim of this study was to provide additional insights into the neural mechanisms 
underlying changes in food preferences after RYGB, using appetizing visual and olfactory cues 
representing high- and low-energy foods, and by including measures of appetite-related hormones 
(eCBs and ghrelin). After RYGB, patients demonstrated a shift in food preferences away from high-
fat/sweet and towards low-energy/savoury food products, which correlated with less deactivation 
of the superior parietal lobule to high-energy food odours and a smaller difference in activation of 
the precuneus to high-energy versus low-energy food pictures. Main findings further included less 
deactivation of the precuneus in response to all cues. After surgery, deactivation in the superior 
frontal gyrus was less towards low-energy food pictures and more similar to high-energy versus 
non-food odours. Further, anandamide concentrations were increased, while other eCB and ghrelin 
concentrations did not change. Neural changes did not correlate with changes in eCB and ghrelin 
concentrations. 
In line with previous research (Hansen, 2014), participants reported a shift in food 
preferences away from high-energy foods, and towards low-energy food products, on the MTPRT. 
These alterations in food preferences may (in part) underlie the success of RYGB surgery as weight-
loss intervention. 
Post- compared to pre-surgery, the left superior frontal gyrus was less deactivated in 
response to low-, but not to high-energy pictures. Previous research into the effects of RYGB 
reported postsurgical reductions in prefrontal cortex activation that were more pronounced for 
high- relative to low-energy cues (Geliebter, 2013). Moreover, decreased differences in desire to eat 
high- versus low-energy foods were predicted by a reduced difference in a more posterior part of 
the superior frontal gyrus response to high-energy versus low-energy food cues (Ochner et al., 
2012b). Unfortunately, these studies only compared surgery-related changes in responses to high- 
relative to low-energy food cues, rather than considering changes in responses to high and low-
energy food cues separately. Perhaps, the decreased difference in activation between high- and low-
energy food cues are in fact largely driven by a diminished response to low-energy food cues, similar 
to our observations. The anteroventral region of the superior frontal gyrus we found has been 
implicated in subjective reward value (Gross et al., 2014) and in processes of self-control (Diekhof 
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et al., 2012). Several studies have reported that activation patterns in this region can act as a 
predictor of food choices (Gross et al., 2014; Schonberg et al., 2014; Van der Laan et al., 2012). 
Changes in superior frontal activation could be related to the beneficial shift in food preferences, 
from high-energy towards more healthy low-energy foods, that is frequently reported after RYGB 
surgery (Behary and Miras, 2015; Berthoud et al., 2012; Ochner et al., 2011; Thirlby et al., 2006) and 
is also confirmed by the current study. 
Here we have extended previous research into RYGB by including olfactory food cues that 
predict the immediate presence of food and the rewarding effects of eating (Bragulat et al., 2010) 
and are processed largely unconsciously (Shepherd, 2006). After surgery, we observed less 
deactivation of the superior parietal cortex, in response to food odours but not pictures. Increased 
superior parietal activation was previously found during anticipation of reward (Krebs et al., 2012). 
This region was also proposed to be part of a top-down control system for attentional processes that 
is modulated by implicit contextual cues, with greater deactivation being associated with increased 
attentional demands (King et al., 2012; Krebs et al., 2012). Less deactivation of the superior parietal 
cortex after surgery found in this study could indicate a decrease in anticipated reward of high-
energy food odours, and thereby a lowered attentional demand. In line with this, the diminished 
activation was positively, albeit not significantly, correlated with (lowered) preference for high-
energy foods, and negatively correlated with (heightened) preference for low-energy foods.  
After surgery, decreased activation of the bilateral precuneus was found in response to high-
, but most pronounced to low-energy dense food cues (pictures and odours). In previous research, 
decreased precuneus responsivity to high- versus low-energy food cues was related to decreased 
food liking (Ochner et al., 2012b). A role in food reward anticipation has been proposed by other 
studies (Bjork and Hommer, 2007; Filbey et al., 2012; King et al., 2012; Stice et al., 2011; Stice et al., 
2012; Stoppel et al., 2011; Takemura et al., 2011; van Duijvenvoorde et al., 2014; Wittmann et al., 
2005). Alternatively, the difference in precuneus activation before and after surgery could be related 
to changes in attentional control (Chen et al., 2010; King et al., 2012). Greater deactivation in this 
region indicates increased attentional demand. In relation to our data this would mean that food 
cues in general, but low-energy food cues in particular, recruit less attention after surgery. Further 
research should focus in more detail on how (changes in) attentional processes relate to changes in 
food preference and choice rather than food cue reactivity. 
The neural regions (the superior frontal gyrus, superior parietal lobe and precuneus) in 
which we find altered responsivity to food cues are all part of a frontoparietal control network 
involved in adaptive top-down control (Schonberg et al., 2014; van den Heuvel et al., 2013). In a 
study by Schonberg et al. (Schonberg et al., 2014) participants who were trained to choose less 
preferred food item showed decreased activation in this frontoparietal network during low-value 
food choices. The authors propose that over the course of extensive training the need for top-down 
frontoparietal control reduces as food preference responses move from goal-directed to more 
habitual behaviour. Speculative, a similar process is set in motion after RYGB. In RYGB patients, 
aversive consequences associated with consumption of sugary and fatty foods (e.g. nausea, light-
headedness, flushing, and diarrhoea; (Berthoud et al., 2011) could lead to a relative preference for 
low-energy food products. Around two months after surgery we see a neural food cue response that 
is in line with a more habitual rather than a goal-directed pattern. 
91 
 
Altered appetite-related hormone concentrations were proposed to mediate the changes in 
neural processing observed after RYGB (Pedersen, 2013; Puzziferri et al., 2016; Svane et al., 2016) 
and could ultimately contribute to beneficial changes in food preference and intake (Berthoud et 
al., 2011). In this study we did not find pre- to post-surgery differences in plasma ghrelin 
concentrations, which might be due the large variation in pre- to post surgery differences in plasma 
ghrelin concentrations, as also seen in previous studies (Borg et al., 2006; Faulconbridge et al., 2016). 
Faulconbridge et al (Faulconbridge et al., 2016) found a correlation between changes in ghrelin 
concentrations and changes in neural responses, which our data do not confirm. Discrepancies in 
neural activation and ghrelin concentrations could be related to a difference in the timing of the 
measurements (6 (Faulconbridge et al., 2016) vs 2 months post-surgery in the current study), as the 
effect of RYGB on ghrelin concentrations might change over time (Saliba et al., 2009).  
Endocannabinoids have been suggested to mediate the orexigenic effects of ghrelin (Kola et 
al., 2008) and are implicated in reward anticipation (Horder et al., 2010; Kroemer et al., 2013; 
Monteleone et al., 2012; Rigamonti et al., 2015; Tudge et al., 2015). Increased eCB concentrations 
have been suggested to be a cause of obesity (Engeli et al., 2005) and may be related to long-term 
weight loss and weight-regain after RYGB. Within the range of eCBs that we measured, we showed 
increased plasma anandamide concentrations after compared to before RYGB. Concentrations of 
the other eCBs we measured did not change. Previous studies assessing eCBs at alternate time points 
after RYGB included only few eCBs and suggest either decreased or unchanged anandamide 
concentrations, and unchanged concentrations of 2-AG, OEA and PEA (Mallipedhi et al., 2015; 
Montecucco et al., 2015; Quercioli et al., 2013). Similar to ghrelin, eCB concentrations may change 
over time and future studies should monitor the progression of eCB concentrations at different time 
points after RYGB.  
It can be seen as limitation that blood samples for plasma eCB and ghrelin concentration 
determination were drawn after at least three hours of fasting, whereas the fMRI measurements 
were performed after a lunch meal. Concentrations directly after this meal may have been more 
closely associated with the neural responses we observed in a satiated state. A particular strength of 
this study was that participants were measured in a satiated state, to mimic overeating situations 
more realistically. However, this may have reduced reward related neural activation, and 
complicates direct comparisons to previous literature (e.g. (Geliebter, 2013; Ochner et al., 2012b). 
Moreover, most other studies looked into pre- to post-surgery changes in the relative difference 
between high-energy and low-energy food cues (Ochner et al., 2011; Ochner et al., 2012a; Ochner 
et al., 2012b), whereas we examined the changes in response to HFHS and LFLS cues relative to 
baseline, as well as compared to non-food cues, to be able to draw more specific conclusions. 
The neural changes we find are in line with the observed increased preferences for low-
energy, and decreased preferences for high-energy foods. The current results suggest that there is 
no relation between changes in ghrelin and endocannabinoid concentrations, and changes in neural 
responses to food cues in RYGB patients. Using olfactory food cues in addition to pictures did not 
reveal new information, but highlights the importance of odours for the anticipation of food. To 
conclude, RYGB leads to alterations in activation of the frontoparietal network, involved in 
cognitive control during (food) cue processing. 
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et al., 2012). Several studies have reported that activation patterns in this region can act as a 
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is also confirmed by the current study. 
Here we have extended previous research into RYGB by including olfactory food cues that 
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Supplementary Table 6.1. Composition of the standardized meal. 
  Men Women 
  Pre Post Pre Post 
Bread Roll (Wheat bread (±22 g/roll)) 4 pcs 2 pcs 3 pcs 1 pc 
Margarine (Low-fat) 30 g 15 g 15 g 15 g 
Cheese (Full-fat semi-cured) 40 g 20 g 40 g 20 g 
Ham 40 g 20 g 20 g - 
Orange Juice 150 g 75 g 100 g 50 g 
kCal total meal 570 174 421 107 
 
 
Supplementary Table 6.2. Stimulus ratings for liking, wanting and intensity pre- and post-RYGB 
surgery 
    Category 
Before 
surgery 
After 
surgery 
Significance 
PICTURE Liking HFHS 46±5 30±5 p<0.001 
   LFLS 39±6 43±6 p=0.246 
   NF 19±4 14±4 p=0.069 
  Wanting HFHS 42±5 26±5 p<0.001 
   LFLS 35±6 37±6 p=0.498 
   NF 10±3 8±3 p=0.244 
ODOUR Liking HFHS 49±7 29±7 p<0.001 
   LFLS 39±6 37±6 p=0.798 
   NF 35±7 23±7 p=0.008 
  Wanting HFHS 38±6 24±6 p=0.018 
   LFLS 33±6 35±6 p=0.804 
   NF 14±4 9±3 p=0.191 
  Intensity HFHS 76±5 76±4 p=0.984 
   LFLS 60±5 66±5 p=0.147 
    NF 68±5 73±5 p=0.114 
Ratings performed on a 100 point VAS. Values are means±SD. HFHS: high-fat/high-sugar; LFLS: low-fat/low-
sugar; NF: non-food; RYGB: Roux-en-Y gastric bypass. 
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Abstract  
BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery is a highly effective weight-loss 
intervention that often reduces preference and intake of high-energy foods. Research into the 
neural mechanisms behind this shift has mainly focused on reward processing of food cues. 
However, the ability to successfully control food intake and thereby weight-loss also depends on 
inhibitory control capacity. We investigated whether RYGB leads to alterations in neural inhibitory 
control in response to food cues.  
METHODS: A food-specific go/no-go task with pictures of high-energy (desserts) and low-energy 
foods (vegetables), was used to assess neural inhibition responses before and after RYGB with 
functional magnetic resonance imaging. Data from 18 morbidly obese patients (15 females; age 
41±11 years; BMI 42±4 kg/m2 before; BMI 36±4 kg/m2 after) were analysed. Pre- and post-RYGB 
BOLD fMRI responses were compared for response inhibition towards high-energy and for response 
inhibition towards low-energy foods. Participants were tested in a satiated state. 
RESULTS: Response inhibition for high-energy food was associated with increased activation of the 
right anterolateral prefrontal cortex (PFC), right medial PFC, dorsolateral PFC, right middle 
cingulate cortex and the right inferior frontal operculum, after compared to before surgery (involved 
in inhibitory control). Response inhibition for low-energy food elicited diminished post- compared 
to pre-surgery responses in the left superior temporal pole, right parahippocampal gyrus and right 
hypothalamus (involved in metabolic control). The dorsolateral PFC, middle cingulate cortex, 
inferior frontal operculum, parahippocampal gyrus and superior temporal pole have also been 
associated with reward processing.  
CONCLUSION: Neural changes indicate improved response inhibition towards high-energy food 
cues, altered influence of satiety during response inhibition toward low-energy food cues and a 
more positive attitude to both high-energy and low-energy food after RYGB. Alterations in neural 
circuits involved in inhibitory control, satiety signalling and reward processing may contribute to 
effective weight-loss after RYGB.  
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Introduction 
Roux-en-Y gastric bypass (RYGB) patients show decreased preferences and consumption of 
high-energy foods, which are associated with long-term weight reduction (Kenler et al., 1990; 
Laurenius et al., 2013; Ochner et al., 2011; Sjöström, 2013; Thirlby et al., 2006). The underlying 
mechanism of this decreased preference for high-energy foods is unclear. Most studies to date 
focused on altered reward processing, but changes in inhibitory control may also play an important 
role. It has been suggested that people with low inhibitory control are more prone to overeating and 
hence to developing overweight or obesity (Guerrieri et al., 2008; Nederkoorn et al., 2009; 
Weygandt et al., 2015). Suppression of automatic tendencies to choose highly rewarding energy-
dense foods over low energy-dense foods could help to decrease caloric intake, which contributes 
to successful weight-loss. 
How well we are able to control our impulses in part determines how much and what we 
consume. Decreased inhibitory control is assumed to increase the odds of eating in the absence of 
hunger, especially in a tempting and food-rich environment (Boutelle and Bouton, 2015; Meule et 
al., 2014; Volkow et al., 2011), and could eventually lead to weight gain. Overeating and obesity 
have been associated with higher impulsivity, both in self-reported and behavioural measures 
(Bongers et al., 2015; Dykes et al., 2004; Nederkoorn et al., 2006; Ryden et al., 2003; Stoeckel et al., 
2007; Vainik et al., 2013). Furthermore, individuals that were unsuccessful in regulating their 
weight show decreased inhibitory control (Houben et al., 2012) while behavioural responses of 
successful weight-loss maintainers to high-energy foods indicate better inhibition (Phelan et al., 
2011). The extent of inhibitory control seems to influence the ability to maintain weight-loss after 
intervention. RYGB surgery is widely viewed as the most effective method for long-term weight 
loss in morbidly obese individuals (Rubino et al., 2004).  
Previous studies into neural responsivity after RYGB surgery have mainly focused on 
(alterations in) reward processing during presentation of high-energy food items (Ochner et al., 
2011; Ochner et al., 2012a). In order to better understand successful weight-loss regulation upon 
RYGB, it is important to consider changes in inhibitory control processes as well (Price et al., 2015). 
Previous studies showed that people who were attempting to lose weight displayed 
increased activation of the inferior frontal gyrus and anterior insula/frontal operculum in response 
to pictures of high-energy foods (Smeets et al., 2013). These areas are involved in inhibitory control. 
Also, successful weight loss maintainers show greater activation to food cues in prefrontal regions 
(superior-, middle frontal gyrus) associated with inhibitory control (McCaffery et al., 2009). 
Batterink et al. (Batterink et al., 2010) have introduced a food-specific go/no-go task to assess neural 
measures of response inhibition to food items. In their study, a higher BMI was related to less 
activation during no-go trials in frontal inhibitory regions, including superior- and middle frontal 
gyrus, ventromedial- and medial prefrontal cortex, and orbitofrontal cortex. A higher BMI was also 
associated with more activation during no-go trials in the temporal operculum. Increased 
understanding of the (neuro)biological mechanisms involved in inhibitory control is necessary to 
improve the outcome of weight-loss interventions.  
With this study we aimed to determine whether RYGB surgical intervention in morbidly 
obese patients results in altered neural activation underlying response inhibition, using a food 
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specific go/no-go task. Participants were tested in a satiated state to better understand alterations in 
mechanisms of overeating. We hypothesized that participants would be better able to suppress 
responses to high-energy (dessert) items after RYGB surgery, as reflected in changes in neural 
responses related to inhibitory control, while behavioural and neural responses to low-energy 
(vegetable) items would remain similar. 
  
Methods  
Overall design 
This study had a 2x2x2 within-subject design, including the factors time point (pre- and 
post-RYGB), stimulus (dessert/vegetable), and task-instruction (go/no-go).  
Participants 
Twenty morbidly obese individuals participated in the food-specific go/no-go task, pre- and 
post- RYGB surgery. All participants were enlisted to undergo RYGB surgery at Rijnstate hospital, 
Arnhem, the Netherlands. Requirements for the surgery were: Body Mass Index (BMI) of >40 kg/m2 
or >35 kg/m2 with co-morbidity that was expected to improve after surgically-induced weight loss, 
long-lasting obesity (>5 years), proven failed attempts to lose weight in a conventional way, 
intention to adhere to a postoperative follow-up programme. Individuals were not considered for 
surgery when they were pregnant or lactating, had psychiatric disorders, alcohol or drug 
dependency, life threatening conditions or when they were dependent on the care of others. 
Patients were screened at Rijnstate hospital. All participants were right-handed, non-smoking, and 
did not have conditions that conflicted with MR safety or would cause artefacts in the MR images 
(e.g. claustrophobic, irremovable ferromagnetic objects in or on their body, pacemaker). 
Participants received financial compensation for their contribution. All participants provided 
written informed consent before entering the study. The protocol was approved by the Medical 
Ethical Committee of Wageningen University (NL45837.081.13) and was executed in accordance 
with the ethical principles of the Declaration of Helsinki of 1975, as revised in 2013. The study was 
registered on clinicaltrials.gov as NCT02068001. 
 
Experimental procedures 
Participants visited the test facilities at three occasions. First, they were familiarized with 
the MRI test environment and the experimental task in a dummy MRI scanner at Wageningen 
University (training session). After the trainings session, actual measurements were performed in 
two identical test sessions. The first test session took place on average 3.3 (SD=1.8) weeks before, 
and the second test session took place on average 9.3 (SD=1.2) weeks after RYGB surgery. 
Participants were instructed to refrain from eating and drinking anything but water and weak tea 
in the three hours before the test sessions. Upon arrival at hospital Gelderse Vallei (Ede, the 
Netherlands), blood samples were taken for analysis of plasma levels of endocannabinoids and 
ghrelin (data reported elsewhere). Participants were tested in comfortably full state, to mimic a 
context of eating in the absence of hunger. We provided a standardized meal that was adapted to 
pre- or post-surgery conditions in order to match the hunger states of the participants before and 
after surgery. Participants first drank orange juice, and after a small break they consumed a 
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standardized meal consisting of bread roll(s), cheese, ham and butter (see Supplementary Table 1). 
Following meal consumption, participants waited for 15 minutes. In order to assess changes in 
general inhibition participants filled in the 24-item BIS/BAS questionnaire (Carver and White, 
1994). Measurements of brain reward responses to visual and olfactory food and non-food cues were 
collected (Chapter 6). At the end of this reward paradigm participants rated their appetite (hunger, 
fullness, prospective consumption, desire to eat, and thirst) on a 100 point visual analogue scale 
(VAS). Then a structural MR image was collected. Finally, participants took part in two functional 
runs during which a food-specific go/no-go task was performed.  
 
fMRI – go/no-go task 
The food-specific go/no-go paradigm was adapted from Batterink et al. (Batterink et al., 
2010). Participants were instructed to press a button as quickly and accurately as possible in response 
to go trials (75% occurrence) and to refrain from responding to no-go trials (25% occurrence). Two 
separate functional runs were performed, each consisting of 48 trials. One run contained go-
vegetable items and no-go dessert items, the other run contained go-dessert items and no-go 
vegetable items (see Figure 7.1). The order of the runs was counterbalanced between participants. 
During each trial a picture was presented for 500 ms, depicting either a low-energy vegetable (i.e. 
corn, peas, Brussels sprouts, radishes, carrot, broccoli, cauliflower, haricots, zucchini) or a high-
energy dessert (i.e. ice cream, cake, frozen yogurt, pudding, chocolate mousse, chocolates, cookies). 
Participants had 2000 ms to respond from stimulus onset. Trials were presented in pseudo-
randomized order. Between trials a fixation cross was presented for a duration of 7-19 seconds. No-
go trials would appear after 1, 2, or 3 go-trials. Reaction times were measured from the beginning 
of trial onset and collected with a fibre-optic response box system. Stimuli were presented visually 
using the Presentation software package (Version 9, Neurobehavioral Systems, Davis, CA) and were 
displayed using a video projector that illuminated a rear projection screen located at the end of the 
magnet bore. Subjects viewed the stimuli through an adjustable mirror attached to the head coil. 
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standardized meal consisting of bread roll(s), cheese, ham and butter (see Supplementary Table 1). 
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magnet bore. Subjects viewed the stimuli through an adjustable mirror attached to the head coil. 
 
 
100 
 
 
Figure 7.1. The food-specific Go/No-Go paradigm. In block A. participants were instructed to press 
a button in response to vegetable items (36 items) and withhold their response to dessert items (12 
items). In block B. the instruction was reversed, participants had to press the button in response to 
dessert items (36 items) and withhold their response to vegetable items (12 items). The block order 
was counterbalanced between participants. 
 
(f)MRI measurements 
Each participant was scanned at approximately the same time of day, between 14:00-17:00 
at hospital Gelderse Vallei (Ede, the Netherlands). Images were acquired with a 3-Tesla Siemens 
Magnetom Verio MRI scanner in combination with a 32-channel head coil. A high-resolution T1-
weighted anatomical MRI scan was acquired (MPRAGE: repetition time = 1900 ms, echo time = 2.26 
ms, 9° flip angle, field of view = 256 x 256 mm, 192 sagittal slices, voxel size = 0.5 x 0.5 x 1 mm). 
Subsequently, 176 T2*-weighted gradient echo images with BOLD contrast (repetition time = 2240 
ms, echo time = 25 ms, 90° flip angle, field of view = 192 x 192 mm, 45 axial slices, ascending order, 
voxel size 3 x 3 x 3 mm) were acquired for each of the two functional runs during which participants 
performed a food Go/No-Go task. The imaging volume was tilted at an oblique angle of 30° to the 
anterior-posterior commissure line to reduce signal dropout in the orbitofrontal and ventral 
temporal lobes (Deichmann et al., 2003). Head movements were restricted by placing foam cushions 
next to the participants’ head. In addition, adhesive tape was placed across the participants’ forehead 
to provide feedback on head movements. Earplugs were provided for noise reduction.  
 
Data analyses 
Participant characteristics. Participant characteristics were analysed using SPSS in IBM 
SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA). Paired-samples T-tests 
were used to test differences in weight, BMI, hunger ratings and BIS/BAS-scores pre- and post-
surgery.  
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Behavioural data go/no-go. Behavioural data of the go/no-go task were also analysed using 
SPSS. Mean commission error rates of the go/no-go task were calculated by dividing the total 
number of incorrect responses to no-go trials by the total number of no-go trials. Mean omission 
error rates were calculated by dividing the total number of non-responses to go-items by the total 
number of go-trials. Mean reaction times (ms) of responses to each type of trial (go-dessert, go-
vegetable, no-go dessert, no-go vegetable) were calculated for each participant. Response times 
below 200 ms and over 2000 ms were excluded. The low number of commission errors rendered the 
reaction time data for the no-go items unsuitable for statistical testing. Pre- to post-surgery 
differences in response time (ms) to go items were analysed by following a linear Mixed Effects 
Models procedure including stimulus type (go-dessert; go-vegetable) as fixed effects factor. Time 
point (pre- and post-gastric bypass surgery), stimulus (dessert/vegetable), and task-instruction 
(go/no-go) were included as repeated variables. A p-value of <0.05 was considered statistically 
significant.  
fMRI data go/no-go. Whole brain functional images were pre-processed and analysed using 
the SPM12 software package (Wellcome Department of Imaging Neuroscience, London, United 
Kingdom) run within MATLAB 7.12.0 (R2011a, The Mathworks Inc). Functional images were slice 
timed, realigned and coregistered. The DARTEL framework was used to create a study-specific 
template and participant-specific deformation fields (Ashburner, 2007). The images were then 
spatially normalized to the Montreal Neurological Institute (MNI) standard brain using the study-
specific DARTEL template and the participant-specific deformation fields. Smoothing was applied 
to the normalized images using an isotropic Gaussian kernel with a 6-mm full width at half 
maximum. Artefact Repair was applied using the ArtRepair toolbox in SPM12 (see: 
http://cibsr.stanford.edu/tools/human-brain-project/artrepair-software.html). Of the twenty 
datasets that were acquired, two datasets were excluded that contained movements more than 4 
mm.  
Subject level analyses: Each test session (pre-/post-surgery) was modelled separately. Four 
conditions were included per model: visual exposure to go dessert trials, no-go vegetable trials, go 
vegetable trials and no-go dessert trials. Motion-correction parameters were included in the model. 
For each subject four contrast images were calculated: nogo_dessertpre vs rest, nogo_dessertpost vs 
rest, nogo_vegetablepre vs rest and nogo_vegetablepost vs rest. Subsequently we subtracted the post-
surgery contrast images from the pre-surgery contrast images using the SPM12 image calculation 
routine.  
Group level analyses: Two one-sample T-tests were performed to test our hypotheses. In 
each test we looked at contrast images containing the difference between activations pre- and post-
surgery (nogo_dessertpre-nogo_dessertpost; nogo_vegetablepre-nogo_vegetablepost). We report whole 
brain results, with a significance level of p=0.001 (unc.) and a cluster extent threshold of k=8 
contiguous voxels. The MarsBar toolbox (http://marsbar.sourceforge.net/) run in Matlab 7.12.0 
(R2011a; The Mathworks Inc., Natick, MA) was used to extract mean beta values from all significant 
clusters. These values were subsequently correlated with pre- to post- surgery changes in BMI, 
changes in body weight, and changes in feelings of hunger, fullness, prospective consumption and 
desire to eat. Correlation analyses were performed in SPSS using Pearson’s correlation coefficient. 
 
7 
 
100 
 
 
Figure 7.1. The food-specific Go/No-Go paradigm. In block A. participants were instructed to press 
a button in response to vegetable items (36 items) and withhold their response to dessert items (12 
items). In block B. the instruction was reversed, participants had to press the button in response to 
dessert items (36 items) and withhold their response to vegetable items (12 items). The block order 
was counterbalanced between participants. 
 
(f)MRI measurements 
Each participant was scanned at approximately the same time of day, between 14:00-17:00 
at hospital Gelderse Vallei (Ede, the Netherlands). Images were acquired with a 3-Tesla Siemens 
Magnetom Verio MRI scanner in combination with a 32-channel head coil. A high-resolution T1-
weighted anatomical MRI scan was acquired (MPRAGE: repetition time = 1900 ms, echo time = 2.26 
ms, 9° flip angle, field of view = 256 x 256 mm, 192 sagittal slices, voxel size = 0.5 x 0.5 x 1 mm). 
Subsequently, 176 T2*-weighted gradient echo images with BOLD contrast (repetition time = 2240 
ms, echo time = 25 ms, 90° flip angle, field of view = 192 x 192 mm, 45 axial slices, ascending order, 
voxel size 3 x 3 x 3 mm) were acquired for each of the two functional runs during which participants 
performed a food Go/No-Go task. The imaging volume was tilted at an oblique angle of 30° to the 
anterior-posterior commissure line to reduce signal dropout in the orbitofrontal and ventral 
temporal lobes (Deichmann et al., 2003). Head movements were restricted by placing foam cushions 
next to the participants’ head. In addition, adhesive tape was placed across the participants’ forehead 
to provide feedback on head movements. Earplugs were provided for noise reduction.  
 
Data analyses 
Participant characteristics. Participant characteristics were analysed using SPSS in IBM 
SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, NY, USA). Paired-samples T-tests 
were used to test differences in weight, BMI, hunger ratings and BIS/BAS-scores pre- and post-
surgery.  
101 
 
Behavioural data go/no-go. Behavioural data of the go/no-go task were also analysed using 
SPSS. Mean commission error rates of the go/no-go task were calculated by dividing the total 
number of incorrect responses to no-go trials by the total number of no-go trials. Mean omission 
error rates were calculated by dividing the total number of non-responses to go-items by the total 
number of go-trials. Mean reaction times (ms) of responses to each type of trial (go-dessert, go-
vegetable, no-go dessert, no-go vegetable) were calculated for each participant. Response times 
below 200 ms and over 2000 ms were excluded. The low number of commission errors rendered the 
reaction time data for the no-go items unsuitable for statistical testing. Pre- to post-surgery 
differences in response time (ms) to go items were analysed by following a linear Mixed Effects 
Models procedure including stimulus type (go-dessert; go-vegetable) as fixed effects factor. Time 
point (pre- and post-gastric bypass surgery), stimulus (dessert/vegetable), and task-instruction 
(go/no-go) were included as repeated variables. A p-value of <0.05 was considered statistically 
significant.  
fMRI data go/no-go. Whole brain functional images were pre-processed and analysed using 
the SPM12 software package (Wellcome Department of Imaging Neuroscience, London, United 
Kingdom) run within MATLAB 7.12.0 (R2011a, The Mathworks Inc). Functional images were slice 
timed, realigned and coregistered. The DARTEL framework was used to create a study-specific 
template and participant-specific deformation fields (Ashburner, 2007). The images were then 
spatially normalized to the Montreal Neurological Institute (MNI) standard brain using the study-
specific DARTEL template and the participant-specific deformation fields. Smoothing was applied 
to the normalized images using an isotropic Gaussian kernel with a 6-mm full width at half 
maximum. Artefact Repair was applied using the ArtRepair toolbox in SPM12 (see: 
http://cibsr.stanford.edu/tools/human-brain-project/artrepair-software.html). Of the twenty 
datasets that were acquired, two datasets were excluded that contained movements more than 4 
mm.  
Subject level analyses: Each test session (pre-/post-surgery) was modelled separately. Four 
conditions were included per model: visual exposure to go dessert trials, no-go vegetable trials, go 
vegetable trials and no-go dessert trials. Motion-correction parameters were included in the model. 
For each subject four contrast images were calculated: nogo_dessertpre vs rest, nogo_dessertpost vs 
rest, nogo_vegetablepre vs rest and nogo_vegetablepost vs rest. Subsequently we subtracted the post-
surgery contrast images from the pre-surgery contrast images using the SPM12 image calculation 
routine.  
Group level analyses: Two one-sample T-tests were performed to test our hypotheses. In 
each test we looked at contrast images containing the difference between activations pre- and post-
surgery (nogo_dessertpre-nogo_dessertpost; nogo_vegetablepre-nogo_vegetablepost). We report whole 
brain results, with a significance level of p=0.001 (unc.) and a cluster extent threshold of k=8 
contiguous voxels. The MarsBar toolbox (http://marsbar.sourceforge.net/) run in Matlab 7.12.0 
(R2011a; The Mathworks Inc., Natick, MA) was used to extract mean beta values from all significant 
clusters. These values were subsequently correlated with pre- to post- surgery changes in BMI, 
changes in body weight, and changes in feelings of hunger, fullness, prospective consumption and 
desire to eat. Correlation analyses were performed in SPSS using Pearson’s correlation coefficient. 
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Results  
RYGB effects - weight loss  
The mean weight of our study population decreased from 121±15 pre-RYGB to 105±16 kg 
post-RYGB (mean±SD), a mean weight loss of 17±3 kg (p<.001). This weight change led to a decrease 
in BMI from 42±4 to 36±4 kg/m2 (p<0.001), with a mean decrease of 6±1 kg/m2. 
 
Hunger ratings 
During the post-surgery test session, participants indicated less hunger before the go/no-go 
task (~50 min after meal intake; p=0.056), rated a higher fullness, a decreased prospective 
consumption and less desire to eat (all p<0.01). Ratings for thirst were comparable between the two 
test sessions (p=0.349; see Table 7.1).  
 
Table 7.1. Weight, BMI, Hunger ratings provided right before the go/no-go task and BIS/BAS scores 
before and after RYGB surgery. 
  
Before 
surgery 
After surgery Significance 
Weight (kg) 121±15 105±16 p<0.001 
BMI (kg/m2) 42±4 36±4 p<0.001 
Hunger 27±31 14±24 p=0.056 
Fullness 43±29 72±18 p=0.001 
Prospective consumption 37±27 17±21 p=0.002 
Desire to eat 44±35 24±26 p=0.009 
Thirst 76±26 70±28 p=0.349 
BAS Drive (max 16) 11.6±2.1 12.1±2.2 p=0.132 
BAS Fun Seeking (max 16) 10.8±2.1 11.3±2.3 p=0.166 
BAS Reward Responsiveness (max 20) 17.8±1.6 18.4±1.6 p=0.045 
BIS (max 28) 20.3±4.4 19.8±3.6 p=0.366 
Hunger ratings performed on a 100 point VAS. Values are means±SD. BMI = Body mass index. 
 
Behavioural data 
No-go items. Commission errors (incorrect responses during the no-go items) for no-go 
dessert items occurred at a mean rate of 8.5% (SD=8.6) pre-surgery, and 8.8% (SD=10.9) post-
surgery. Commission errors for no-go vegetable items occurred around 16.8% (SD=15.8) pre-
surgery, and 14.8% (SD=14.7) post-surgery. 
The go/no-go task included 12 no-go items per run. Commission errors to no-go dessert 
items occurred at 443±87 ms (mean±SD) pre-surgery and at 501±132 post-surgery. Commission 
errors in response to no-go vegetable items had a mean reaction time of 526±125 ms. After surgery, 
responses to no-go vegetable items occurred at 504±143. 
Go items For the go dessert items, the omission error rate (non-responses during the go-
trials) changed from 0.9% (SD=1.7) before surgery to 1.7% (SD=2.5) after surgery. The mean rate of 
omission errors for go vegetable items was 4.0% (SD=2.7) before surgery and 3.4% (SD=2.0) after 
surgery.  
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There were no significant differences between reaction times to go dessert items before 
(543±90 ms; mean±SD) versus after RYGB (567±122 ms; p=0.395), nor between reaction times to go 
vegetable items before (544±138 ms) and after RYGB (538±135 ms; p=0.395).  
 
Functional imaging data 
No-go desserts. Comparisons between pre- and post-surgery fMRI BOLD responses for the 
no-go dessert trials revealed increased post-surgical activation of the right middle frontal gyrus 
(lateral part), the medial part of the right superior frontal gyrus, the right inferior frontal gyrus (pars 
triangularis), the right middle cingulum and the inferior frontal operculum (see Table 7.2 and Figure 
7.2). There were no regions in which no-go activation was significantly decreased post- compared 
to pre-surgery.  
There were no significant correlations between pre- to post-surgery changes in neural 
responses during no-go dessert trials and changes in BMI or body weight, changes in feelings of 
hunger, fullness, prospective consumption and desire to eat (all p>0.05). 
 
Table 7.2. Regions in which brain activation during go or no-go food items was significantly 
different pre- and post RYGB surgery 
  
 
  
cluster 
size Z-score Peak coordinates 
       x y z 
DESSERT 
no-gopre < no-gopost R Middle Frontal Gyrus / Anterolateral PFC 30 4.42 45 54 6 
 R Medial Superior Frontal Gyrus / Medial PFC  23 4.02 12 60 27 
 
R Inferior Frontal Gyrus (Tri) / Dorsolateral 
PFC 15 3.87 57 27 18 
 R Middle Cingulum (posterior part) 10 3.59 3 -27 33 
        
VEGETABLE 
no-gopre > no-gopost R Hypothalamus 10 3.65 3 3 -12 
 L Superior Temporal Pole 11 3.63 -36 12 -27 
 R Parahippocampal gyrus 9 3.34 18 -15 -21 
 
No-go vegetables. Pre-surgical neural activation to no-go vegetable items was significantly 
higher in the right hypothalamus, left superior temporal pole and right parahippocampal gyrus, 
relative to post-surgery (see Table 7.2 and Figure 7.3). There were no regions in which activation 
was significantly increased post- compared to pre-surgery.  
Pre- to post-surgery changes in activation of the right parahippocampal gyrus during no-go 
vegetable items were correlated with changes in ratings of fullness provided right before the go/no-
go task (r=-0.625, p=0.007). No significant correlations were found between pre- to post-surgery 
changes in neural responses during no-go vegetable trials and BMI or body weight, and changes in 
feelings of hunger, prospective consumption and desire to eat (all p>0.05). 
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Figure 7.2. Regions in which brain activation during response inhibition to dessert items was 
significantly different pre- and post RYGB surgery. Brain images were thresholded at p=0.005 for 
visualisation. Upper: The right inferior frontal gyrus (Tri; MNI: 57 27 18) was more activated after 
compared to before surgery and the right inferior frontal operculum (MNI: 51 9 24) showed more 
activation after compared to before surgery. Middle: The right middle frontal gyrus (MNI: 45 54 6) 
was more activated after than before surgery and the right medial superior frontal gyrus (MNI: 12 
60 27) showed deactivation before surgery and activation after surgery. Lower: The right middle 
cingulate cortex (MNI: 3 -27 33) was more activated after surgery. 
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Figure 7.3. Regions in which brain activation during response inhibition to vegetable items was 
significantly reduced post- compared to pre-RYGB surgery. Brain images were thresholded at 
p=0.005 for visualisation. Left: The right hypothalamus (MNI: 3 3 -12) was activated before surgery 
and deactivated after surgery. Middle: The right parahippocampal gyrus (MNI: 18 -15 -21) displayed 
activation before and deactivation after surgery. Right: The left superior temporal pole (MNI: -36 
12 -27) showed activation before surgery and deactivation after surgery. 
 
Discussion 
To our knowledge, this is the first study to investigate changes in neural inhibition to food 
cues after RYGB. We found pre- to post-surgery increases in neural response to no-go high-energy 
dense food items in regions involved in inhibitory control (middle, medial superior- and inferior 
frontal gyrus). Further, neural activation in response to no-go low-energy dense food items was less 
pronounced in regions related to satiation (hypothalamus, parahippocampal gyrus, superior 
temporal pole) after surgery. Alterations in reward related activation were found for both no-go 
dessert and no-go vegetable trials (inferior frontal gyrus, middle cingulate gyrus, inferior frontal 
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Figure 7.2. Regions in which brain activation during response inhibition to dessert items was 
significantly different pre- and post RYGB surgery. Brain images were thresholded at p=0.005 for 
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was more activated after than before surgery and the right medial superior frontal gyrus (MNI: 12 
60 27) showed deactivation before surgery and activation after surgery. Lower: The right middle 
cingulate cortex (MNI: 3 -27 33) was more activated after surgery. 
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Figure 7.3. Regions in which brain activation during response inhibition to vegetable items was 
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activation before and deactivation after surgery. Right: The left superior temporal pole (MNI: -36 
12 -27) showed activation before surgery and deactivation after surgery. 
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gyrus) after surgery. Previous research has linked increased activation in these regions to greater 
exertion and success of inhibitory control (Chikazoe et al., 2009; Hutcherson et al., 2012; Kober et 
al., 2010; Li et al., 2006; Scharmuller et al., 2012; Sebastian et al., 2012; van der Meer et al., 2011). 
This suggests that activation in these frontal regions can serve as an indicator for response inhibition 
capacity. Interestingly, Lapenta et al. found that it is possible to induce changes in response 
inhibition processes by transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal 
cortex (dlPFC; Lapenta et al., 2014). They showed that this type of neural stimulation leads to 
significant changes in neural markers of inhibitory control, and also to reduced craving and food 
intake. In our study, increased prefrontal cortex activation post-surgery could indicate an increase 
in neural inhibitory control in response to appetizing food items. In contrast to Batterink et al. 
(Batterink et al., 2010) who found correlations between current BMI and prefrontal activation 
during inhibitory control, we did not find significant correlations between changes in prefrontal 
activation and changes in body weight or BMI. This is likely related to greater variation (from lean 
to obese) in current BMI in their study (Batterink et al., 2010), versus limited variation in within-
subject changes in BMI in the current study. The observed changes in neural processing after RYGB 
support an improved response inhibition towards high-energy food. 
Post-surgical reductions in parahippocampal gyrus, superior temporal pole, and also 
hypothalamus activation during low-energy no-go items, but not during high-energy no-go items, 
could relate to metabolic signals of satiety. In the current study, participants were equally satiated 
directly after meal intake in both test sessions (see Supplementary Table 7.2), but felt less hungry 
and more full post- compared to pre-surgery before starting the go/no-go task. This could be related 
to accelerated digestion and absorption of nutrients after RYGB (Bojsen-Moller et al., 2015). 
Moreover, a significant correlation was found between pre- to post-surgery changes in 
parahippocampal gyrus activation and changes in ratings of fullness. Previous studies found 
increased brain activation to high-energy food cues (visual, taste) in the parahippocampal gyrus and 
hypothalamus in a hungry compared to a satiated state (Haase et al., 2009; LaBar et al., 2001; Leidy 
et al., 2011; van der Laan et al., 2011), and related this to an increased salience of energy-rich 
products during hunger (Mohanty et al., 2008; van der Laan et al., 2014). In light of this, the decrease 
in hypothalamic, parahippocampal and superior temporal pole activation during response inhibition 
after surgery suggests that the increase in feelings of fullness is related to a decrease in salience of 
low-energy products, but not high-energy products.  
Besides increased activation in prefrontal regions of inhibitory control, we found increased 
activation in the inferior frontal gyrus, inferior frontal operculum and middle cingulate cortex 
during response inhibition towards high-energy food. Although, activation in these regions has 
been linked to selective attention and more effective response (Booth et al., 2003; Cojan et al., 2009; 
Hirose et al., 2009; Li et al., 2006), these regions are also implicated in processing of reward value 
and taste evaluation in response to cue exposure during anticipation, consumption (Nummenmaa et 
al., 2012; Small et al., 2001; Stice et al., 2008b), and self-regulation (Hare et al., 2011; Vollm et al., 
2006; Zotev et al., 2011). Our results thus suggest greater engagement of these reward-related areas 
during response inhibition for high-energy products after surgery. Decreased post-surgery 
activation of the parahippocampal gyrus and superior temporal pole during response inhibition for 
low-energy food products could also be associated with changes in reward processing. Increased 
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activation in the parahippocampal gyrus during exposure to taste and smell of food was associated 
with decreasing reward value in healthy (Small et al., 2001) and obese subjects (Bragulat et al., 2010). 
The observed reduction in parahippocampal gyrus deactivation during response inhibition to low-
energy food cues thus could imply a more positive attitude towards these cues. However, we have 
no ratings of liking or wanting ratings for the food stimuli, so we can only speculate about a link 
between the decrease in inhibitory activation and higher preference for low-energy products. 
Nevertheless, the relative increase in preference for low-energy food found in RYGB patients 
(Kenler et al., 1990; Ochner et al., 2012b; Thirlby et al., 2006), does support a more positive attitude 
towards vegetables after surgery. 
As mentioned above, the regions in which we find increased activation in response to no-
go dessert items after surgery have been linked to increased exertion of neural inhibitory control 
and also to more successful behavioural inhibition (Chikazoe et al., 2009; Hutcherson et al., 2012; 
Kober et al., 2010; Li et al., 2006; Scharmuller et al., 2012; Sebastian et al., 2012; van der Meer et al., 
2011). It would be interesting to link these neural data to actual behavioural changes. However, the 
limited amount of no-go trials (n=12) in the task we used, unfortunately rendered the behavioural 
data for this condition unsuitable for reliable statistical inferences about correlation to neural 
outcomes. Further, reaction times to go-dessert and go-vegetable items were not significantly 
different between the pre- and post-surgery test session. Thus, with the current data we cannot 
conclude whether the changes we find solely reflect increased exertion of neural inhibitory control 
or whether they have implications for actual behaviour. Future research including more extensive 
behavioural measures is needed to clarify the link between changes in neural and behavioural 
response inhibition in RYGB patients. However, the food specific go/no-go task does approach real-
life decision-making processes better than the passive reward tasks that have been used in previous 
research. Because of limited statistical power due to the small sample size, we have used a relatively 
lenient threshold for the fMRI analyses. We are aware that this increases the risk of false positive 
results. Nonetheless, this research provides unique additional insight in the mechanisms underlying 
the effectivity of RYGB surgery. The within-subject design provides a solid method for testing 
RYGB related changes. Moreover, unlike most previous research, measurements in this study have 
been obtained in a satiated state, to better mimic a context of overeating that has a greater ecological 
relevance in obesity. Despite high effectiveness of RYGB on weight loss and promising results 
demonstrated in a 20 year follow-up study (Sjöström, 2013), weight regain after more than one year 
post-surgery is a recurring problem in a subset of patients (Himes et al., 2015). Perhaps additional 
(cognitive) treatment focused on improving and maintaining response inhibition skills can reduce 
weight-regain after RYGB surgery. 
 
Conclusion 
After RYGB surgery, patients showed increased activation during a food specific go/no-go 
task to high-energy food cues in prefrontal brain regions implicated in inhibition. These neural 
changes after surgery indicate improved response inhibition towards high-energy food cues and 
increased influence of satiety on processing of low-energy food cues. We found altered neural 
responses during response inhibition towards both high- and low-energy food cues in reward-
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related areas, which indicate a more positive attitude towards these cues after RYGB. It is plausible 
that changes in the (re)activity of neural circuits involved in inhibitory control, satiety and reward 
processing together underlie effective weight-loss by contributing to the shift in preference and 
intake from high- to low-energy dense foods observed after RYGB. Future research should aim to 
clarify the association between the neural changes we found and actual measures of eating 
behaviour and put effort into improving effectivity of weight-loss treatment. 
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Supplementary Table 7.1. Composition of the standardized meal. 
  Men Women 
  Pre Post Pre Post 
Bread Roll (Wheat bread (±22 g/roll)) 4 pcs 2 pcs 3 pcs 1 pcs 
Margarine (Low-fat) 30 g 15 g 15 g 15 g 
Cheese (Full-fat semi-cured) 40 g 20 g 40 g 20 g 
Ham 40 g 20 g 20 g - 
Orange Juice 150 g 75 g 100 g 50 g 
kCal total meal 570 174 421 107 
 
 
Supplementary Table 7.2. Hunger ratings provided after meal intake and around 50 minutes before 
the go/no-go task commenced, before and after RYGB surgery. 
  Pre-surgery Post-surgery Significance 
Hunger 11±21 11±24 p=0.954 
Fullness 74±25 67±35 p=0.335 
Prospective consumption 25±26 8±18 p=0.051 
Desire to eat 18±19 12±23 p=0.435 
Thirst 66±27 53±29 p=0.049 
Ratings performed on a 100 point VAS. Values are means±SD   
7 
 
108 
 
related areas, which indicate a more positive attitude towards these cues after RYGB. It is plausible 
that changes in the (re)activity of neural circuits involved in inhibitory control, satiety and reward 
processing together underlie effective weight-loss by contributing to the shift in preference and 
intake from high- to low-energy dense foods observed after RYGB. Future research should aim to 
clarify the association between the neural changes we found and actual measures of eating 
behaviour and put effort into improving effectivity of weight-loss treatment. 
 
Acknowledgements 
This research was funded by Graduate School VLAG and NWO (The Netherlands Organization for 
Scientific Research), Veni grant nr. 451-11-021, awarded to SB. Further financial support was 
provided by Graduate School VLAG. The use of the 3T fMRI facility has been made possible by 
CAT-AgroFood (Shared Research Facilities Wageningen UR). We thank Lieke van Genderen, 
Louise Mulder, Monique Zwinkels and Elbrich Postma for their help during data acquisition, and 
Els Siebelink, Jose Bluemer and Annemarie Kruitwagen for their help in composing the standardized 
meals. 
 
  
109 
 
 
Supplementary Table 7.1. Composition of the standardized meal. 
  Men Women 
  Pre Post Pre Post 
Bread Roll (Wheat bread (±22 g/roll)) 4 pcs 2 pcs 3 pcs 1 pcs 
Margarine (Low-fat) 30 g 15 g 15 g 15 g 
Cheese (Full-fat semi-cured) 40 g 20 g 40 g 20 g 
Ham 40 g 20 g 20 g - 
Orange Juice 150 g 75 g 100 g 50 g 
kCal total meal 570 174 421 107 
 
 
Supplementary Table 7.2. Hunger ratings provided after meal intake and around 50 minutes before 
the go/no-go task commenced, before and after RYGB surgery. 
  Pre-surgery Post-surgery Significance 
Hunger 11±21 11±24 p=0.954 
Fullness 74±25 67±35 p=0.335 
Prospective consumption 25±26 8±18 p=0.051 
Desire to eat 18±19 12±23 p=0.435 
Thirst 66±27 53±29 p=0.049 
Ratings performed on a 100 point VAS. Values are means±SD   

General discussion
CHAPTER 8
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Food reward is a major driver of food intake. Consuming food for pleasure, mostly referred 
to as hedonic eating, can trigger overeating and thus contribute to obesity. Food reward starts at the 
sight or smell of food and fluctuates during the food intake cycle, which is often divided into an 
anticipatory, consummatory, and post-ingestive phase (Kringelbach et al., 2012). The studies 
described in this thesis focus on behavioural, sensory, physiological and neurophysiological reward 
responses across the food intake cycle. Figure 8.1, already introduced in chapter 1, provides a 
schematic overview of this cycle. The topics of the different chapters are also indicated in the figure. 
This general discussion starts with an overview of the main findings, which is followed by their 
interpretation in view of other findings. Subsequently, methodological considerations and 
translational issues are addressed. This discussion ends with suggestions for future research and main 
conclusions. 
 
 
Figure 8.2. Schematic overview of the food intake cycle (Based on Blundell et al., 2010; Kringelbach 
et al., 2012).  
 
Main findings 
To approach food reward from a behavioural perspective, food preference was used as main 
outcome measure in this thesis. To be able to measure preferences for four macronutrient and two 
taste categories, a new method had to be developed. This Macronutrient and Taste Preference 
Ranking Task (MTPRT) has been described and applied in chapter 2. It was found that food 
preferences as assessed with this method were highly correlated over two test sessions in a hungry 
condition. This shows that the MTPRT has good test-retest reliability. In addition, the MTPRT was 
found to be able to discriminate between different conditions, as shown by successful discrimination 
of sensory-specific satiety. After consumption of a sweet meal, preference for sweet foods decreased, 
and after consumption of a savoury meal preference for sweet foods increased. These results indicate 
that the MTPRT is a valid method to detect changes in food preferences. 
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The sensory and physiological perspective of food reward was addressed by studying the 
role of the endocannabinoid system (ECS). The ECS is a neuromodulatory system that plays in 
important role in food reward. We hypothesized that modulation of the ECS would alter food 
preferences and affect sensory perception with regard to sweet taste intensity perception 
(psychophysics) and liking (psychohedonics). To this end, we used cannabis preparations, and 
administered by inhalation low doses of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and 
placebo, respectively . In contrast to our hypothesis, we found that perceived sweetness intensity 
and liking did not differ between the THC, CBD and placebo conditions. These results suggest that 
modulation of the ECS with low doses of THC and CBD does not affect sweet taste intensity 
perception and liking in humans. Aiming to investigate the connection between the ECS and food 
reward from an opposite perspective, we set out to study the effect of food taste liking on the ECS. 
In chapter 4, participants were exposed to a palatable and a neutral food, but they did not know 
palatability of the food until their first bite. This enabled us to study the effect of food taste liking 
on physiological responses to food intake, and eliminate effects of prior expectations about food 
palatability. However, with the experimental set-up used endocannabinoid, ghrelin and pancreatic 
polypeptide plasma concentrations did not differ between palatable and neutral food intake across 
anticipation, consumption and post-ingestion. These results suggest that, in the absence of prior 
expectations about food palatability, food taste liking does not affect endocannabinoid plasma 
concentrations. 
The studies with patients who underwent Roux-en-Y gastric bypass (RYGB) surgery were 
intended to gain more insight into alterations in food reward. Building on previous reports, we 
hypothesized that food preferences would change after RYGB, and that this would correlate with 
changes in brain responses to food cues. Indeed, at two months and one year after RYGB surgery, 
preferences for high-carbohydrate and high-fat foods were relatively decreased compared to the 
situation before RYGB, whereas preference for low-energy foods was increased (chapter 5). Possible 
mechanisms behind these changes in food preferences include alterations in brain response to cues 
of high-energy and low-energy foods, and shifts in appetite-related hormone levels. 
In chapter 6, brain responses to pictures and odours of high-energy and low-energy foods 
were compared before and at two months after RYGB. We showed that pictures of low-energy foods 
induced less activation in the left superior frontal gyrus two months after RYGB surgery. Moreover, 
the difference in activation between pictures of high- and low-energy foods in the left precuneus 
was smaller. The smaller this difference in activation observed, the larger the decrease in preference 
for high-energy relative to low-energy foods. For low-energy food odours, we found activation in 
both the left and the right precuneus after surgery, while the right precuneus was deactivated in 
response to those odours before surgery. In addition, high-energy food odours induced less 
deactivation in the right precuneus and the left superior parietal lobule after surgery. A more 
pronounced reduction of deactivation in this latter area was correlated with a greater increase in 
preference for low-energy foods. Together, these results point to a role for changes in brain 
responses to food cues in changed food preferences after RYGB surgery. 
With regard to appetite-related hormones and other signalling molecules, we found that 
plasma concentrations of the endocannabinoid anandamide were increased following RYGB 
surgery. Plasma concentrations of other endocannabinoids and ghrelin did not change. Moreover, 
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responses to food cues in changed food preferences after RYGB surgery. 
With regard to appetite-related hormones and other signalling molecules, we found that 
plasma concentrations of the endocannabinoid anandamide were increased following RYGB 
surgery. Plasma concentrations of other endocannabinoids and ghrelin did not change. Moreover, 
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neural changes did not correlate with changes in endocannabinoids or ghrelin plasma 
concentrations. Thus, in our study we did not find evidence for a role of endocannabinoids and 
ghrelin in changed brain responses to food cues. 
To further study brain responses to food cues, changes in brain activation in response to 
inhibitory responses to high- and low-energy food pictures were studied in chapter 7. After RYGB 
surgery, activation in reward-related brain areas was decreased in response to both high- and low-
energy food pictures. Prefrontal brain areas were more activated in response to high-energy 
pictures, which might indicate increased inhibitory control. 
 
Discussion and interpretation 
The aim of this thesis was to add on to the existing knowledge on food reward. To this end, 
the phenomenon was approached from a behavioural and a (neuro)physiological perspective in 
healthy individuals and in gastric bypass populations. In this section of the thesis, the different 
results obtained will be interpreted and discussed. First, the behavioural perspective will be 
discussed with a focus on the main outcome measure used here, which was food preferences. Next, 
the learnings about the role of ECS in food reward in humans are discussed. To this end, effects of 
the pharmacological challenge with the cannabis preparations on sweet taste perception and food 
preferences will be considered first and then the physiological responses to food intake will be 
discussed. This is followed by a discussion of changed food preferences and underlying mechanisms 
following RYGB surgery. In this last section, the neurophysiological perspective is included as well. 
 
Liking ratings and desire to eat rankings 
The behavioural perspective of this thesis focussed mainly on food preferences. To be able 
to measure relative food preferences for four macronutrient and two taste categories, the MTPRT 
was designed. The MTPRT consists of a liking part, in which liking of the different foods is rated, 
and a ranking part in which arrays of four foods are presented and participants are asked to rank 
those foods on how much they desire to eat the food at that moment. This combination of liking 
ratings and desire to eat rankings is an important strength of the MTPRT, and makes that the 
MTPRT provides more information on food preferences than liking ratings or desire to eat rankings 
alone would. The ranking scores provide insight in behavioural outcomes of changed liking or 
changed preference for a specific food category (Finlayson et al., 2008). In the MTPRT, the rankings 
are used to calculate preference scores as explained in chapter 2. The rankings, and thus the 
preference scores, depend on each other in the sense that they are relative scores. If for example 
preference for high-carbohydrate foods increases, preference for high-fat, high-protein and/or low-
energy foods has to decrease. Similarly, preference for sweet foods and for savoury foods are each 
other’s opposites. Individual liking ratings, on the other hand, are independent of each other and 
changes in liking ratings for one food category do not have to result in changes for other food 
categories. If for example liking of high-carbohydrate foods increases, liking of high-fat, high-
protein and low-energy foods can remain unchanged. Individual ratings, however, can be used to 
gain more insight into the reason behind changed preference scores. An example of this can be 
found in chapter 5 of this thesis. In this chapter we showed that preference for high-carbohydrate 
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and high-fat foods was decreased at two months and one year after RYGB surgery. Moreover, 
preference for low-energy foods increased after RYGB. The changes in liking ratings for the 
different food categories provided more insight into these changes. Similar to the rankings, liking 
of high-carbohydrate and high-fat foods decreased after RYGB surgery, but changes in liking of 
low-energy foods were minimal. The changes in liking ratings suggest that the decreased preference 
for high-carbohydrate and high-fat foods leads to an increased preference for low-energy foods. 
This might explain why some, but not all, studies found increased preference for fruits and 
vegetables after RYGB surgery (Laurenius et al., 2013; Mathes and Spector, 2012; Ullrich et al., 
2013). 
 
Effects of endocannabinoid modulation on food reward in humans 
As described in the introduction, the ECS plays an important role in food reward (Jager and 
Witkamp, 2014; Piazza et al., 2017), but most evidence for this notion comes from studies in rodents. 
These studies suggest a role for the ECS in food liking, specifically for sweet taste (De Luca et al., 
2012; Higgs et al., 2003). Moreover, endocannabinoids were found to selectively modulate sweet 
taste responses (Yoshida et al., 2010). In humans, only one study assessed the effects of oral THC on 
perception of sweet, salty, sour and bitter taste, and this study found no effect (Mattes et al., 1994b). 
However, Cannabis (i.e. preparations from the Cannabis (spp.) plant) use was found to increase 
intake of sweet snacks (Foltin et al., 1988), which suggests an effect of Cannabis on sweet taste liking. 
Therefore, in chapter 3 Cannabis providing a low dose of Δ9-tetrahydrocannabinol (THC) or 
cannabidiol (CBD), and a placebo Cannabis were administered to healthy volunteers and effects of 
these pharmacological challenges on sweet taste intensity perception (psychophysics) and liking 
(phychohedonics), and on food preferences were assessed. In our study, we found no effect of low 
doses of THC or CBD on sweet taste intensity perception and liking in humans. Moreover, food 
preferences as assessed with the MTPRT did not differ between the THC, CBD and placebo 
condition. However, based on the findings in the MTPRT performed in the same study, one might 
expect to find effects of THC on preference for fat foods in humans. In the THC condition, 
preference for high-fat food was 2.6 (scale 1-4), compared with 2.4 in both the CBD and placebo 
condition, a difference of 0.2. Although this difference was not statistically significant, the effect 
size, partial η2 = 0.23, can be considered as rather large (Richardson, 2011). We think the difference 
reflects a meaningful increase in preference for fat foods in the THC condition that may become 
significant with an increased sample size. In the other two chapters of this thesis that used the 
MTPRT (chapter 2 and 5) and that included larger sample sizes, smaller differences in relative 
preference scores (ca 0.15) were found to be statistically significant and considered meaningful. 
Evidence for the role of the ECS in preference for fat foods comes from a food intake survey in 
Cannabis users that showed increased consumption of meat, cheese and salty snacks in users 
compared with non-users (Smit and Crespo, 2001). This points to a modulated preference for 
savoury high-fat foods. Importantly, evidence from animal studies also suggests a prominent role of 
the ECS in preference for fat (Di Marzo, 2011; DiPatrizio et al., 2011; DiPatrizio et al., 2013). 
Therefore, studies with larger sample sizes are merited, focussing on the role of the ECS in 
preference for fat foods in humans. 
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Endocannabinoid responses across the food intake cycle 
Next to the study into effects of ECS modulation on food reward, we also studied the effects 
of palatable versus neutral food intake on endocannabinoid plasma concentrations. At the start of 
this thesis there was one published study that suggested that anticipation of palatable food intake 
induces a response of the ECS (Monteleone et al., 2012). In chapter 4 of this thesis, it was 
investigated whether consumption of palatable food also triggers an ECS response when food 
palatability is unknown until the first bite. By keeping the participants unaware of food palatability, 
the effects of expectations were eliminated. In addition to investigating effects on the ECS, 
physiological responses across the food intake cycle were studied in this chapter. Whereas exposure 
to the food through sight and smell led to increased hunger levels and increased appetite for 
something sweet, this did not induce a physiological response; endocannabinoid, ghrelin and PP 
plasma concentrations did not change in response to the sight and smell of the food. In addition, 
palatable versus neutral food consumption did not results in differences in the endocannabinoid 
response. Together, these results suggest that expectations about food palatability are necessary to 
increase ghrelin and endocannabinoid release in response to palatable food exposure, as was found 
in other studies (Monteleone et al., 2012; Rigamonti et al., 2015). 
Our results do suggest an orexigenic role for endocannabinoids, the response comparable 
with that of ghrelin. After food intake, endocannabinoid plasma concentrations decreased (chapter 
4). This is in line with a previous study that showed a pre-prandial peak in anandamide 
concentrations and a drop after food intake (Gatta-Cherifi et al., 2012). More support comes from 
results of a rat study that showed increased endocannabinoid concentrations in brains of food-
deprived rats, and decreased concentrations during feeding (Kirkham et al., 2002). Our study design, 
in which the first blood sample was taken five minutes before food intake, was less suitable to 
investigate pre-prandial changes in endocannabinoid and ghrelin plasma concentrations. Future 
studies could look into this, for example by taking additional blood samples one hour and thirty 
minutes before food intake. 
 
Food preferences after RYGB-induced weight loss 
To gain more insight into alterations in food reward, chapters 5, 6 and 7 of this thesis 
focussed on changes in food preferences and food reward after RYGB surgery. First, in chapter 5 
food preferences were assessed before, and two and one year after RYGB surgery. It was shown that 
rankings of foods high in carbohydrate and fat became lower, indicating decreased preference for 
these foods after RYGB surgery. In addition, low-energy foods were ranked higher, reflecting higher 
preference following RYGB surgery. Liking ratings decreased for the high-carbohydrate and high-
fat foods, but did only marginally increase for the low-energy foods, which makes it likely that the 
increased preference for the low-energy foods is relative and a consequence of decreased desire to 
eat foods high in carbohydrate or fat. These results are in line with previous studies that showed 
decreased desire to eat high-energy foods with no change for low-energy foods (Miras et al., 2012; 
Ochner et al., 2012b). These results suggest that a shift towards a healthier food intake behaviour is 
mainly driven by a lower preference for high-energy foods and not by increased liking of low-
energy fruits and vegetables. 
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Mechanisms behind changed food preferences after RYGB-induced weight loss 
To explore potential mechanisms behind the changed food preferences found in chapter 5, 
we compared brain responses to food cues of high-energy and low-energy foods, and 
endocannabinoid and ghrelin plasma concentrations, before and after RYGB surgery in chapter 6, 
and response inhibition-related brain activation in chapter 7. In chapter 6 we compared neural 
responses to odours and pictures before surgery with those two months after RYGB, when 
participants were in a satiated state. Furthermore, we investigated differences in endocannabinoid 
and ghrelin plasma concentrations after a three hour fast. The changes in neural responses to food 
cues were found to be primarily located in a frontoparietal network, which is involved in cognitive 
control during (food) cue processing. Importantly, we did not find changes in activation in the 
mesolimbic system as other studies found (see e.g. Faulconbridge et al., 2016; Ochner et al., 2012b; 
Scholtz et al., 2014). A possible explanation for this is that our participants were scanned in a satiated 
state, whereas in other studies participants were hungry. A previous study that scanned participants 
in a satiated state did not find significant changes in brain activation from before to after RYGB 
surgery, possibly due to the small sample size (Ochner et al., 2012a). Together, these results suggest 
that changes in neural responses to food cues after RYGB surgery are more prominent when 
individuals are hungry. The changes in neural responses to food cues might facilitate selection of 
healthier foods (Ochner et al., 2012b).  
With respect to the endocannabinoids and ghrelin, anandamide concentrations were 
increased two months after RYGB surgery compared to those before surgery. This change did not 
correlate with neural changes, which might be a suggestion that the ECS does not play a role in 
changed neural responses to food cues, and is possibly not involved in altered food choice behaviour. 
However, more studies are necessary to be able to draw firm conclusions. An important limitation 
is also that (changes in) plasma endocannabinoid levels do not necessarily reflect events taking place 
in the brain. We did find correlations between differences in food preferences and neural changes, 
which strengthens the evidence that alterations in food preferences from before to after RYGB 
surgery are related to changes in neural processing of food cues. 
An important brain area that was found in our study in chapter 6 (neural responses to food 
cues) is the precuneus, a brain area previously implicated in decreased liking of high-energy foods 
after RYGB (Ochner et al., 2012b). In a previous study that compared neural responses to food cues 
in RYGB patients at least six months after surgery with neural responses in an obese population not 
undergoing surgery, precuneus activation was found to be higher in the nonsurgical group (Frank 
et al., 2016). In addition, resting state activity in the precuneus has been shown to be greater in 
obese versus lean individuals (Zhang et al., 2015), and to be negatively correlated with obesity 
preventive eating tendency (Nakamura and Ikuta, 2017). Taken together, the changes in precuneus 
activation from before to after RYGB surgery might relate to better impulse control and be an 
important factor in the apparently healthier food intake behaviour after RYGB surgery. 
In chapter 7 neural changes to inhibition were assessed with a food-specific go/no-go task, 
in which participants were asked to respond to one set of food stimuli and to withhold response to 
another set of food stimuli. Our behavioural data in the go/no-go task showed that participants made 
relatively few mistakes before surgery, resulting in a ceiling effect with no room for significant 
improvement. A more difficult task could have provided more insight into functional outcomes of 
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the neural changes that we found. A previous study that compared good and bad responders to 
RYGB at 9-15 years after RYGB surgery showed that the bad responders performed worse in food-
related paradigms that require impulse control (Hogenkamp et al., 2015). Moreover, better 
inhibition was shown to be related to increased weight loss at six months after RYGB surgery 
(Kulendran et al., 2017). Taken together, being able to resist impulses and execute response 
inhibition are factors in successful weight management after RYGB surgery. 
 
Methodological considerations 
In this section some methodological considerations regarding the studies described in this 
thesis are discussed. First, the relevance of food preferences as measured with the MTPRT is 
discussed. Then considerations regarding the study populations are elaborated upon; sex differences 
in the effects of the Cannabis challenge on sweet taste perception, and the study population in the 
RYGB-studies are discussed. Finally, considerations regarding hunger state in the study of food 
reward are discussed. 
 
Macronutrient and taste preference ranking task 
Measurement of food preferences instead of actual food choice. In the MTPRT, participants 
rank food products that differ in macronutrient content (carbohydrate, fat, protein and low-energy) 
and taste (sweet and savoury) according to what they desire to eat at that moment. The rankings are 
then used to calculate preference scores for the different macronutrient and taste categories. The 
MTPRT has been shown to be a reliable and valid method to assess food preference in a behavioural 
experiment, but it is important to note that food choices as made in the MTPRT have not yet been 
compared with actual food choices. It therefore remains to be determined to what extent the 
MTPRT reflects actual behaviour. Based on previous studies that found strong correlations between 
choices in a forced-choice procedure and actual intake (Griffioen-Roose et al., 2010; Griffioen-Roose 
et al., 2011), we expect that rankings in the MTRPT correlate with actual food intake behaviour. 
Importantly, the MTPRT is the first food preference task that uses a ranking procedure to assess 
food preferences for four macronutrient and two taste categories. As for the studies described in 
chapter 3 (effect of cannabis challenge on food preferences) and chapter 5 (food preferences after 
RYGB surgery) we were specifically interested to include a broad range of food categories. 
Therefore, we considered the MTPRT to be the most suitable method to measure food preferences.  
 
Study population 
Males versus females. The study that focused on the role of the ECS in sweet taste perception 
(chapter 3) included only male participants. It has been shown that endocannabinoid pharmacology 
differs between males and females (Craft et al., 2013; Diaz et al., 2009), with males being more 
susceptible to increasing their food intake, and females being more responsive to feelings of 
depression and anxiety (Fattore and Fratta, 2010). In animals, males were found to be more sensitive 
to the appetite-modulation properties of cannabinoid administration than females (Diaz et al., 2009). 
If there would be an effect of low doses of THC and CBD on sweet taste perception, we would have 
expected to find this effect in our male study population. 
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Gastric bypass patients. The studies in gastric bypass patients (chapters 5, 6 and 7) did not 
include a control group that underwent another type of gastric bypass like vertical sleeve 
gastrectomy, or was exposed to a dietary weight-loss intervention. It is therefore not possible to say 
whether the changes in food preference and neural processing of food cues we found are specific 
for the RYGB patient group, or whether similar changes occur after other types of gastric bypass 
surgery or behavioural weight loss methods. The within-subjects design enabled us to gain more 
insight into alterations in food reward after weight loss and strengthened the evidence for the notion 
that altered food preferences after RYGB are related to changes in neural responses to food cues. 
 
Hunger state 
It is important to consider hunger state in the study of (palatable) food intake and food 
reward. Even though so-called homeostatic eating has a hedonic component, it has been argued that 
participants should feel satiated to be able to study hedonic eating (Monteleone et al., 2012). That is 
the reason why, in both chapter 4 and chapter 6, we provided participants with a standardized meal 
to satiate them before studying palatable versus neutral food intake, and food reward. In chapter 4, 
this was performed following the design of Monteleone and colleagues (2012), and other studies 
have followed this design (Monteleone et al., 2016; Rigamonti et al., 2015). Participants were 
provided with a standard breakfast before they were asked to consume the palatable or the neutral 
food. 
The inclusion of satiated participants is less common in the study of (changes in) food reward 
in RYGB patients. Most other studies that assessed changes in food reward processing in gastric 
bypass patients scanned participants in a hungry state (see e.g. Faulconbridge et al., 2016; Ochner et 
al., 2012b; Scholtz et al., 2014), whereas in our study (chapter 6), participants were satiated. To our 
knowledge, one other study also included participants in a fed state, but this study did not find any 
differences when comparing pre- to postsurgery. This is possibly due to the small sample size (n=5) 
(Ochner et al., 2012a). The comparison of our results with results described in literature suggests 
that changes in brain reward responses from before to after RYGB surgery depend on hunger state. 
More studies that include participants in a satiated state or that compare neural responses of 
participants in a hungry versus a satiated state are needed to obtain more conclusive insights on 
these differences and their relation with changes in food preferences. 
 
Translational issues 
As mentioned before in this general discussion, most evidence for the role of the ECS in 
food reward comes from animal studies. In this thesis, it was tried to translate some of these findings 
to the human situation. Some issues related to translating methodology from animal to human 
studies are discussed in the following section. First, the use of pharmacological challenges to 
modulate the ECS in human studies is elaborated upon, followed by discussion of the relevance of 
plasma endocannabinoid concentrations. 
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Pharmacological challenge 
Modulating the ECS with pharmacological compounds is a challenge in humans, especially 
when it comes to inhibiting the ECS. Different compounds are available for use in animal studies, 
e.g., AM 251 and rimonabant (Pertwee, 2006), but these are not approved for use in humans. In this 
thesis, cannabidiol (CBD) was used aiming to inhibit the ECS. However, the pharmacodynamic 
properties of CBD are not completely understood (Ligresti et al., 2016; McPartland et al., 2015; 
Pertwee, 2008). CBD displays a wide spectrum of activities on various molecular targets and 
produces multiple pharmacological effects. It is therefore considered to be more of a multiple-target 
molecule than a classical cannabinoid (Ligresti et al., 2016; Pertwee, 2008). However, CBD has been 
suggested to antagonize the ECS via CB1 (Pertwee, 2008) and some animal studies, but not all, found 
decreased food intake upon CBD administration (Farrimond et al., 2012; Ligresti et al., 2016; 
Wierucka-Rybak et al., 2014; Wiley et al., 2005). The design of the study described in chapter 3 
(cannabis challenge) benefited from administering not only an agonist, THC, but also a potential 
antagonist. In this way, the effects of ECS activation and inhibition could be studied and this might 
provide more insight into the role of the ECS in sweet taste intensity perception and liking than 
ECS activation alone. As options for CB1 antagonists for human use are limited, we decided to 
include CBD. 
Another issue to consider it the use of Cannabis plant material, which is a mixture of 
compounds (McPartland et al., 2015), compared with pure compounds. With a pure compound, it 
is clear what is administered allowing to directly link this to the effects observed. Using a mixture 
of compounds, this is not so clear. However, the placebo Cannabis that was used in chapter 3 of this 
thesis had identical moisture and terpenoid profile to the active Cannabis, and thus taste and smell 
experiences were similar (Kowal et al., 2015). Thus, the only difference between active and placebo 
Cannabis was the presence of the active compound under study. Moreover, we showed successful 
blinding, as only one out of the ten participants could convincingly and correctly identify the THC 
condition. If we would have used pure THC, this number would most likely have been higher (Van 
Hell et al., 2011). 
 
What is the relevance of plasma endocannabinoids? 
Evidence from animal studies suggests that endocannabinoid activity in different brain areas 
relates to food intake behaviour (see e.g. Kirkham et al., 2002) and that the ECS in the gut plays a 
role in fat intake (see e.g. DiPatrizio et al., 2011). To translate these findings to humans is 
complicated. In human studies, often plasma or serum samples are used to assess endocannabinoid 
concentrations. However, the source and role of blood endocannabinoids are at present unclear. It 
has been suggested that endocannabinoids in the blood stream are the result of spill-over from other 
organs, like the brain and gut, but further research is necessary to gain more insight into this. One 
important factor to consider is that endocannabinoids are formed and released on demand, rather 
than stored in vesicles in the cell (Di Marzo et al., 2009). This suggests that increased plasma 
concentrations reflect increased endocannabinoid formation but delay-effects and degradation may 
play a role. 
Even though we do not know the exact source and role of blood endocannabinoids, they 
have been found to be related to weight status (Engeli et al., 2005), and olfactory function (Pastor 
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et al., 2016), and to respond to challenges like food intake (Monteleone et al., 2012) and negative 
mood induction (Schrieks et al., 2015). These findings suggest that blood endocannabinoids are a 
relevant source of information about functioning of the endocannabinoid system, and in humans 
they are the best option to study physiological responses of the ECS.  
 
Suggestions for future research 
The results of this thesis answered questions regarding food reward, but they also gave rise 
to new questions. Therefore, suggestions for future research are discussed in the following section. 
As for the ‘discussion and interpretation’-section, this section will follow the line of the chapters. 
First, food preferences are discussed, followed by the role of the ECS in food reward. Finally, 
suggestions for research into obesity and weight-loss interventions such as RYGB are provided. 
 
Measurements of food preferences: predictor of food choice? 
As mentioned in the methodological considerations, it is unknown to what extent food 
preferences as measured with the MTPRT relate to actual food choice. To be able to use the MTPRT 
as a predictor of actual eating behaviour, it should first be determined whether food preference 
scores as assessed with the MTPRT indeed predict actual food choice, for example in a buffet setting. 
It would be of interest to compare different experimental conditions, by including differences in 
hunger state (hungry versus satiated) or taste of a previous meal (sweet or savoury). By including 
these different conditions, it is not only possible to relate food choice in the MTPRT to actual food 
choice, but changes in food preference scores as assessed with the MTPRT can also be related to 
changes in actual food choice. 
 
Endocannabinoid responses to food exposure during the day 
Over the past years, it has been established that anticipation of palatable food intake induced 
a rise in endocannabinoid plasma concentrations (Monteleone et al., 2012; Rigamonti et al., 2015). 
In chapter 4, we showed that endocannabinoid plasma concentrations decrease after food intake. 
Previously, it has been shown that endocannabinoids follow a circadian rhythm (Vaughn et al., 
2010). For example, 2-AG concentrations increase throughout the morning, reaching a maximum 
early afternoon, and decrease during the late afternoon and evening, to a minimum during the night 
(Hanlon et al., 2015). This pattern was not disturbed by food intake. Importantly, participants 
received standardized meals that were not highly palatable. In other studies, palatable foods were 
shown to increase 2-AG concentrations (Monteleone et al., 2012; Rigamonti et al., 2015). It would 
therefore be interesting to assess the effect of palatable food intake on circadian endocannabinoid 
patterns. As exposure to palatable foods modulates endocannabinoid concentrations, we would 
expect that it also modulates the circadian pattern of endocannabinoids, possibly by increasing 
endocannabinoid concentrations. Increased endocannabinoid concentrations might in turn increase 
food intake and lead to overeating. It would be interesting for future studies to relate (changes in) 
endocannabinoid concentrations to feelings of hunger and food intake, and possibly to overeating 
and obesity. 
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The hyperactive endocannabinoid system in obesity 
Animal studies have provided evidence for increased endocannabinoid concentrations in 
response to food. Orosensory exposure to fat increases anandamide and 2-AG concentrations in the 
rat jejunum (DiPatrizio et al., 2011; DiPatrizio et al., 2013), and infusion of a CB1 antagonist in the 
intestine decreased ad libitum sham intake of fat (DiPatrizio et al., 2011) and reduced preference for 
specific fatty acids (DiPatrizio et al., 2013). Similarly, a high-fat diet increases anandamide and 2-
AG concentrations in plasma and jejunum in mice. Moreover a high-fat diet induces overeating and 
body weight gain in these mice, possibly through overactivation of the ECS (Argueta and DiPatrizio, 
2017). 
Higher endocannabinoid concentrations have been found in obese compared with lean 
individuals (Bluher et al., 2006; Engeli et al., 2005), but is unknown whether this is a cause or an 
effect of obesity. It is also unknown what the functional consequences of these increased 
endocannabinoid concentrations are. Ideally, long-term follow-up of a large cohort could provide 
more insight into these questions, but that is an expensive and time-consuming method. In a more 
realisitic study design, changes in endocannabinoid tone during weight gain could be studied in an 
animal model. Furthermore, differences in endocannabinoid responses across the food intake cycle 
between lean, overweight and obese individuals can be studied. 
 
The endocannabinoid system after weight loss 
As mentioned before, it is not known whether increased endocannabinoid tone in obesity 
is a cause or an effect. Similarly, the number of studies that assessed the effect of weight loss on 
endocannabinoid tone is limited and findings are contradicting. In chapter 5 of this thesis, we have 
shown increased anandamide concentrations two months after RYGB surgery, which corresponds 
to ca 10% weight loss. Other studies showed decreased anandamide and PEA concentrations one 
year after RYGB (Montecucco et al., 2015) or no change in endocannabinoid concentrations at six 
months or two years after RYGB (Mallipedhi et al., 2015; Quercioli et al., 2013). Importantly, 
contradicting results have also been found in weight loss trials, with some studies that did not find 
differences in endocannabinoid concentrations (Engeli et al., 2005; Engeli et al., 2008), and others 
that found decreased 2-AG and anandamide concentrations (Di Marzo et al., 2008) or increased PEA 
concentrations (Abdulnour et al., 2014). These discrepancies can be related to differences in the 
duration of the weight loss intervention, which also relates to how fast weight is lost over time, and 
warrant further investigations. 
 
Weight loss through RYGB versus dietary intervention 
As mentioned in the methodological considerations, our studies in RYGB did not have a 
control group. For future studies it would be advisable to compare weight loss after RYGB surgery 
with behavioural weight loss methods or other types of weight loss surgeries, as some studies have 
also done (Bruce et al., 2014; Faulconbridge et al., 2016; Primeaux et al., 2015). This will help 
identify changes in food reward specifically related to RYGB, and not to other surgical or 
behavioural weight loss interventions. As RYGB is the most successful method to lose weight 
(Buchwald et al., 2004; Gloy et al., 2013), these differences might guide the development of a 
successful non-surgical weight loss intervention. 
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Another point of interest is time of follow-up. Meta-analyses of weight loss outcomes of 
RYGB indicate that patients start to regain some weight after eighteen to twenty-four months 
(Buchwald et al., 2004; Gloy et al., 2013). In this thesis, food preferences were assessed up to twelve 
months and changes in neural responses to food cues was only assessed at two months after RYG 
surgery. It would be interesting to include a longer follow-up as to be able to identify potential 
reversal of food preferences or food reward processing to the before-surgery situation and a possible 
relation between reversal and weight gain.  
 
Conclusions 
Modulation of the endocannabinoid system with low doses of THC and CBD does not 
influence sweet taste intensity perception and liking and food preferences. Vice versa, food 
palatability in the absence of expectations does not affect endocannabinoid responses to food intake. 
RYGB surgery induces a decreased preference for high-carbohydrate and high-fat foods, and 
increased preference for low-energy foods, which is related to altered brain reward processing, but 
not to changes in endocannabinoid tone. The success of RYGB surgery and the changes in food 
choice might in part be caused by an improved inhibitory response to high-energy foods. 
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endocannabinoids and ghrelin did not change. Moreover, changes in endocannabinoid or ghrelin 
concentrations did not correlate with changes in food preferences or neural response to food cues. 
Together, these results suggest that changes in neural processing of food cues contribute to changes 
in food preferences towards low-energy foods, and provide a first indication that the 
endocannabinoid system does not seem to play a role in this process.  
To gain more insight into behavioural responses to food cues, a response-inhibition 
paradigm was used in chapter 7, in which response-inhibition to high-energy and low-energy food 
cues was assessed during brain imaging. The behavioural data did not show differences in 
performance when comparing before and two months after RYGB surgery. The brain imaging data 
showed that activation in reward-related brain areas was decreased in response to both high- and 
low-energy food pictures after RYGB surgery. Also, prefrontal brain areas were more activated in 
response to the high-energy pictures, which suggests improved response inhibition. 
In conclusion, the findings in this thesis show that modulating the ECS with low doses of 
THC and CBD does not influence sweet taste perception and liking and food preferences, and vice 
versa, food taste liking in the absence of expectations does not affect endocannabinoid responses to 
food intake. With regards to RYGB surgery it was uncovered that changes in food preferences after 
RYGB surgery are related to altered brain reward processing, but no relation with changes in 
endocannabinoid tone was found. The success of RYGB surgery and the changes in food choice 
might in part be caused by an improved inhibitory response to high-energy foods. 
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Summary 
Food reward is an important driver of food intake and triggers consumption of foods for 
pleasure, so-called hedonic eating, even in the absence of any energy deficits. Hedonic eating can 
trigger overeating and may therefore lead to obesity. Given the rise in obesity rates and the health 
risks associated with being obese, hedonic eating and food reward are important phenomena to 
study. This thesis aimed to add on to the existing knowledge on food reward. The phenomenon was 
approached from a behavioural, sensory and (neuro)physiological perspective in healthy, lean and 
in obese gastric bypass populations. 
For the behavioural perspective, the main outcome measure used in this thesis was food 
preferences. To be able to study food preferences for four macronutrient and two taste categories, a 
new food preference task was developed. In chapter 2, the development and validation of the 
Macronutrient and Taste Preference Ranking Task (MTPRT) were described. The MTPRT uses a 
ranking method to determine preferences for four macronutrient (high-carbohydrate, high-fat, 
high-protein, low-energy) and two taste (sweet and savoury) categories. 
For the sensory and physiological perspective, focus was put on the endocannabinoid system 
(ECS): a neuromodulatory system that plays a role in food reward. To gain more insight into this 
role, the effect of ECS modulation with pharmacological challenges on sensory perception of sweet 
taste and on food preferences were studied, as well as endocannabinoid responses to food intake. In 
chapter 3 it was shown that inhaling Cannabis with low doses of Δ9-tetrahydrocannabinol (THC) 
and cannabidiol (CBD) does not alter sweet taste intensity perception and liking in humans, nor 
does it affect food preferences. Vice versa, in chapter 4 it was found that liking of a food taste does 
not affect endocannabinoid responses to food intake, after controlling for expectations. When 
palatability of the food is unknown until the first bite, response of endocannabinoids, ghrelin and 
pancreatic polypeptide did not differ between a palatable and a neutral food across anticipatory, 
consummatory and post-ingestive phases of food intake. Endocannabinoid and ghrelin plasma 
concentrations decreased after food intake, which suggests an orexigenic function for 
endocannabinoids. 
In chapters 5, 6 and 7, studies with patients who underwent Roux-en-Y gastric bypass 
surgery were described. These studies were intended to gain more insight into alterations in food 
reward in relation to (morbid) obesity and in response to surgical treatment by RYGB surgery.  
First, in chapter 5 food preferences were assessed before, and at two months and one year 
after RYGB. It was shown that patients have decreased preference for high-carbohydrate and high-
fat foods, and increased preference for low-energy foods after compared with before surgery. In 
addition, liking ratings for the high-carbohydrate and high-fat foods were decreased after RYGB 
surgery, whereas liking of low-energy products changed minimally. Potential mechanisms behind 
these alterations in food preferences include changes in neural processing of food cues and changes 
in appetite-related gut hormones.  
In chapter 6, it was shown that alterations in food preferences after RYGB surgery are 
indeed related to changes in neural activation in response to food cues. With regards to the appetite-
related hormones it was shown that plasma concentrations of the endocannabinoid anandamide 
were increased after compared with before surgery. Plasma concentrations of other 
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Samenvatting in het Nederlands 
De belonende waarde van voedsel is een belangrijke motivatie voor voedselinname. Deze 
beloning leidt tot eten omdat het lekker is - zogenaamd hedonisch eten - zelfs als er geen 
energietekort is. Hedonisch eten kan leiden tot overeten, wat obesitas tot gevolg kan hebben. Gezien 
de toename in obesitas en de gezondheidsrisico’s die met obesitas geassocieerd zijn, is het belangrijk 
om onderzoek te doen naar hedonisch eten en voedselbeloning. Deze thesis had als doel om bij te 
dragen aan de kennis over voedselbeloning. Dit fenomeen is benaderd vanuit een gedrags-, 
sensorisch en (neuro)fysiologisch perspectief in gezonde, dunne en in obese bariatrische chirurgie 
populaties. 
Voor het gedragsperspectief waren voedselvoorkeuren de belangrijkste uitkomstmaat. Om 
voedselvoorkeuren voor vier macronutriënten en twee smaken te kunnen meten is tijdens dit 
project een nieuwe methode ontwikkeld. In hoofdstuk 2 is de ontwikkeling en validatie van de 
Macronutrient and Taste Preference Ranking Task (MTPRT; Nederlands: macronutriënt- en 
smaakvoorkeurrankingtaak) beschreven. De MTPRT gebruikt een rankingmethode om voorkeuren 
voor vier macronutriënten (hoog-koolhydraat, hoog-vet, hoog-eiwit, en laag-energie) en twee 
smaken (zoet en hartig) te meten. 
Voor het sensorische en het fysiologische perspectief lag de focus op het endocannabinoïde 
systeem (ECS): een belangrijk biologisch systeem dat een rol speelt bij voedselbeloning. Om meer 
inzicht in deze rol te krijgen is tijdens dit project gekeken naar zowel het effect van farmacologische 
modulatie van het ECS op sensorische perceptie van zoete smaak, en op voedselvoorkeuren, als naar 
de endocannabinoïde reactie op voedselinname. Hoofdstuk 3 laat zien dat het inhaleren van 
Cannabis met lage doseringen THC en cannabidiol geen effect heeft op de waarneming van zoete 
smaakintensiteit en het lekker vinden van zoete smaak, en ook niet op voedselvoorkeuren. 
Andersom, in hoofdstuk 4 blijkt dat het lekker vinden van een voedingsmiddel geen effect heeft op 
de reactie van endocannabinoïden op voedselinname, als gecontroleerd wordt voor verwachtingen. 
Als onbekend is hoe lekker het voedingsmiddel is tot de eerste hap wordt genomen, dan is er geen 
verschil in de reactie van endocannabinoïden, ghreline en pancreatisch polypeptide op een lekker 
of een neutraal voedingsmiddel tijdens anticipatie, consumptie en post-ingestive fasen van 
voedselinname. Plasmaconcentraties van endocannabinoïden en ghreline daalden na 
voedselinname, wat duidt op een hongeropwekkende functie voor endocannabinoïden. 
In hoofdstukken 5, 6 en 7 worden studies beschreven met patiënten die een Roux-en-Y 
gastric bypass (RYGB) operatie ondergaan. De bedoeling van deze studies is om meer inzicht te 
krijgen in veranderingen in voedselbeloning in relatie tot (morbide) obesitas en in reactie op 
chirurgische behandeling door RYGB operatie. 
Eerst zijn in hoofdstuk 5 voedselvoorkeuren gemeten op twee weken voor, twee maanden 
na en een jaar na de operatie. Na de operatie hebben patiënten een verminderde voorkeur voor 
hoog-koolhydraat en hoog-vet voedingsmiddelen, en een verhoogde voorkeur voor laag-energie 
voedingsmiddelen in vergelijking met voor de operatie. Daarnaast worden de hoog-koolhydraat en 
hoog-vet voedingsmiddelen na de operatie minder lekker gevonden, terwijl het lekker vinden van 
de laag-energie voedingsmiddelen minimaal veranderde. Mogelijke mechanismen achter de 
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veranderingen in voedselvoorkeuren zijn veranderingen in neurale verwerking van voedselcues en 
veranderingen in honger-gerelateerde darmhormonen. 
Hoofdstuk 6 toont aan dat veranderingen in voedselvoorkeuren inderdaad gerelateerd zijn 
aan veranderingen in neurale activatie in reactie op voedselcues. Wat betreft de honger-gerelateerde 
darmhormonen is aangetoond dat de plasmaconcentratie van de endocannabinoïde anandamide na 
operatie hoger was dan voor de operatie. Plasmaconcentraties van andere endocannabinoïden en 
ghreline veranderden niet. Veranderingen in plasmaconcentraties van endocannabinoïden en 
ghreline correleerden niet met veranderingen in voedselvoorkeuren of neurale reacties op 
voedingscues. Samengenomen suggereren deze resultaten dat veranderingen in neurale verwerking 
van voedselcues bijdragen aan veranderingen in voedselvoorkeuren richting laag-energie 
voedingsmiddelen, en ze zijn een eerste indicatie dat het ECS geen rol speelt in dit proces. 
Om meer inzicht te krijgen in de gedragsreactie op voedselcues is in hoofdstuk 7 een reactie-
inhibitie paradigma gebruikt. Neurale activatie tijdens reactie-inhibitie op hoog-energie en laag-
energie voedselcues is gemeten. De gedragsdata liet geen verschil zien in prestatie voor operatie en 
twee maanden na operatie. The hersendata liet zien dat activatie in beloningsgerelateerde 
hersengebieden na operatie is verlaagd in reactie op zowel hoog-energie als laag-energie 
voedselcues. Daarnaast zijn prefrontale hersengebieden meer geactiveerd in reactie op hoog-energie 
voedselcues na operatie in vergelijking met voor operatie. Dit wijst op verbeterde reactie-inhibitie. 
In conclusie: de bevindingen in deze thesis laten zien dat het moduleren van het ECS met 
lage doseringen THC en CBD geen invloed heeft op de waarneming en het lekker vinden van zoete 
smaak, en op voedselvoorkeuren. Andersom, de aangenaamheid van voedselsmaak in afwezigheid 
van verwachtingen heeft geen invloed op de endocannabinoïde reactie op voedselinname. Met 
betrekking tot bariatrische chirurgie is aangetoond dat veranderingen in voedselvoorkeuren 
gerelateerd zijn aan veranderingen in verwerking van beloning in het brein, maar niet aan 
veranderingen in endocannabinoïden. Het succes van RYGB operatie en de veranderingen in 
voedselkeuze kunnen gedeeltelijk veroorzaakt worden door verbeterde reactie-inhibitie op hoog-
energie voedsel.  
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